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Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, affects over 33 million 
people worldwide. Catheter ablation (CA) has become a first-line treatment for drug-refractory 
AF and is particularly effective in paroxysmal AF patients in the early stages of the disease. 
However, CA has high recurrence rates in patients with chronic forms of the disease. This is 
due to the empirical nature of the procedure and lack of mechanistic knowledge of optimal 
ablation sites and strategies in these patients, whose atria is altered by AF-induced electrical 
and structural remodelling. The purpose of the work presented in this thesis is to investigate the 
influence of patient-specific atrial structure on electrophysiological function, specifically the 
dynamics of re-entrant drivers (RDs) of AF, and to establish a mechanistic link between the 
atrial structure and location of RDs. Establishing such a link would allow for non-invasive 
identification of the RD locations, which could ultimately guide CA in chronic AF patients.  
The first part of the study focused on atrial wall thickness (AWT) and to a lesser extent on atrial 
fibrosis, both of which can be reconstructed from medical imaging data and have been linked 
to atrial structural remodelling underlying the progression of AF. The effect of the atrial 
structure was investigated using two sets of computational models: 1) a simple model of an 
atrial slab with a step-change in AWT and a synthetic fibrotic patch, and 2) patient-specific 
atrial models with geometry and fibrosis reconstructed from magnetic resonance imaging 
(MRI) of 6 AF patients. The simple atrial slab model demonstrated that RDs drift towards and 
then along the AWT step. Furthermore, in the presence of a fibrotic tissue patch near the step, 
the RDs were attracted to the patch, and the ultimate RD location was determined by both 
fibrosis and AWT. In patient-specific 3D atrial models, the behaviour of the RDs was governed 
by the interaction between AWT and fibrosis in the right atrium (RA), owing to its trabecular 
structure with large AWT gradients. In the left atrium (LA) with more uniform AWT, the 
extensive fibrosis distribution played a more prominent role in influencing the RD dynamics.  
 
Abstract    
 
 
In the following part, RD locations in LA were investigated by: 1) developing image-based 3D 
atrial models from patient MRI data, 2) applying the models to dissect the mechanistic links 
between atrial structure and the RD dynamics and 3) using the modelling outcomes to quantify 
the ultimate patient-specific RD locations. Simulations in the patient-specific models revealed 
that the RD dynamics were strongly influenced by the amount and spatial distribution of fibrotic 
tissue. RDs were typically found at fibrotic regions in AF patients from Utah 3 and 4 categories 
with high fibrotic burden (>25%), but more often near the pulmonary veins (PVs) in patients 
from Utah 2 category. The RDs anchored to specific, relatively small regions, labelled as target 
areas, with a high percentage of target areas located within the fibrotic tissue region in patients 
from Utah 3 and 4 categories. The patient-specific target areas showed that areas that harboured 
the RDs were much smaller than the entire fibrotic areas, indicating potential targets for therapy. 
Finally, CA strategies based on the knowledge of target areas were evaluated in-silico to 
terminate RDs efficiently. Ablation strategies that connected the target areas with linear lesions 
to the PVs or the mitral valve have superior anti-fibrillatory effect compared to ablating the 
target areas alone, as well as compared to clinically applied strategies such as the PV isolation. 
Thus, the novel image-based modelling workflow presented in this thesis has been applied to 
dissect multiple effects of atrial structure on the genesis of RDs, providing a deeper 
understanding of the mechanisms of AF sustenance and paving the way to designing patient-
specific CA treatments.
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Chapter 1  
Introduction 
1.1 Motivation and Aims 
Atrial fibrillation (AF), the most common sustained cardiac arrhythmia [1], is characterised by 
rapid and irregular activations of the upper chambers of the heart [2]. This disrupts the 
coordinated contraction of the atrial chambers, and as a result, AF patient suffers from 
significantly decreased cardiac output, which leads to morbidity and poor quality of life and 
requires long term medical treatment. Moreover, AF is associated with a 5-fold increase in the 
risk of stroke [3] and is independently associated with a two-fold increase in all-cause mortality, 
as well as with increased risks of heart failure and cognitive impairment [4]. AF affects about 
33.5 million people worldwide, and its prevalence is predicted to rise progressively over the 
coming decades, bringing with it the increased burden of high morbidity and mortality of  the 
affected population [5].  
Catheter ablation (CA) is a well-established clinical therapy for the restoration of normal sinus 
rhythm in AF patients who do not respond well to anti-arrhythmic drugs, with success rates of 
up to 70% in patients with episodes of AF lasting less than 1 week (paroxysmal AF). The widely 
accepted CA strategy is the electrical isolation of pulmonary vein (PV) sleeves in the left atrium 
(LA), which are believed to be the primary substrate for the generation of the ectopic electrical 
impulses and/or anchoring of re-entrant drivers (RDs) responsible for triggering and sustaining 
AF [6–10]. However, approximately 30% of AF patients are asymptomatic, which leads to 
delayed diagnosis and the development of persistent AF lasting for months and years. In these 
patients, the success rate of CA drops to about 40% [11], and their therapy often requires 
repeated ablation procedures. A potential factor for the low efficacy of CA in these patients is 
the presence of high degrees of electrophysiological and structural remodelling, which alters 
the AF substrate, making the underlying electrical dynamics more complex and the drivers more 
difficult to locate and eliminate. Understanding the mechanisms behind the AF drivers and 
quantifying their locations, and thus changing the focus of CA strategies from anatomy-based 
Chapter 1: Thesis Overview   | 20 
 
 
targets (such as the PVs) to patient-specific functional targets (such as the RDs themselves), 
could lead to significant improvement of the efficiency of CA therapy. 
In recent years, advances in catheter and electro-anatomic mapping technologies have enabled 
the development of more patient-specific CA strategies that complement standard approaches 
in persistent AF patients, by targeting either the AF drivers or the underlying substrate for AF 
maintenance. However, such techniques are limited by the challenges of invasive mapping and 
visualising electrical activity on the surface of the fibrillating atria with sufficiently high 
resolution. Moreover, they don’t contribute to the mechanistic understanding of the AF drivers. 
Therefore, the success rates of such enhanced CA strategies remain suboptimal.  
With the advancement of novel imaging tools, the paradigm is shifting towards non-invasive 
identification of patient-specific regions where the atrial substrate can be arrhythmogenic 
[12,13]. The novel imaging data also facilitates the development of patient-specific biophysical 
models that can be used for both elucidating the mechanisms of AF drivers and identifying their 
locations. Such image-based models have been successfully applied for investigating 
physiological and pathological factors that contribute to cardiac arrhythmogenesis [12–16]. 
The goal of this dissertation is to apply image-based computational modelling of the atria to 
explore the mechanisms of RDs sustaining AF, and thus identify patient-specific RD locations 
that can be targeted by CA therapy. This is achieved by designing a series of studies that focus 
on specific structural features of the atria, which can be quantified from patient imaging. Such 
features include the atrial wall thickness (AWT) and fibrosis, both of which can be quantified 
from magnetic resonance imaging (MRI) and integrated into the patient-specific 3D atrial 
models. The models then enable the investigation of the mechanistic influence of such features 
on the dynamics of RDs and their ultimate locations in a given patient. Hence, the models will 
help generate personalised targets for CA, primarily focusing on RDs in LA. Ultimately, this 
will create an image-based computational platform for guiding CA therapy in AF patients.  
1.2 Thesis Overview 
The thesis is organised into 6 Chapters, and an outline of the structure is presented below.  
Chapter 2 provides the necessary background to the interdisciplinary work presented in the 
following chapters. First, the basic principles of cardiac anatomy and electrophysiology are 
introduced. The mechanisms underlying cardiac arrhythmias, AF in particular, are then 
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discussed, along with the existing treatment options and related challenges. Finally, the theory 
behind cardiac electrophysiology is outlined, methods used for the construction of biophysical 
cardiac models are summarised, and the contribution of modelling and simulation to exploring 
AF is highlighted. 
Chapter 3 describes the investigation of the effects of AWT gradients on the dynamics of RDs 
and compares these effects to other known structural influences, such as those of atrial fibrosis. 
In this proof-of-concept study, all the simulations are performed using a simple 3D slab 
representation of the LA wall, allowing us to gain insights into mechanistic links between AWT 
and the dynamics of RDs. 
Chapter 4 builds upon the investigation presented in Chapter 3, extending it to realistic 3D 
atrial geometries created using imaging data from AF patients. In addition to exploring the 
effects of patient-specific AWT gradients on the atrial RD dynamics, the comparative effects 
of such gradients and patient-specific fibrosis distribution on the RDs are evaluated. Thus, the 
influence of several structural factors on the RD localisation in the atrial is explored. 
Chapter 5 focuses on the in-depth investigation of the effects of fibrosis on the RD dynamics 
in patient-specific LA models. Here a semi-automated image-based computational pipeline is 
created to construct patient-specific LA models from late gadolinium enhanced (LGE) MR 
images and then apply the model simulations to generate patient-specific maps of RD locations. 
Such maps could provide personalised targets areas for guiding CA. 
Chapter 6 uses the imaged-based model predictions of the previous chapter and utilises the 
predicted patient-specific target areas to perform virtual ablation, specifically applying the CA 
lesions to the target areas. Success rates of such image-based modelling-guided CA are 
compared to the success of virtual ablations that are based on existing clinical CA strategies. 
Besides, the sensitivity of this approach to the image-processing and modelling steps is 
investigated. 
Chapter 7 summarises the main conclusions of each chapter and links them together. 
Moreover, it outlines the clinical implications of this work and future directions. 
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Chapter 2  
Background  
2.1 Section Outline 
The chapter aims to provide the biomedical and mathematical background needed to understand 
the work presented in the following chapters. In Section 2.2 and 2.3, details of cardiac anatomy 
and electrophysiology relevant to atrial fibrillation (AF) are presented. In Section 0, the 
mechanisms underlying cardiac arrhythmias, AF in particular, are discussed along with the 
existing treatment options and related challenges. Section 2.5 presents the mathematical 
background behind cardiac electrophysiology, computational modelling and simulation 
techniques for AF.  
 
Figure 2.1: The position of the heart in the body, adapted from [17]. 
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2.2 The Cardiovascular System 
The heart is the mechanical pump of the body. Together with the network of blood vessels, it 
constitutes the cardiovascular system, which is responsible for the delivery of nutrients, 
electrolytes, dissolved gasses and waste products to the entire body and lungs. On average, the 
heart pumps approximately 7,000 L of blood every day and contracts about 2.5 billion times 
over its lifetime [18]. It has become one of the most studied organs, because of its crucial 
importance for the normal function of the body and the increasing morbidity and death rates 
linked to cardiac diseases. The following sections will provide a brief overview of cardiac 
anatomy and physiology, whereas more comprehensive details can be found in books [17]. 
 
Figure 2.2: The gross anatomy of the heart and the cardiovascular system. (A) Schematic image of the structure of 
the heart with white arrows indicating the direction of blood flow through the 4 chambers [19]. (B) Schematic 
image of the blood flow through the circulatory system, where the systemic circulation involves the exchange of 
blood between the heart and the body [20], while the pulmonary circulation system consists of the exchange of 
blood between the lungs and the heart. Here the oxygenated and deoxygenated blood is shown in red and blue, 
respectively.  
2.2.1 The gross anatomy of the heart 
The heart is a hollow muscular organ situated just to the left of the midline of the thoracic cavity 
between the lungs (Figure 2.1). The size of an average human heart is approximately the size 
of a person’s closed fist [21]. It is surrounded by a fluid-filled sac-like double layer called the 
pericardium (Figure 2.2A), which serves to protect this vital organ. A cross-section cut through 
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the heart walls reveals several layers: the outer protective epicardium, the myocardium and 
inner endocardium [17]. 
The heart is composed of four distinct chambers shown in Figure 2.2A. This four-chamber 
structure of the heart enables the separation of the systemic from the pulmonary circulation 
system (Figure 2.2B). The former is regulated by the left side of the heart (left atrium and 
ventricle), which is responsible for the distribution of oxygenated blood throughout the body 
while bringing deoxygenated blood back to the heart. The right side of the heart, on the other 
hand, controls the movement of blood between the heart and the lungs for blood oxygenation. 
The atria and ventricles are separated, on the epicardial side, by the coronary sulcus, while the 
left and right halves of the heart are separated via a septum to prevent the mixing of blood. The 
flow of blood from the atria to the ventricles is regulated by the atrioventricular (AV) valves 
located on the plane of this sulcus. These consist of the mitral valve (MV) on the left and the 
tricuspid valve on the right. These valves ensure unidirectional flow of blood between the atria 
and the ventricles. A cross-section cut through the heart walls reveal several layers: the outer 
protective epicardium, thick middle myocardium and inner endocardium. Amongst them, the 
myocardium is the contracting layer of the heart and consists of circularly and spirally arranges 
network of cells called the cardiac myocyte [17]. 
  
Figure 2.3: Internal anatomy of the atria. On the left, (A) the right atrium has been opened to reveal the internal 
structure, and on the right, (B) is the left atrium with PVs highlighted. Images adapted from [17]. 
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2.2.2 Atrial structure 
The right atrium (RA) is larger in size than the left atrium (LA) (Figure 2.3) [17]. The terminal 
sulcus, an external groove extending from the superior vena cava to the inferior vena cava 
separates the RA into two parts: the principal cavity (sinus vearum) and the anteriorly located 
right atrial appendage (RAA). In the internal surface of the RA shown in Figure 2.3A, this 
groove is marked by the crista terminalis (CT), a vertical smooth muscular ridge. Behind the 
CT the atrial surface is smooth, while the front of it resembles a tooth-like structure consisting 
of muscular fibres called the pectinate muscles. The RA (Figure 2.3A) receives deoxygenated 
blood from the upper part of the body via the superior vena cava and the inferior part of the 
body via the inferior vena cava.  
Freshly oxygenated blood from the lungs enters the LA through the pulmonary veins (PVs), 
usually four in number, which opens into the upper posterior surface of the LA shown in Figure 
2.3B. The left atrial appendage (LAA) is a finger-shaped extension originating from the main 
body of the LA with a well-defined narrow orifice. Externally, the LAA appears as a flattened 
tubular structure with one or more bends and terminating in a pointed tip directed 
anterosuperiorly [22]. A large variation in the size and shape of the LAA has been reported 
clinically, and its function in the cardiac cycle has been attributed to increasing the cardiac 
volume. However, in the presence of cardiac rhythm disorders, LAA is often regarded as the 
site for thrombus formation due to its reduced contractibility and blood stasis.  
2.2.3 The flow of blood through the heart 
A schematic image of the blood flow through the chambers of the heart is shown in Figure 
2.2A. The deoxygenated blood flows into the RA via the superior vena cava and inferior vena 
cava from the systemic circuit. As the RA contracts, the deoxygenated blood passes into the 
right ventricle (RV) via the tricuspid valve. The subsequent contraction of the ventricles forces 
the tricuspid valve to close and the blood to flow through the pulmonary valves into the right 
and left pulmonary arteries, transporting it to the lungs. The deoxygenated blood passes through 
the lung’s capillary network, where gas exchange occurs. The freshly oxygenated blood is then 
returned to the heart via the PVs into the LA. The contraction of the LA results in blood moving 
into the left ventricle (LV) through the MV. When the LV contracts, the MV closes, and the 
oxygenated blood is forced into the aorta and distributed throughout the body via arteries and 
capillaries. In this sequence of events, the right and left side of the heart contracts 
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simultaneously, which is known as systole, with each side pumping the same volume of blood 
in each cardiac cycle. The systole is followed by diastole, where the relaxation of the heart 
muscles allows for the blood to refill the chambers. The heart muscle cannot receive oxygen 
from the blood within its chambers. Instead, it has its own system of capillaries embedded in 
the walls, which is known as coronary circulation. 
2.2.4 The electrical conduction system 
In healthy conditions, during sinus rhythm, electrical impulses follow a regimented route, and 
the arrival of supra-threshold electrical stimuli results in active contraction of cardiac muscle 
cells, myocytes. This allows for the coordinated rhythmic contraction of the four chambers of 
the heart. A schematic image for the cardiac conduction system is shown in Figure 2.4.  
 
Figure 2.4: The cardiac conduction system. A Schematic image of the electrical conduction system in green with 
the sequence of events labelled 1-5. Image adapted from [23].  
The primary electrical signal is initiated by the sinoatrial node (SA node) located at the base of 
the superior vena cava in the RA (Figure 2.4, 1). The SA node consists of a small collection of 
specialised cells that are autonomous electrical oscillators and spontaneously generate electrical 
impulses known as action potentials (AP) at an intrinsic rate between 60 and 100 beats per 
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minute (bmp) [24]. Each AP spreads through the cardiac wall and is responsible for the normal 
heart rhythm of about 60-100 bpm, and hence the SA node is referred to as the pacemaker of 
the heart. Moreover, the SA node is controlled by the autonomic nervous system (ANS), which 
can regulate its firing rate, and hence the heart rate [25,26]. The parasympathetic input slows 
down the firing rate, thereby decreasing the heart rate. The sympathetic input, on the other hand, 
increases the firing rate, and thus the heart rate [24]. This regulatory system allows the heart to 
adapt to various physiological stressors, for example during exercise, where the sympathetic 
system increases the heart rate to meet the body’s increased demand in oxygen. 
The APs propagate across the RA with fast conduction along the CT and pectinate muscles 
resulting in the contraction of the RA (Figure 2.4, 2). Trans-septal conduction is facilitated by 
several fibrous bundles such as the Bachmann’s bundle (BB), which is one of the largest 
collection of fibres in the atria, running from the top of the RA into the anterior surface of the 
LA (Figure 2.4, 2). As the AP passes from right to left, the LA contracts right after the RA with 
a slight delay which is usually considered negligible.  Here the cardiac impulses can reach the 
AV node located at the base of the atria (Figure 2.4, 3), which introduces a slight delay before 
the electrical signal reaches the ventricles. This delay allows for the atria to contract and the 
ventricles to refill before the conducted AP triggers ventricular contraction. Therefore, the AV 
node plays an important role in maintaining normal cardiac rhythm. From the AV node, the 
electrical impulses pass into the intraventricular septum through a specialised collection of 
fibres called the AV bundle (or the bundle of His), extending into Purkinje fibres (Figure 2.4, 
4). The bundle spreads in a tree-like manner, branching into the left and the right bundles 
throughout the interior of the ventricles (Figure 2.4, 5). The impulses originating from the 
Purkinje fibres stimulation causes contraction of the ventricular walls in a twisting motion to 
facilitate blood flow into the aorta and the pulmonary trunk.  
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2.3 Cardiac Electrophysiology 
The myocardium is a highly organised structure comprising of cardiac muscle cells 
(cardiomyocytes) and fibroblasts, which are involved in the maintenance of the extracellular 
matrix [27]. Blood vessels (which are part of the coronary system) and nerves can also be found. 
The fundamental property of the myocardium, which enables it to generate and conduct 
electrical signals and induce contraction, is through the function of the cardiac myocytes that 
are the primary constituents of the heart muscle. In the section, we will provide a brief review 
of cardiac electrophysiology, the study of the electrical activity of the heart. We will discuss 
the structural components of cardiac myocyte and put them in a functional context to explain 
their electrophysiological properties.  
 
Figure 2.5: Myocardial tissue histology. (A) Strained cardiac tissue showing the arrangement of multiple cardiac 
myocytes. (B) Schematic image of the junction between two myocytes and some of the intercellular components. 
2.3.1 Functional anatomy of cardiac myocyte 
The cardiac myocyte is the contractile unit of the myocardium whose primary function is to 
produce mechanical tension. In mammalian atrial and ventricular tissue, they are approximately 
cylindrical in shape and roughly 50 – 150 µm in length and about 10 to 20 µm in diameter [27]. 
Unlike skeletal muscle cells, cardiac myocytes are often single nucleated and branched at the 
ends (Figure 2.5A). The fluid in the intracellular space of the cardiac myocyte is called the 
sarcoplasm, which contains various ionic species as well as several biomolecules and organelles 
[27]. The sarcolemma surrounds each myocyte with a phospholipid bilayer that forms a semi-
permeable barrier to the movement of ions between the sarcoplasm and the extracellular space 
(Figure 2.6B). The movement of ions between inter and extracellular spaces occurs only via 
specific protein structures embedded in the sarcolemma called ionic channels. The flow of ions 
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through these channels results in inward and outward currents underlying the generation of AP, 
the details of which will be discussed in Section 2.3.3. Moreover, specialised structures called 
intercalated disks form cell-to-cell junction between adjacent cardiac myocytes (Figure 2.5B). 
This allows for mechanical coupling between cardiomyocytes, as well as providing a passage 
for the flow of ions between cells for rapid conduction of APs [28]. 
Among organelles within the myocyte, there are mitochondria, myofibrils, the sarcoplasmic 
reticulum, the sarcomere and finally, the cytoskeleton holding all the organelles together [27]. 
The mitochondria are present in abundance, occupying almost 40% of the cell volume, thus 
emphasising the immense energy demands of the myocyte [28]. Each myocyte composed of 
bundles of myofibrils that contain myofilaments. The sarcoplasm also contains myofibrils, with 
distinct repeating unit termed sarcomere, the primary contractile unit of the cell. Each 
sarcomere is composed of thick and thin filaments (Figure 2.5B). The chemical interactions 
between these filaments enable the sarcomere to change length during excitation-contraction 
coupling. Another organelle, the sarcoplasmic reticulum (SR) is an intracellular membrane 
network which wraps around the myofibrils without touching them. SR acts as calcium (Ca2+) 
store and plays an important role in calcium homeostasis and contraction-excitation coupling, 
further discussed in Section 0. 
 
Figure 2.6: The cardiac myocyte. (A) Electron microscopy image of the cell membrane in E. Coli bacteria [29] 
showing the sarcolemma, phospholipid layer. (B) Schematic image of the cell membrane showing the phospholipid 
bilayer, modified and adapted from [30]. 
2.3.2 The cell membrane and ion transporters  
The cell membrane of the cardiomyocyte, or sarcolemma, is a phospholipid bilayer which 
encapsulates the sarcoplasm and separates the cell from its extracellular space (Figure 2.6). The 
fundamental function of the sarcolemma is to provide a barrier for diffusion. Hence, the lipid 
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molecules are arranged in a specific fashion, such that their hydrophilic heads are facing 
outward, interacting with the fluid on either side of the membrane. This specific configuration 
allows the sarcolemma to interact with both the extra and intracellular fluids, while its 
hydrophobic core renders it impermeable to charged molecules (Figure 2.6B). Moreover, there 
exists a difference in charge distribution between the extracellular fluids and the intracellular 
fluids resulting in a potential difference across the sarcolemma. This is referred to as the 
transmembrane potential, 
 𝑉 = 	𝑉! − 𝑉"    (2.1) 
Here 𝑉! and 𝑉" denote the intracellular and extracellular potentials. 
Embedded within the phospholipid bilayer are different protein structures that are found either 
bound to the membrane surface (peripheral membrane proteins) or buried within the membrane 
with domains on one or both side (integral membrane proteins) [31]. Integral proteins spanning 
the entire phospholipid bilayer, particularly those that form pores and channels, take part in 
moving molecules between intra and extracellular spaces (Figure 2.6B). These specialised 
protein structures are responsible for the excitability of the cardiac myocyte.  
The opening and closing of these channels are typically dependent on stimuli from either change 
in the membrane potential, neurotransmitters, ions or mechanical stretch. Moreover, when a 
channel opens, it only becomes selectively permeable to a restricted set of ions, where the 
selectivity comes from the specific interactions of the ions with the channel pore. Hence, many 
different types of ion channels can be found across the membrane. In cardiac myocytes the 
primary channels are for sodium (Na+), potassium (K+) and calcium (Ca2+) ions [32]. Chlorine 
is involved to a lesser extent. The channels can be further divided into different categories 
depending on their electrical behaviour determined by their underlying protein structure. 
Relevant to this context, there are primarily 3 different ion-transporting protein structures, 
namely channels, exchangers and pumps. Ions pass through channels down their 
electrochemical gradient without the input of metabolic energy. Other ion-transporter proteins, 
such as the pumps, move ions against their concentration gradient through active transport using 
cellular metabolic energy. However, ion exchangers can be classified neither as active nor as 
passive transporter protein. Instead, they use energy from the ion flowing down the 
electrochemical gradient to move another ion against it. The role of ionic pumps and exchangers 
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is critical in the ability of the cell to be excited repeatedly and in preventing the build-up or 
depletion of ion concentration in the intracellular space. 
2.3.3 The cardiac action potential 
When a sufficiently large external electrical stimulus is applied to the cell membrane, the 
transmembrane potential rises above a threshold potential before returning, typically more than 
100 ms later, to its original state. This cyclic change in the membrane potential in response to 
the external stimulus is referred to as the action potential, AP.  
 
Figure 2.7: The Action Potential. (A) A generic AP morphology with different phases labelled. The shape and 
currents in the atrial and the ventricular myocyte are shown in panels (B) and (C), respectively. Images replicated 
with permission from [7]. 
The AP consists of 5 distinct phases (Figure 2.7, A) where each phase corresponds to the action 
of one or more ionic channels. A schematic image of the atrial AP with all the phases labelled 
is shown in Figure 2.7A.  
Phase 4: When the cardiac myocyte is at rest, the transmembrane potential is referred to as the 
resting membrane potential (RMP), which is typically within -65 and -85 mV for atrial cells 
[33]. This is labelled at Phase 4 of the cardiac AP. The critical balance of background currents 
determines the RMP.  
Phase 0: When the membrane voltage is sufficiently perturbed from the RMP, either by 
stimulus from an external source or neighbouring cells, after a threshold voltage is reached, the 
fast Na+ channels rapidly activate and remains activated for 2-10 ms. During this time, there is 
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an influx of Na+ ions from the extracellular to the intracellular space down its electrochemical 
concentration gradient. As the positive charge flows into the cell, the membrane potential 
rapidly increases, and the cell depolarizes. This forms the rapid upstroke observed in Phase 0 
of the AP. It is important to note that the velocity of AP propagation across the heart is related 
to this upstroke.  
Phase 1: After the inactivation of the Na+ current (INa), the transient outward current (Ito) 
becomes active. This is carried mainly by K+ ions flowing out of the cell and partially 
repolarizing the membrane. The current is referred to as transient as it inactivates within 30-40 
ms, hence giving rise to the characteristic notch observed in Phase 1 of the AP (Figure 2.7).  
Phase 2: During this phase, the delicate balance between the inward L-type Ca+ current (ICaL) 
and the outward K+ currents (IKr and IKs) results in a plateau phase of the AP, which is critical 
for the contraction of the myocyte. Moreover, the influx of Ca2+ ions in the intracellular space 
initiates Ca2+ induced Ca2+ release from Ca2+ stores in the SR. The high concentration of Ca2+ 
ultimately causes the myocyte to contract (as discussed further in section 0).  
Phase 3: The final phase of AP is marked by the termination of Ca2+ current, and a progressive 
increase in K+ currents (IKr and IKs) to fully repolarize the cell membrane to the RMP. The most 
critical role in the repolarization is played by an inward rectifier K+ current, IK1, which is larger 
than all the other K+ currents and only activates over a very narrow range of voltage (-30 mV 
to -80 mV). During this phase, the sodium-calcium exchanger (INa/Ca) also helps decrease the 
cytoplasmic Ca2+ concentration by exchanging 3 Na+ ions entering the cell for every 1 Ca2+ ion 
being expelled. This results in an inward current which helps prolong the plateau while slowing 
repolarization. As the membrane repolarizes and the potential becomes negative, the K+ 
channels inactivate, and AP returns to the stable Phase 0 until another stimulus is applied. 
Across the myocardium, a large degree of heterogeneity in the morphologies of the APs can 
also be found depending on which region of the heart they belong to [34,35]. Typically, the 
human atrial AP is shorter and presents a more triangular morphology (Figure 2.7, B) compared 
to the spike and dome-shaped with a prominent longer plateau of the ventricular counterpart 
(Figure 2.7, C). The differences can be attributed to the distinct ion-channel properties and 
distribution of the atrial and ventricular myocytes. Furthermore, the atria itself is characterised 
by variations in AP morphology. Differences in APs between the CT, pectinate muscles, atrial 
wall, appendage and atrioventricular rings have been reported [36].  
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2.3.4 Characterisation of action potentials  
A standardised framework for characterising APs exists such that it allows for comparing APs 
from different regions, species and disease state (Figure 2.8). In the following table, some of 
the key terminology used throughout the thesis has been summarised. 
Attribute Definition  
Resting Membrane 
Potential (RMP) 
RMP is potential at which non-pacemaker cells remain at their 
resting state. In atrial myocytes, it varies between -65 and -80 mV 
[33].  
Peak Amplitude This is the maximum positive voltage reached during an AP. 
Amplitude It is the difference in voltage between peak and RMP. 
Action Potential 
Duration (APD) 
It is defined as the amount of time for which the voltage remains 
above a specific threshold. Experimentally this threshold is chosen 
anywhere from 50% to 90% for recovery from the peak to the RMP.  
In atrial myocytes APD90 at 1Hz is highly variable, typically ranging 
from 150 to 500 ms [33]. 
Effective Refractory 
Period (ERP) 
ERP is a short period of time following an AP when another AP 
cannot be generated regardless of the size of the stimulus. This is 
because the Na+ channels are inactivated and remain until 
repolarization is complete. This helps in prevention of the back 
propagation of the impulse. 
 
 
Figure 2.8: Properties of atrial action potential. Image adapted from [37]. 
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2.3.5 Action potential restitution  
When myocytes are stimulated at a regular interval, the AP properties such as APD, plateau, 
amplitude, upstroke velocity, etc. are affected by the size of the interval referred to as the basic 
cycle length (BCL). In fact, as BCL is decreased, APD becomes shorter and upstroke velocity 
slower. The relationship between BCL and APD is known as the APD restitution curve. 
Mechanistically, APD restitution occurs because at fast pacing rate the ion channels involved 
in AP generation are not fully recovered before the next AP occurs, and therefore generate less 
current. The ability of the cardiac myocytes to adapt to a faster rate by shortening APD allows 
for adequate contraction of the heart and pumping of blood under a wide range of physiological 
conditions.  
The APD restitution curve can be constructed by varying BCL using the S1-S2 protocol. When 
myocytes are stimulated at a regular interval, these are known as the S1 stimuli. In the S1-S2 
protocol, however, a number of S1 stimuli is followed by a shortly coupled S2 stimulus. Note 
that APs cannot be initiated earlier than a refractory period (which roughly corresponds to 
APD90) because Na+ channels are inactivated and remain closed until repolarization is 
complete. This helps in the prevention of back propagation of AP and puts a limit on the size 
of S2. The shape and characteristics of the APD restitution curve provide important information 
about arrhythmogenesis [38]. A sufficiently steep restitution curve could lead to instability [39]. 
2.3.6 Action potential propagation and excitation-contraction coupling 
Cardiac myocytes are electrically coupled to their neighbours through specific protein channels, 
gap junctions, which are located on the intercalated disks (Figure 2.5B). The flow of ions and 
electrical impulses occur between cells via these gap junctions. For example, when the first cell 
is simulated in a single 1D strand of myocytes, the ions from the intracellular space of this cell 
flows into the adjacent cell and increase its potential. When the threshold for the activation of 
Na+ current is reached, the cell membrane depolarizes triggering a new AP. This chain of events 
allows for the propagation of APs through the myocardium.  
The proteins constituting the gap junction are known as connexins (Cx). In the cardiac tissue, 
there are 3 main types of connexions, named based on their molecular weight: Cx40, Cx43, and 
Cx45, amongst which Cx43 is the most abundant [32] and responsible for the fastest flow of 
ions between myocytes. Moreover, there exist regional variation in gap junction distribution 
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between and within the atria and ventricles. Nodal tissue (SA and AV node) lacks Cx43 
compared to atrial and ventricular tissue, making conduction there much slower [40,41]. 
Cardiac myocytes are arranged end to end in a longitudinal manner, forming fibre-like 
structures. There are more gap junctions along the fibres than across them (at the lateral sides). 
This results in faster AP conduction along the fibre than in the transverse direction. In normal 
conditions, the longitudinal conduction velocity in the human atria varies between ~50 and 
~120 cm/s [42]. Under pathological conditions like AF, the velocity values could be reduced 
by ~15% in human [43] and even more in animals. A summary of conduction velocities 
measured in human tissues reported in the literature can be found in a review paper by Dossel 
et al. [42]. Note also that myofibres in the atria, have a very complex arrangement, often with 
different orientations across different transmural layers [44]. 
As mentioned previously, electrical waves spread across the cardiac myocardium, initiating and 
regulating contraction. Coupling of the electrical excitation of the heart with its contraction is 
known as excitation-contraction coupling or EC coupling. Here we will only provide a brief 
description of the events that lead to the contraction of the myocyte (Figure 2.9).  
During Phase 2 of the AP, the L-type Ca2+ channels on the membrane activates, resulting in an 
influx of Ca2+ ions into the intracellular space (Figure 2.9, 1). The increase in intracellular 
calcium concentration triggers the release of Ca2+ ions from the SR by binding to the ryanodine 
receptors (RyR) (Figure 2.9, 2). Following the increase in the intracellular Ca2+ concentration, 
two events occur. First, the intracellular Ca2+ ions inactivate the L-type Ca2+ channels to prevent 
further influx of Ca2+ ions. Second, the Ca2+ ions activate the contractile unit of the myofibrils, 
resulting in myocyte contraction (Figure 2.9, 3). The myofibrils are composed of filaments 
known as myofilaments which in cardiac muscle are constructed from proteins, principally actin 
and myosin. The Ca2+ ions bind to troponin, which in turn binds to the actin filament. This 
binding causes a change in the shape of troponin and exposes areas of the actin. The head of 
the myosin filament binds to these areas resulting in the formation of a cross-bridge structure. 
The myosin head utilises adenosine triphosphate (ATP) produced by the mitochondria to move 
the actin filaments. This results in shortening of the muscle as the actin filament slides across 
the myosin filament. Following this, the myosin head detaches from the actin and returns to its 
original position. It then binds to another part of the actin filament to produce another 
contraction, shortening the muscle even further. This process continues until Ca2+ is removed 
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from the cell. In the absence of Ca2+ ions, the troponin changes shape and blocks the binding 
site of the actin filaments, which causes the muscles to relax. The decrease in Ca2+ is driven by 
Ca2+ transporters: (i) the SR Ca2+ pump, which transports Ca2+ back into the SR, and (ii) the 
Na+/Ca2+exchanger and the sarcolemma Ca2+ pump, which pumps Ca2+ ions out of the 
intracellular fluids and restores intracellular calcium concentration (Figure 2.9, 4). Note that the 
above description of excitation-contraction coupling is simplified, and further detail can be 
found elsewhere [45,46].  
 
Figure 2.9: Schematic image of excitation-contraction coupling. The arrows indicate the sequence of events 
(labelled 1 to 4) showing the direction of Ca2+ movement. Here, the inner grey compartment is the SR. 
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2.4 Atrial Fibrillation 
Atrial fibrillation (AF) is the most commonly sustained cardiac arrhythmia, characterised by a 
rapid and irregular rhythm of the atria. During AF, atrial cells fire at a rate of 400 to 600 beats 
per minute as compared to 60 beats per minute in sinus rhythm [2]. The AV node, owing to its 
filtering effect, acts as a barrier and prevents all the atrial impulses from conducting to the 
ventricles. This averts an extremely rapid ventricular rate which could result in compromised 
cardiac contraction and rapid death. However, the ventricular rate during AF is still high, 
approximately 150 bpm, and irregular as the SA node no longer regulates it, but instead by the 
interaction between the AV node and the atrial rate. Although they are sometimes 
asymptomatic, a short-lived episode of AF in healthy individuals may also result in chest pain, 
palpitation and light headiness. AF is not directly lethal, but when sustained for a long duration, 
can result in loss of effective atrial contraction leading to reduced cardiac output, fatigue, 
morbidity, decreased quality of life and increased risks of stroke and heart failure [47]. In 2010, 
approximately 33.5 million people worldwide were affected by AF, and in coming decades, 
studies predict a progressive increase in the prevalence and incidence of AF accompanied by 
high morbidity and mortality [5]. The clinical risk factors for AF include several cardiac 
diseases, such as heart failure, and advancing age [48,49]. 
AF initially presents in paroxysmal (PAF) form, which can self-terminate within 7 days and 
spontaneously convert to normal sinus rhythm. Persistent AF (PsAF) lasts for more than 7 days 
and requires pharmacological or direct-current electric cardioversion, while the restoration to 
sinus rhythm becomes impossible in cases of permanent AF (PerAF) [50,51]. Despite its 
clinical importance and high prevalence, limited knowledge of the mechanisms responsible for 
initiation and sustenance of AF have prevented clinicians from treating the arrhythmia 
efficiently. In the following sections, a brief review of what is known about AF mechanisms 
and its treatment strategies is presented, along with an overview of challenges that need to be 
addressed to improve the efficiency of AF treatment and make it more patient-specific. 
2.4.1 Mechanisms underlying AF 
Mechanisms underlying AF are complex and multifactorial. A schematic image summarising 
the major factors contributing to the genesis of AF are presented in Figure 2.10. The common 
factors to AF initiation and maintenance are a trigger and a substrate (Figure 2.10, green boxes). 
The trigger can act on the substrate to generate re-entrant drivers (RDs) for AF (Figure 2.10, 
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blue boxes). Such drivers are believed to be the main mechanism underlying AF [51]. During 
AF, these rapidly discharging drivers can result in irregular electrical activations of the atria 
wall. Moreover, as AF progresses, it promotes atrial remodelling (Figure 2.10, yellow) which 
favours the development of triggers and substrate for re-entry, hence further facilitating AF. 
This self-reinforcing property of AF is described as “AF begets AF”, which highlights the 
progressive nature of this complex disorder. A detailed review of mechanisms underlying AF 
can be found elsewhere [2,50–54]. Here, a brief overview of the well-known triggers and 
substrates for AF, as well as types of atrial remodelling that enhance the vulnerability of the 
heart to AF, is presented below. 
 
Figure 2.10: A schematic representation of the major contributors to the genesis of AF, which explains the notion 
“AF begets AF”. The flow diagram shows that once triggered directly by ectopic sources or via re-entrant drivers 
formed due to interactions of the ectopic with tissue substrates, AF causes atrial remodelling which promotes AF 
maintenance by generating more triggers and substrates. Electrical remodelling reduces ERP and facilitates re-
entry, and also promote further development of ectopic activity. Structural remodelling causes atrial dilation and 
development of fibrosis, which facilitates slow and heterogeneous AP conduction and more re-entrant drivers.  
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The three main classical mechanisms proposed since the early 20th century for initiation and 
maintenance of AF are [52,54]: (i) ectopic AP firing either by a single focus followed by 
fibrillatory conduction or by multiple simultaneously discharging foci (Figure 2.11, a), (ii) 
formation of a single localised re-entrant circuit, a “mother rotor” (Figure 2.11, b) or (iii) 
multiple re-entrant circuits with fibrillatory conduction  (Figure 2.11, c). Determining the 
underlying mechanism could have a profound therapeutic implication, especially for catheter 
ablation treatment for AF.   
  
Figure 2.11: The three main classical mechanisms proposed for initiation and maintenance of AF. Image adapted 
from [52] with permission. 
Advance mapping and computational modelling technologies have shed further light into the 
mechanisms contributing to the genesis of AF [52]. Narayan et al. [55], used high-density 
invasive mapping in AF patients and showed the presence of small number of stable RDs at 
fixed locations. However, Haissaguerre et al. [56] and Cochet et al. [13] used non-invasive 
mapping in combination with modelling to show the existence of transient RDs which localised 
at fibrotic regions. Endocardial–epicardial dissociation has emerged as a novel AF mechanism. 
Simultaneous epicardial and endocardial mapping by Van der Does et al. [57], De Groot et al. 
[58] and Gutbrod et al. [59] showed breakthrough activations at either surface that could 
facilitate AF perpetuation. 
2.4.1.1 AF triggers  
Ectopic activity can act as AF trigger, and can also maintain AF when occurring repetitively 
over a long period of time. Such triggers can arise from micro-re-entry, enhanced automaticity 
(spontaneous diastolic depolarization) or triggered activity (afterdepolarizations) [60]. A vast 
majority of triggers are localised at the PV sleeves [10] and are thought to arise from either 
early afterdepolarizations (EADs) or delayed afterdepolarization (DADs). EADs occur during 
phases 2-3 of AP, as a result of APD prolongation, which allows for inactivated Ca2+ channels 
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to recover and generate inward Ca2+ current leading to secondary depolarization of the cell 
membrane (Figure 2.10, A). DADs, on the other hand, occur during phases 3-4, as a result of 
an abnormal increase in diastolic Ca2+ concentration, which enhances the activity of the 
Na+/Ca2+ exchanger. The exchanger works by extruding 1 Ca2+ ion for 3 extracellular Na+ ions 
causing a net inward current which can depolarize the cell membrane [51,54] (Figure 2.10, B). 
The mechanisms for myocytes developing autonomic activations are not fully understood. 
However, early experimental studies have shown that blocking autonomic behaviour suppresses 
AF while promoting DADs by facilitating the release of Ca2+ ions from the SR increases AF 
inducibility [61].  
2.4.1.2 Re-entry  
RDs are one of the key mechanisms of AF maintenance [62]. The formation of RDs requires a 
trigger and a suitable tissue substrate.  When the substrate is an anatomical obstacle, anatomical 
re-entry is generated (for example, AV node re-entry tachycardia, typical atrial flutter, etc.). In 
such cases, ectopic foci act as a trigger, while anatomical obstacles (such as the AV node or 
PVs) act as substrate sustaining anatomical re-entry. An example of an ectopic focus initiating 
a single RD around an anatomical obstacle is shown in Figure 2.12. 
 
Figure 2.12: Schematic images of anatomic re-entry formation around an obstacle. (A) Anatomic re-entry circuit 
with an excitable gap. (A1) Depolarization of a triangular junction of several cardiac fibres by an AP propagating 
in the direction indicated by arrows. (A2) an ectopic focus (☼) emerges from location 1, while location 2 is still 
refractory (grey), which results in conduction block towards location 2. (A3) The AP propagates along an 
alternative path (clockwise) and reaches location 2 when it is no longer refractory, resulting in the formation of a 
persistent re-entrant circuit.  
The minimum path length required for formation of re-entry around an obstacle is equal to the 
wavelength (λ) of the AP, which is defined as the distance travelled by the AP with a 
conduction velocity (CV) over one refractory period [2]:  
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 λ = ERP	 × CV (2.2) 
Hence, substrates that are characterised by lower refractory period and CV are more likely to 
sustain RDs. Moreover, a shorter λ allows more RDs to fit in the atria and maintain AF [2]. 
The formation of RDs, however, does not always require an anatomical obstacle. The RDs can 
be formed when an ectopic wave encounters a transiently refractory region (or a region with 
heterogeneous ERP) and break downs generating a singularity around which the newly formed 
RDs can rotate [63,64]. This mechanism is known as functional re-entry (Figure 2.13C). 
 
Figure 2.13: Conceptual theories of functional re-entry: (A) Leading circle, (B) Spiral wave. (C) Experimental 
recording of wave-break resulting in the formation of two RDs, replicated with permission from [64]. 
Re-entry has been conceptualised by using either the leading circle or the spiral wave theory. 
Historically, the leading circle model proposed by Allessie et al. [65] in the 1970s suggested 
that re-entry organises itself in circuits whose circumference is equal to or greater than the 
wavelength and central region is unexcitable, as it is rendered refractory due to the centripetal 
excitation wavefront (Figure 2.13, A). However, this concept was later replaced by a widely 
accepted spiral wave paradigm proposed by Wiener et al. [66], according to which impulses 
propagate around a functionally unexcitable core (Figure 2.13, B). In a spiral wave, the curved 
wavefront and wave-tail meet at one point – the tip or phase singularity – which travels around 
the core. The curvature of the wavefront progressively increases towards the core where it 
reaches a critical value [67]. The higher the curvature, the slower the wave propagation; 
therefore, the critically high curvature at the core makes it impossible for the AP to invade the 
core [68]. In this sense, the core is unexcitable. Currently, the spiral wave paradigm is dominant 
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in the theory of RDs and fibrillation [69]. It accounts for the wave curvature effects and 
meandering behaviour of RDs, as observed in experimental recordings [70]. In simulations 
presented in the dissertation, we used spiral waves to model re-entrant mechanisms of AF. 
Therefore, in all chapters, RDs will refer to spiral waves. 
In cardiac muscle, the spiral wave dynamics is affected by the excitability of the underlying 
tissue. Excitability is a measure of the stimulus current strength required to excite cardiac tissue. 
A higher excitability would mean a smaller current is required to initiate an AP and a faster AP 
propagation, and visa-versa [71]. For instance, fibrotic and ischemic regions would have a 
significantly lowered excitability compared to healthy myocardium. 
Modelling and simulation studies using a wide range of models have shown that the spiral wave 
tip rotates around a circular core in tissues with lower excitability, whereas complex flower-
like meandering pattern with linear core are seen as the tissue excitability is increased (this will 
be discussed further in Chapter 3 Section 3.4.1). Computational simulations by Krinsky, 
Efimov and Jalife [72,73] have demonstrated such transitions from circular rotation to hyper-
meander by altering the fast sodium current conductance. However, the existing cardiac 
mapping methods do not allow a full characterisation of the meander patterns in a patient with 
the same resolution as in numerical simulations. Limited experimental studies have identified 
transient meander patterns of spiral waves with linear core in the normal myocardium 
[71,73,74]. 
2.4.1.3 AF-induced atrial remodelling 
The generation and maintenance of RDs in the heart can be favoured by the alteration of the 
electrophysiological and structural properties on the underlying tissue substrate, for example, 
by reducing the ERP and/or CV. Such an alteration occurs naturally during AF in the form of 
AF-induced remodelling (see also above in Section 2.4.1), which alters atrial structure and 
function. Hence, atrial remodelling can be broadly classified into electrical and structural 
remodelling.  
Electrical remodelling alters ion channel expression of the cardiac myocyte in such a way that 
atrial APD/ERP and wavelength becomes shorter, which promotes the formation of re-entry 
and helps sustain AF [2,51,54].  Electrical remodelling processes have been extensively 
reviewed elsewhere [2,51,53]. Briefly, its major determinants of reduced APD are: (i) 
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downregulation of L-type calcium current (ICaL), which shortens the AP plateau and (ii) 
upregulation of K+ currents (such as IK1 and acetylcholine-dependent K+ current), which 
accelerates AP repolarization. Moreover, remodelling may also cause alterations in the 
distribution of gap junctions and decrease the amount of the gap junction forming connexins, 
thus altering atrial CV and anisotropy. Electrical remodelling can, therefore, result not only in 
wavelength reduction but also in wave-breaks due to increased anisotropy.    
Structural remodelling alters atrial size and the underlying atrial tissue properties, down to 
cellular ultrastructure. This can lead to pathological changes in conduction pathways, which 
contribute to RD formation and stabilisation. Most notably, structural remodelling is associated 
with the development of atrial fibrosis which plays an important role in the maintenance of AF. 
Fibrosis is characterised by the formation of excessive extracellular matrix  and collagen 
deposition in the myocardium [75]. Numerous factors can contribute to the development of 
fibrosis during AF, such as atrial stretch, neurohumoral activity and oxidative stress. 
Importantly, the development of fibrosis is linked to AF itself. Experimental studies in dog 
hearts [76] have demonstrated a great increase in fibrosis during chronic AF. Conversely, 
increased AF susceptibility has been reported across numerous animal models that develop 
atrial fibrosis. Both patient medical imaging and ex-vivo histology of atrial tissue have shown 
an increase in the amount of fibrosis in PsAF compared to PAF patients and healthy individuals 
[77] (see in Figure 2.14). This suggests that AF progression itself is among factors that either 
predispose or contribute to the development of atrial fibrosis.  
 
Figure 2.14: Increase in the severity of fibrosis with AF disease progression. Figure reproduced from [77] with 
permission, shows a light microscopic image of atrial tissue specimens from crista terminalis of patients with, (A) 
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permanent AF, (B)  paroxysmal AF and (C) healthy individual without the history of AF. The myocytes have red 
stains, and fibrosis is in white. Percentages of fibrotic tissue in A, B and C are 51%, 2% and 5%, respectively.  
2.4.2 Atrial fibrosis 
In the healthy myocardium, fibroblasts provide a 3D mechanical scaffold which helps in the 
integration of all the myocytes into an effective pump. However, cell damage from injury, 
hypertension and AF progression triggers the profibrotic signalling process, which promotes 
the differentiation of fibroblast to myofibroblast. The latter proliferate rapidly and deposit 
collagenous extracellular matrix at high rates, allowing for wound healing by scar formation 
[75]. This auto-protective mechanism of the myocardium is critical for mechanical stability of 
the heart. However, the increase of the non-conductive collagenous tissue affects electrical 
conduction by impairing inter-myocyte coupling and often forming conduction barriers. Hence, 
fibrotic regions facilitate slow conduction or a complete conduction block, which increases the 
susceptibility to initiation and maintenance of RDs [75]. Additionally, fibroblast and 
myofibroblasts can be electrically coupled to myocytes, acting and as current sources/sinks and 
modifying their electrical properties, which can promote automaticity and ectopic activity [78]. 
In summary, fibrosis is a structural change that promotes arrhythmogenesis in multiple ways, 
generating a vulnerable substrate for the initiation of RDs and ectopy. 
2.4.2.1 Arrhythmogenic potential of fibrosis 
Fibrosis has been broadly categorised into compact, diffuse, patchy and interstitial based on 
distinct patterns observed in histological data, as shown in Figure 2.15 [79]. Compact fibrosis 
(also refers to as scar) arises from previous infarct or ablation. These regions are composed of 
collagen and devoid of myocytes, hence electrically non-conductive. Compact fibrotic regions 
provide obstacles for anatomical macro-re-entry (Figure 2.15, B). However, regions of diffuse, 
patchy and interstitial fibrosis can generate slow discontinuous conduction because they are a 
mixture of collagen and conductive tissue, which facilitates the formation of RDs (Figure 2.15, 
C). Hence, the latter cases of fibrosis present greater arrhythmogenic risk.  
In a structurally remodelled atria, all types of fibrosis can exist and be spatially distributed in a 
patient-specific manner [80]. This makes it extremely challenging to clearly distinguish among 
different types of fibrosis from imaging data and evaluate their effects on AF. 




Figure 2.15: Different types of fibrosis based on their spatial patterns. The red and yellow regions denote the 
collagen and myocardium, respectively. (A) Starting from the left, (i) Compact fibrosis or scar which is devoid of 
myocytes, (ii) diffuse fibrosis which is uniformly scattered throughout the tissue, (iii) patchy fibrosis with larger 
infiltrations of collagenous regions present between myocyte bundles and (iv) interstitial fibrosis with long fibrotic 
strands leading to increased anisotropy [79]. Compact fibrosis generates obstacles for formation of macro-entry 
(B) while diffuse, patchy and interstitial fibrosis generates heterogeneous conduction (C) giving rise to RDs.  
2.4.2.2 Imaging of atrial fibrosis 
Traditionally, invasive 3D electroanatomic mapping (EAM) has been used for the assessment 
of electrical changes in the atria [49]. However, advances in imaging have facilitated the non-
invasive assessment of atrial fibrosis. Magnetic resonance imaging (MRI) with late gadolinium 
enhancement (LGE) is one of the methods used for identification, localisation and 
quantification of atrial fibrosis [81]. A Gadolinium (Gd) based contrast agent accumulates in 
the extracellular matrix owing to the slow washout kinetics in the diseased tissue compared to 
healthy tissue. This results in an increase in signal intensity in the fibrotic areas due to the 
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abundance of extracellular matrix  [82]. Specific MRI protocols have been developed for 
imaging and quantification of atrial fibrosis, as shown in Figure 2.16, from [81].  
 
Figure 2.16: Quantification of atrial fibrosis from LGE-MRI. The steps involved are proposed by Marrouche et al. 
[81]: (i) Step 1 is the acquisition of high resolution 3D LGE-MR images of the LA, (ii) Step 2 is the segmentation 
of the LA wall from the images, (iii) Step 3 is the quantification of fibrosis based in relative contrast enhancement 
and finally, (iv) Step 4 is the colour-coded fibrosis map projected on the LA wall.  
LGE-images are typically acquired 15-30 min after the injection of the contrast agent, to allow 
it to accumulate preferentially in fibrotic tissue. The presence of the contrast agent shortens the 
longitudinal relaxation time constant, T1, of the fibrotic tissue, making fibrosis appear brighter 
than healthy tissue in T1-weighted images. The in-plane resolution ranges from 1.2-1.6 mm 
while, slice thickness ranges from 1.5-4.0 mm.  
Image processing is then performed to detect the atrial wall and fibrosis. The wall 
segmentations are typically carried out manually by clinicians. After the atrial wall has been 
segmented, thresholding techniques are applied with a cut-off value to distinguish between 
healthy and fibrotic tissue. However, clinically and experimentally, highly variable image 
intensity thresholding techniques have been used for defining fibrosis [83]. In particular, 
histogram-based intensity thresholding is widely used for detection of scar tissue from ablation 
[84]. Here, the cut-off value is defined as being 2 or 3 standard deviations above a reference 
value (either atrial wall or blood pool intensity). Recent studies have adopted this approach to 
detect atrial fibrosis [81,85]. Despite being promising, the reproducibility and reliability of 
fibrosis assessment with LGE-MRI in the atria is a controversial issue.  
The lack of standardised image acquisition and processing protocols result in poor 
reproducibility across different clinical centres and present the main limitation of LGE-MRI for 
the assessment of atrial fibrosis. A recent analysis performed by Chubb et al [86], showed that 
the choice and dose of contrast agent, image acquisition time after administration of the contrast 
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agent and scanner strength affects the assessment of scar tissue. Moreover, lack of 
standardisation is also an issue in image processing techniques that are highly operator 
dependent, especially in identifying patchy fibrosis or inhomogeneous grey LGE areas [83]. 
Alternative techniques such as image intensity ratio (IIR), which normalises myocardial 
intensity with the mean blood pool intensity are being developed [87,88]. This allows for 
reducing intra-patient and inter-scan variability by reducing the confounding effects of 
physiological parameters (surface to coil proximity, contrast dose, body mass index, etc.) that 
affect the images globally and are unrelated to the underlying tissue characteristics [87]. 
Moreover, the IIR threshold to distinguish between healthy tissue, fibrosis and scar are 
established by assessing the correlation between IIR values and local bipolar voltage recorded 
via EAM. Although this approach helps in standardisation, the choice of the IIR threshold 
values to distinguish between healthy and fibrotic myocardium is still an open question.  
Another challenge associated with LGE-MRI is the capability of LGE-MRI to reliably detect 
fibrosis. Gd is not a specific marker for atrial fibrosis and it accumulates in regions with 
increased volume of extracellular matrix, which could also be linked with other pathological 
processes, such as inflammation and edema. Most reliable validation would be based on 
histological analysis, but this is not straightforward to perform in humans and can only be 
performed in localised areas [89]. An alternative method commonly used for validation is based 
on comparing image intensity from LGE-MRI with voltage maps from EAM (discussed in 
Section 2.4.3.3) [85,87]. However, this approach involves high density invasive mapping, 
which is affected by several technical variables such as the mapping catheter’s tip size, shape, 
orientation and coverage on the atrial surface and lack of consensus on the cut-off voltage to 
define scar. Moreover, registering atrial shell obtained from EAM with MRI data is very 
challenging and small miss-alignment can affect the classification of fibrotic regions from non-
fibrotic regions [83]. 
An alternative tool for assessment of atrial fibrosis is post-contrast cardiac MRI atrial T1 
mapping [90]. This imaging technique has been shown to reliably index atrial fibrosis which 
correlates with tissue voltage and outcome of catheter ablation [91]. However, T1 mapping 
technique does not provide a spatial localisation of fibrosis necessary for guiding treatment. 
Therefore, LGE remains the most promising tool for the detection of localised and cohesive 
fibrosis in the atria.   
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2.4.3 Current treatment strategies for AF 
The treatment of AF follows two main strategies, rate control and rhythm control, depending 
on the patient-specific disease condition and history [4]. Rate control is aimed exclusively 
towards controlling the ventricular rate despite continuing fibrillation in the atria. It is carried 
out either using pharmacological agents that slow down the maximum rate of conduction 
through the AV node (beta-blockers and calcium channel blockers) or by isolation of the AV 
node with catheter ablation (CA). Rhythm control, on the other hand, aims to restore the sinus 
rhythm via: electrical or pharmacological cardioversion, the use of either anti-arrhythmic drugs 
(AADs) or CA. Although the normal atrial function is only restored with rhythm control, 
clinical trials comparing the rate to rhythm control till date have comparable outcomes [4]. 
2.4.3.1 Anti-arrhythmic drugs 
AADs work by altering cardiac electrical properties to regain sinus rhythm. One of the most 
common strategies to restore sinus rhythm is by applying class III anti-arrhythmics that block 
K+ channels and therefore prolong APD, increasing the wavelength, reducing the excitable gap 
and terminating RDs. However, APD prolongation could also be pro-arrhythmic, giving rise to 
a distinct form of ventricular tachycardia known as Torsades de Pointes (TdP) arrhythmias 
(long QT syndrome) [92]. Therefore, an important side effect of AADs is the risk of severe 
ventricular arrhythmias which can be life-threatening. It is believed that prolonged APD causes 
EAD events in Purkinje fibres, which propagate to ventricles and give rise to intraventricular 
re-entry associated with TdP [93,94]. Moreover, AADs affect more than one ionic channel, 
making their net effect on the atria and also the ventricles difficult to predict. Computational 
models are thus being increasingly used to aid the design of safe AADs [95].  
CASTLE-AF trial (Catheter Ablation versus Standard Conventional Therapy in Patients with 
Left Ventricular Dysfunction and Atrial Fibrillation) found CA to result in a lower recurrence 
rate and better sinus rhythm maintenance compared to AADs in AF patients with heart failure 
[96]. Another recent clinical trial, CABANA (Catheter Ablation vs Anti-arrhythmic Drug 
Therapy for Atrial Fibrillation) showed symptomatic AF patients to have a greater quality of 
life (at 12 months evaluation) when treated with CA compared to AADs [97]. However, there 
is yet no evidence that it significantly reduces mortality, stroke, bleeding and cardiac arrest 
compared to medical therapy [98].  
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2.4.3.2 Radio-frequency catheter ablation 
Over recent decades, technical advancements in clinical electrophysiology have bought radio-
frequency CA to the forefront of treatment for arrhythmias. CA is an invasive procedure where 
catheters are used to deliver localised energy to burn tissue around or within arrhythmogenic 
areas, thus isolating them from the surrounding healthy tissue. Ablation procedures for 
paroxysmal AF have been successful by isolation of the PVs (Figure 2.17, A), which is believed 
to be the main source of rapid spontaneous focal activity or local RDs [10]. Therefore, PV 
isolation has been established as the gold standard of treatment for paroxysmal AF [99].  
 
Figure 2.17: Different types of CA procedures. (A) PV isolation with red circles indicating the location of the 
ablation lesion [100], (B) PV isolation plus additional linear lesions in white [101], (C) Box ablation around low 
voltage areas [100] and (D) regional ablation across the entire low voltage areas [102]. The LA voltage is colour 
coded such that red corresponds to voltage < 0.5 mV and purple – to voltage > 1.5 mV for panels A, C and D.   
In fact, CA may result in conversion of AF to macroreentrant atrial tachycardia in many cases 
[103,104]. Atrial tachycardia (AT) is a supraventricular tachycardia which causes that atria to 
beat rapidly (100 - 200 bpm), usually with regular rhythm on the continuum between AF and 
sinus rhythm [105]. Successful ablation of AT often results in the restoration of sinus rhythm. 
AT can either be focal or macro-entrant in nature. The former is characterised by radial and 
centrifugal atrial activation from the point of origin, which can be located anywhere in the atria 
(PVs, superior vena cava, coronary sinus, etc.) [105]. The mechanism underlying focal 
discharge could be rapid depolarizations, microreentry or afterdepolarizations. In 
macroreentrant AT, on the other hand, activation is continuous and uninterrupted due to re-
Chapter 2: Atrial Fibrillation   | 50 
 
 
entrant wavefront rotating around an obstacle formed by anatomical obstacles (venous or 
valvular orifices), scars, or areas of functional block. 
However, despite its high success rates in paroxysmal AF patients, PV isolation has suboptimal 
outcomes and high AF recurrence rates among long-standing PsAF patients [8,106]. In order to 
address this, additional strategies to improve the outcome of CA in these patients have been 
developed over the years. These include such standardised approaches as: (i) creation of 
additional linear lesions in the LA (Figure 2.17, B) consisting of a roof line connecting left and 
right superior PV and/or LA isthmus ablation between left inferior PV and the MV [107], (ii) 
automatic ganglionic plexi ablation [108] and (iii) ablation of the vein of Marshall [109]. Other, 
more personalised strategies directly target substrate or/and drivers of AF using EAM, which 
include targeting atrial regions with: (iv) complex fractionated electrograms (CFAEs) [110], 
high dominant frequency (DF) [111], high Shannon entropy (ShEn) [112]. More recently, (v) 
direct ablation of AF drivers (ectopic triggers or RDs) identified invasively using basket 
catheters [113] or non-invasively using body surface electrodes [114] has also been applied.  
The lack of consensus is reflected in a lack of reproducibility of such strategies across 
multicentre trials. For example, the randomised trial STAR-AF II failed to demonstrate any 
significant reduction in AF recurrence when comparing PVI plus additional linear lesion or 
CFAE group to PVI group alone [106]. AF driver-guided ablation is also limited by the 
challenges of mapping and visualising electrical activity on the endocardial surface with 
sufficiently high resolution [115]. This can explain contradictory outcomes of multicentre trials, 
where some centres have shown favourable outcomes of AF driver-guided ablation [116], while 
others have failed to find advantages in this approach compared to PVI [117]. Therefore, despite 
the low long-term efficiency, PVI is still the primary ablation strategy for PsAF patients.  
This brings us the question of why PVI is inefficient in long-standing PsAF patients. This could 
be because of changes in the complexity of AF mechanisms as it progresses [118]. Initially, AF 
is driven by localised focal or re-entrant sources clustered in relatively limited atrial region 
(such as the PVs), which send rapid activations to other regions of the atrial wall [119]. AF 
progression leads to more and more advanced levels of atrial remodelling, which generates 
more arrhythmogenic substrates and allows the atria to sustain multiple triggers or/and RDs 
outside the PV region, whose locations become harder to predict [2]. Therefore, we can 
hypothesise that the efficacy of CA in PsAF patients could be greatly improved by targeting the 
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remodelled atrial substrates in addition to PVI. This requires reliable methods for the accurate 
identification of these arrhythmogenic substrates during AF. Identifying such locations 
throughout the atria requires a better understanding of the interplay between structural and 
functional mechanisms underlying various stages of AF in individual patients.  
 
Figure 2.18: The Utah classification for atrial fibrosis quantified using LGE-MR images and AF recurrence [81]. 
(A-D) Example of left atria with increasing atrial fibrosis (green) burden classified as stages 1-4. (D) The 
cumulative incidence of AF recurrence after 475 days indicates increasing recurrence proportion in patients with 
increasing fibrosis burden. The image has been adapted from [81].        
2.4.3.3 Ablation strategies targeting atrial fibrosis 
There is growing evidence linking AF progression and treatment efficacy with atrial fibrosis. 
Specifically, a multicentre clinical observation study, DECAAF, has demonstrated that AF 
recurrence after PVI correlates with fibrotic burden (FB) assessed using LGE-MRI (discussed 
in Section 2.4.2.2). Briefly, the trial was conducted by Marrouche et al. [81], on a cohort of 272 
PAF and PsAF patients undergoing their first PVI. These patients were classified into 4 groups 
according to their total amount of atrial fibrosis (FB), as shown in Figure 2.18. These groups 
were: (i) Utah 1 (FB < 10% of the atrial wall), (ii) Utah 2 (10% ≤ FB < 20%), (iii) Utah 3 (20% 
≤ FB < 30%), and (iv) Utah 4 (FB ≥ 30%). The cumulative incidences of AF recurrence after 
475 days of PV isolation (Figure 2.18, B), was 15.3%, 35.8%, 45.9% and 69.4% in Utah 1, 2, 
3 and 4, respectively. Furthermore, studies performed by other centres have confirmed these 
findings, suggesting AF recurrence and CA failure to be more frequent in patients with FB  ≥  
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30% [120]/ 35%[121]. This clearly highlights the arrhythmogenic potential of fibrosis in AF 
patients and emphasising the importance of fibrosis quantification as a critical tool for patient 
stratification for CA treatment. Moreover, these outcomes lay the foundation for substrate 
modification-based ablation strategies in patients with higher FB. 
Furthermore, high LGE-MRI intensity has been linked with fibrotic regions identified from 
histology [89], as well as correlated with low-voltage areas identified from electro-anatomic 
mapping [85,87], broadly defined as regions with bipolar voltage < 0.5 mV during sinus rhythm 
[122]. Hence, low voltage areas are often regarded as a surrogate for atrial fibrosis. CA 
strategies that target low voltage areas in addition to PVI have shown improved success rates 
[100,102,122–126]. This technique is known as scar homogenization, and the rationale behind 
is to eliminate low voltage areas within the atrial walls and convert them to electrically non-
conductive regions. Even though some studies have shown promising results when comparing 
this substrate-based ablation strategy to PVI only, others have failed to find the advantage of 
this procedure over PVI [117,127]. Large scale randomised studies are required to confirm the 
efficiency of this strategy. Specific challenges related to this approach include its poor 
standardisation in terms of (i) detection of low voltage areas, which is dependent on the type 
and resolution of mapping electrode used, (ii) low voltage area ablation protocols that vary 
across multiple centres. For example, Kottkamp et al. [100] proposed box isolation of fibrotic 
areas (BIFA) by circumferential isolation of the low voltage areas (Figure 2.17, C). On the other 
hand, Yamaguchi et al. [102] ablated over the entire low voltage areas (Figure 2.17, D).  Second, 
the extensive ablation at the low voltage areas across the atrial wall has led to a significant 
decline in left atrial function in these patients [102]. 
In summary, even though different CA approaches discussed above have led to a reduction in 
AF recurrence in PsAF compared to PVI, the success and reproducibility across multicentre 
trials are controversial. This may be due to a lack of knowledge of how structural remodelling 
influences AF dynamics in PsAF patients. Understanding the latter in a clinical setting is 
challenging due to the poor resolution of invasive mapping and non-invasive imaging tools that 
are unable to capture the complex AF dynamics. Moreover, even limited mapping methods 
require lengthy and often unsafe procedures, further undermining their clinical value. 
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2.5 Mathematical Modelling and Simulations 
Mathematical models of biological systems provide a platform for simulation processes that are 
difficult to explore in an experimental setting. Over the years such models have been used to 
explore mechanisms of processes as varied as electrical function of the brain [128] and 
perfusion in tumour blood vessels [129], proving the effectiveness of the modelling approach. 
The work presented in this thesis uses this approach to model the electrical activity of the atria 
(described in section 2.2) and to improve the understanding of AF. Moreover, the developed 
models can be used as a platform for testing treatment strategies in-silico, which would be 
impossible to perform with the same level of detail in a clinical setting. 
This section will provide a brief overview of the different components required for the 
construction of a 3D atrial model and discuss the techniques used for the simulation of AF. 
First, the development of single cell models (Figure 2.19, Step 1 and 2) using an example of 
the very first mathematical cell model by Hodgkin-Huxley will be discussed. Second, the 
mathematical formulation of cardiac tissue models, the underlying assumptions and methods 
for solving the relevant equations numerically are presented. Finally, a brief review of AF 
simulations performed with 3D atrial models is provided (Figure 2.19, Step 3). 
 
Figure 2.19: The steps involved in creating mathematical model of cardiac electrophysiology and run simulations.  
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2.5.1 Modelling atrial electrophysiology  
Hodgkin and Huxley (H-H) laid the foundation for electrophysiology modelling in 1952 with 
the publication of the first quantitative model for propagation of electrical impulses along an 
axon of a squid neuron [130]. In 1962 they were awarded the Nobel Prize in Physiology or 
Medicine for their work. They modelled the electrical activity of an excitable cell by treating 
individual components of the cell membrane as elements of an electrical circuit and described 
its properties using a set of ordinary differential equations. Their work paved the way for the 
extension of computational modelling studies to cardiac cells. In any such model, the change 




(𝑉, 𝑡) + 𝐼&'!# = 0 (2.3) 





The derivation of the equations comes from formalism laid down by Hodgkin and Huxley, who 
modelled the cell membrane as a capacitor connected in parallel with variable resistors and 
batteries representing the ionic currents (Figure 2.20, A-B). Here	𝐶#	is the membrane 
capacitance, 𝑉 is the membrane potential (Section 2.3.2, equation 2.1) and is defined as the 
potential difference between intracellular and extracellular spaces, and 𝐼!$%	is the sum of ionic 
currents flowing through channels, pumps and exchangers across the membrane (equation 2.4).  
The different ionic currents 𝐼(	that constitute 𝐼!$%	can be computed using the product of their 
respective conductance 𝐺(	and their driving potential, 𝑉 − 𝑉(_!$%. Here 𝑉(_!$% is the Nernst (or 
reversal) potential of the xth type ion, which is defined as the membrane potential at which the 
ion’s rate of movement from one side to other side of the membrane due to the ion’s 
concentration gradient is balanced by the rate of movement in the opposite direction due to the 
electric fields associated with the transmembrane voltage [131].   
Hodgkin and Huxley also introduced the concept of gating to explain the time and voltage 
dependent behaviour of the ionic channels. According to their model, each ionic channel has 
one or more gates which can be either in an open or closed position independently of one 
another. A channel is said to be in their open state when all its gates are open, and vice versa. 
Therefore, the conductance (𝐺() of each ion channel is the product of the gating variables (𝛾!) 
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that describe the open probability of the channels and their respective maximum conductivity 
(𝑔(), as shown in equation 2.5-2.6. Here 𝛼*! 	and 𝛽*!	are the rate constants that describe the 
transition of the gates from open to close state and vice versa. Their values can be obtained 
from fitting experimental voltage clamp data with mathematical functions [132]. 
 𝐼( = 𝑔(C𝛾!
!
D𝑉 − 𝑉(!"#E (2.5) 
 𝑑𝛾!
𝑑𝑡 = 	𝛼*!
(1 − 𝛾!) − 𝛽*!𝛾! (2.6) 
By solving equations 2.3-2.6 numerically, we can reproduce the resulting AP due to application 
of a stimulating current, 𝐼&'!#, to a single cell (solution shown in Figure 2.20C) and the 
behaviour of individual gating variables (Figure 2.20D).  
 
Figure 2.20: The Hodgkin-Huxley (H-H) model.  (A) The cell membrane represented as a capacitor and ionic 
channels as conductors. (B) The electrical circuit proposed by H-H for the squid nerve axon, where the cell 
membrane is represented as capacitor (𝐶$), the voltage and time-dependent ionic channels as variable resistors 
with electrical conductance (𝑔% , 𝑥 = 𝑁𝑎,𝐾, 𝑙𝑒𝑎𝑘) and the electrochemical gradients (𝐸% , 𝑥 = 𝑁𝑎,𝐾, 𝑙𝑒𝑎𝑘), driving 
the flow of respective ions depending on the concentration of ions on either side of the membrane, and hence 
generating a current (𝐼% , 𝑥 = 𝑁𝑎,𝐾, 𝑙𝑒𝑎𝑘). (C) Changes in membrane potential with time on the application of a 
stimulus current of 10 mA and finally, and (D) Changes in the gating variables controlling the Na+ current 
(𝑚	and	ℎ) and the K+ current (𝑛) during the AP [133]. 
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2.5.1.1 Atrial cell models  
In the early 1980s, the advancement of patch clamp techniques [134] and the characterisation 
of the biophysical properties of various ionic currents in human atrial cells led to the 
formulation of detailed biophysical models specifically for those cells [135,136]. Over the 
years, such techniques have aided in the measurement of various membrane currents, resulting 
in increasing complexity of Iion (equation 2.4) in the atrial cell models. Some models also 
incorporate the influence of paracrine or autonomic effects [137] or intracellular calcium 
dynamics [138,139] on the cell electrophysiology, which can play significant roles in 
influencing atrial repolarization in both normal and pathological conditions. These models have 
facilitated simulation of the effect of anti-arrhythmic drugs and channel mutations on cellular 
and organ function, linking the molecular level effects of drugs and disease conditions with 
cellular and organ level function, and helped in translating molecular and preclinical 
physiological studies into clinical practice [140]. However, no single model incorporates all 
key molecular and cellular components. Therefore, limitations of a model need to be considered 
before applying them to clinical problems [141]. 
2.5.1.2 Simplified cell models  
The focus of this work is primarily to study the behaviour of re-entry in 3D atrial geometries 
subjected to variability in structure and electrophysiology. This requires the use of large-scale 
tissue simulations involving millions of computational grid points to represent the geometry. In 
such cases both computational efficiency and tractability of the simulation results can be 
improved by using simplified cell models with significantly lower number of variables and 
equations compared to biophysically detailed models [27].  
Simplified models fall under three categories: direct reductions of more detailed models, 
generic models and phenomenological models. Out of these, reduced models [142] and generic 
models [143], despite being computationally efficient, lack the ability to reproduce realistic 
cellular properties like APD restitution and memory which are critical for RD mechanisms.  
Phenomenological models such as the Fenton-Karma (FK) model [71], on the other hand, aim 
to reproduce key dynamical properties of cells and tissue without including much biophysical 
detail. For instance, rather than including the descriptions of ten or more ion channels, pumps, 
and exchangers, a phenomenological model constitutes of a summary of inward and outward 
Chapter 2: Mathematical Modelling and Simulations
   | 57 
 
 
currents relying on fewer variables and equations. These models allow us to substantially reduce 
computational costs, while providing a level of detail sufficient to preserve re-entrant behaviour 
seen in more complex models [27]. As the focus of this work is on the behaviour of re-entry in 
atrial myocardium, we used the FK model modified for atrial myocytes [144]. The following 
section will provide a brief overview of the FK model, which was originally proposed for a 
ventricular myocyte, and explain the modifications made in order to reproduce behaviour 
observed in atrial myocytes in normal and pathological conditions. 
 
Figure 2.21: The atrial Fenton-Karma model.  (A) The membrane potential during periodic pacing (BCL of 200 
ms) of FK-CNTRL (blue) and FK-CAF (orange) models with parameters obtained from Goodman et al. (Table 1). 
The respective changes in gating variables; v and w, after application of the stimulus current is shown with respect 
to time (B) and the membrane potential (C). These changes can be directly compared against the 3 gating variables 
in H-H model [133], where the curves are smoother (D).  
2.5.1.3 Ionic model: The Fenton-Karma model   
In the FK ionic model [71], 𝐼!$% is a combination of three currents: 
 𝐼!$% =		 𝐼,!(𝑉; 𝑣) + 𝐼&$(𝑉) + 𝐼&!(𝑉;𝑤) (2.7) 
The currents are: (i) fast-inward current	(𝐼,!)	analogous to Na+ current, which is responsible for 
depolarization of the membrane; its kinetics is controlled by the inactivation-activation gating 
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variable,	𝑣	, which inactivates this current after depolarization and reactivates it after 
repolarization, (ii) the slow outward current (𝐼&$) analogous to the K+ currents, which is 
responsible for the repolarization of the membrane and is the only current which is ungated and 
purely voltage dependent and (iii) the slow inward current (𝐼&!) analogous to Ca2+ current that 
balances the 𝐼&$	during the plateau phase and is dependent on the gating variable 𝑤.  
The equations for the model are presented in a simplified form and adopted from the original 
paper [71] by defining the dimensionless membrane potential 𝑢 (such that 𝑢 = 0	when the 
voltage V is at RMP (𝑉$)	and 𝑢 = 1	when V is at its peak	(𝑉,!), equation 2.8) and currents 𝐽%	are 
the scaled version of 𝐼%-,!,&$,&! 	 (equation 2.7) with the units of inverse time (equation 2.9).  
 𝑢 = (𝑉 − 𝑉$)/(𝑉,! − 𝑉$) (2.8) 
 𝐽% = 𝐼%/(𝐶#(𝑉,! − 𝑉$))       𝑛 = 𝑓𝑖, 𝑠𝑜, 𝑠𝑖 (2.9) 
The equations for the gating variables are: 
 𝑑𝑢
𝑑𝑡 = −𝐽,!




(𝑢/ − 𝑢) S
1 − 𝑣	
𝜏01(𝑢)








(𝑢/ − 𝑢) S
1 − 𝑤	
𝜏51




The equations for the currents are: 
 𝐽,!(𝑢; 𝑣) = −
𝑣
𝜏6
Θ(𝑢 − 𝑢/)(1 − 𝑢)(𝑢 − 𝑢/) (2.13) 
 𝐽&$(𝑢) = −
𝑢
𝜏$
Θ(𝑢/ − 𝑢) +
1
𝜏7
Θ(𝑢 − 𝑢/) (2.14) 
 𝐽&!(𝑢;𝑤) = −
𝑤
2𝜏&!
D1 + tanh	[𝑘D𝑢 − 𝑢/&!E]E (2.15) 
It is worth noting that, unlike the equations for gating variables in detailed models such as H-H 
model (equation 2.6), which are based on smooth functions, in the FK model the gating 
variables are modelled using Heaviside step function, Θ(x) defined by:  
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 Θ(x) = ^1							𝑥 ≥ 00							𝑥 < 0 (2.16) 
The original study performed by Fenton and Karma presented parameter values for ventricular 
myocyte models. In this study, however, our goal is to study re-entry in AF, and we will be 
parameterising the model to match the restitution curves recorded from healthy and electrically 
remodelled atrial tissue. Due to lack of data from human atrial cells, we have chosen the 
available parameter set for sheep atria published by Goodman et al. [144], which is summarised 
in Table 2.1. Here, we have two sets of parameters for the atrial FK model: (i) for healthy cells 
(FK-CNTRL) and (ii) chronic AF (FK-CAF). The dimensionless membrane potential, 𝑢, 
computed with the two sets of parameters are presented in Figure 2.21A, while the three FK 
model variables; 𝑢, 𝑣	and 𝑤 computed only for FK-CAF are plotted as a function of time 
(following a supra-threshold stimulus) in Figure 2.21B-C.  
Variable FK-CAF FK-
CNTRL 
 Variable FK-CAF FK-
CNTRL 
𝝉𝒅 0.125 ms 0.125 ms  𝝉𝒘𝒄𝒍𝒐𝒔𝒆 300 ms 300 ms 
𝝉𝒓 70 ms 65 ms  𝝉𝒘𝒐𝒑𝒆𝒏 400 ms 90 ms 
𝝉𝒔𝒊 114 ms 47 ms  𝒖𝒄 0.16 0.16 
𝝉𝒐 32.5 ms 32.5 ms  𝒖𝒗 0.04 0.04 
𝝉𝒗𝒄𝒍𝒐𝒔𝒆 5.75 ms 5.75 ms  𝒖𝒄𝒔𝒊 0.85 0.85 
𝝉𝒗𝟏 82.5 ms 160.0 ms  𝒌 10 10 
𝝉𝒗𝟐 60 ms 40 ms  𝑪𝒎 1 µFcm-2 1 µFcm-2 
Table 2.1: Parameters of the FK model obtained from Goodman et al [144] who calculated them by fitting APD 
and CV restitution curves from sheep atria. Here time is in the units of ms and	𝝉𝒅 ≡	𝐶$/𝑔'(. 
2.5.1.4 The Courtemanche-Ramirez-Nattel ionic model   
Another model that has been used in this dissertation is a modified version of Courtemanche-
Ramirez-Nattel (CRN) model [136]. The CRN model was developed in 1998 (Figure 2.22A), 
and unlike FK (Figure 2.22B) captures the detailed ion channel kinetics, calcium dynamics and 
cellular ion homeostasis with 21 variables, providing a balance between complexity and utility. 
This complex model provides a high level of biophysical detail and can be used to validate 
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findings from the simplified FK model. In this study, we use a modified version of the CRN 
model by Colman et al. [145], which captures cell electrophysiology of AF patients.   
 
Figure 2.22: A schematic representation of (A) the CRN model and the (B) FK model. In both schematics, the bi-
lipid layer of the cell membrane is represented in light blue, while the ionic pumps, exchangers and currents 
included in the model are represented by yellow objects. The CRN model has an additional isolated compartment 
for calcium exchange in the sarcoplasmic reticulum (SR) which is absent in the FK model. Figures adopted from 
CellML model repository [146].     
2.5.2  Modelling multiscale excitation propagation in the atria 
The advancement of imaging techniques, both ex-vivo (histology) and in-vivo (MRI, CT), 
provided an abundance of the organ level data of cardiac structure, including patient-specific 
3D geometries and approximate fibre orientations[147,148]. This facilitated the simulation of 
the electrical behaviour at the organ level, with the cell electrophysiology models incorporated 
into anatomically detailed 3D models of the atria and the ventricles. This section provides a 
brief overview of the modelling transition from the cellular level to the tissue and organ level. 
2.5.2.1 Mono-domain equations  
The propagation of AP in cardiac tissue occurs through cardiac myocytes that are electrically 
coupled via gap junctions which allow the passage of ions between the intracellular fluids of 
adjacent cells as described in detail in Section 0. At the cellular level, the AP propagation is 
discrete, as there is a small delay between the depolarization of a myocyte and its neighbours 
due to limited bandwidth of the gap junctions [27]. However, at a larger special scale of the 
tissue level, the propagation can be considered continuous, as shown in experimental recordings 
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from cultured ventricular cells of a rat [149]. This forms the basis for the continuum assumption 
underlying cardiac tissue electrophysiology modelling. According to this assumption, cardiac 
tissue can be considered as a continuum excitable medium where “cells” have shared 
extracellular and intracellular spaces with finite conductivities. There are two main types of 
mathematical representation for the continuum model: the monodomain model and the 
bidomain model [27]. The bidomain model account for the distinctive extracellular and 
intracellular conductivities, while the monodomain is based on an assumption that these 
conductivities are proportional. Although the bidomain model is arguably a better 
representation of reality, it has been shown that differences in simulation of AP propagation on 
the scale of the human heart using both models is extremely small in the absence of currents 
applied into the extracellular space (i.e., external pacing, defibrillation shocks, etc) [150]. The 
full derivation of both models can be found, for example, in Keener and Sneyd [18]. The 
monodomain equation is given by:  
 
𝜕𝑉










Here,	∇	is the gradient operator and 𝑫	is the diffusion coefficient tensor derived from the values 
of conductivities between the myocytes, the membrane capacitance and the surface to volume 
ratio. The diffusion coefficients are measured in units of m2s-1. In cardiac tissue, excitation 
propagation is faster or slower depending on the distribution and orientation of the fibres 
therefore, 𝑫 is a tensor whose components determine the rate of spread of electrical activity. 
The coordinate system represented by the diagonal matrix, 𝑫j	(equation 2.18), is localised along 
the local fibre directions, and these directions form the eigenbasis of D. Here	𝐷GG, 𝐷H3and	𝐷H4 
are the diffusion coefficients along the axis of the fibre, transverse to it and across the 
myocardial sheet, respectively. Due to a lack of sheet structure in the atria,	𝐷H3 = 𝐷H4 = 𝐷His 
considered and the ratio 𝐷II/𝐷H is called the anisotropic ratio (AR). In case of isotropic 
myocardium, AR = 1 and the monodomain equation reduces to equation 2.17B, where D is a 
scalar quantity.   
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In reaction-diffusion equation 2.17B, J!"#
K)
 is the reaction term corresponding to the current 
generated locally at the cell membrane during AP propagation, while	𝐷∇4	V	is the diffusion 
term, which corresponds to the flow of currents between cells.   
2.5.2.2 Boundary conditions 
To implement the mono-domain model (equation 2.17) in a 2D-3D tissue geometry, the 
extracellular space is assumed to be bounded. This means that there is no current flowing from 
the extracellular space into the adjacent spaces. This can be implemented mathematically by 
using the Neuman (no-flux) conditions on the boundary (equation 2.19).  
 𝒏o. (𝑫∇V) = 0 (2.19) 
Here, 𝒏o is the normal unit vector to the boundary. In the 3D studies presented in this thesis, the 
boundary condition is applied by creating a boundary layer around the outer surfaces of the 
atria (both epicardial and endocardial) and applying the Neuman conditions along the normal.  
2.5.3 Numerical solvers 
The general solution to nonlinear partial differential equations (PDEs), such representing the 
monodomain equation (Section 2.5.2.1, equation 2.17), cannot be obtained analytically. 
Numerical methods provide a convenient way in which these continuous equations can be 
discretised, such that their solutions can be computed in an iterative manner using computers. 
It is noteworthy that the choice of numerical scheme has a significant influence on the accuracy, 
stability and the computational cost of the implemented method [27], all of which should be 
considered while designing the modelling approach. In the following sections, we discuss in 
detail numerical schemes used to perform the simulations presented in this thesis.  
2.5.3.1 Explicit Euler method 
The explicit forward Euler (FE) method is the simplest numerical integration method to solve 
the 1st order differential equations describing the time-dependent propagation of the AP. Let’s 
first consider an ODE of the form of equation 2.20 (which is similar to the equations (2.6)). 
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(𝑦, 𝑡) (2.20) 
It can be assumed that over a small time	interval,	𝑑𝑡, there is a constant rate of change in 𝑦. 
Then the value of 𝑦 at the new time step, 𝑡 + 𝑑𝑡, can be estimated by equation 2.21:  
 𝑦'26' = 𝑓(𝑦, 𝑡) ∗ 𝑑𝑡 + 𝑦'                                                                                 (2.21) 
If the value for 𝑦 at	𝑡 = 0 is known, then the values for 𝑦 at 𝑡 = 𝑑𝑡, 2𝑑𝑡, … , 𝑁𝑑𝑡 can be 
calculated from equation 2.21 over the entire time interval	𝑁𝑑𝑡, provided that 𝑑𝑡 is small. 
The explicit nature of this method makes it easy to implement and each time step is associated 
with a low computational cost. However, the time step needs to be small enough to increase the 
accuracy and guarantee the stability of the diffusion operator [27] (discussed below in Section 
2.5.4.2). Implicit methods, such as the implicit Runge-Kutta methods [151], could allow for a 
larger time step without the loss of accuracy and stability, but at the expense of the 
computational cost of solving a set of non-linear system of equations at each time step. 
Therefore, its simplistic and cost-effective nature makes the explicit forward Euler a popular 
numerical scheme for solving the monodomain equations for cardiac tissues [27,152]. 
2.5.3.2 Finite difference method  
In cardiac electrophysiology, the monodomain equations can be solved in a 3D geometry using  
the finite difference method (FDM), the finite elements method (FEM) and the finite volume 
method (FVM) [27]. Amongst them, FDM is relatively simple and one of the most commonly 
used technique of discretizing the monodomain equations [150,153] and has therefore been 
used throughout the studies presented in this thesis. The region over which the simulations are 
performed is discretised in space and time, and approximations of the continuous solutions are 
computed at these discrete space or time points.  
The principle behind FDM is simple: approximating the partial derivatives in the PDEs by 
replacing them with difference quotients calculated based on the Taylor series expansion of the 
required function (equation 2.22, 23). The geometry is represented by a structured grid: 
typically, uniform squares in 2D problems and cubic voxels for 3D geometries.  
In a 2D case (Figure 2.23), the partial derivatives of a differentiable function, 𝑢(𝑥, 𝑦), can be 
approximated (equation 2.24 and 2.25) using a central difference scheme derived from the 
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Taylor expansion of 𝑢(𝑥, 𝑦). Here	𝑑𝑥 and	𝑑𝑦 represents the spacing between measurements in 
the x and y direction respectively (Figure 2.23). The error between the approximate and the 
exact solution is called the discretization or truncation error, as it comes from the fact that only 
a finite part of the Taylor series is used in the approximation. For a sufficiently small spatial 
step	𝑑𝑥, the error associated is dominated by the term	𝑂(𝑑𝑥4), as all the higher order terms are 
neglected. Therefore, the step size (𝑑𝑥) must be small enough to keep this approximation valid.  
 
Figure 2.23: Finite difference approximation in a 2D grid. 
Using the Taylor expansion for 𝑢 around	𝑥: 
 𝑢(𝑥 + 𝑑𝑥, 𝑦) = 𝑢(𝑥, 𝑦) + 𝑑𝑥 ∗ 𝜕(𝑢	(𝑥, 𝑦) +
𝑑𝑥4
2 ∗ 𝜕((𝑢	
(𝑥, 𝑦) + ⋯ (2.22) 
 𝑢(𝑥 + 𝑑𝑥, 𝑦) = 𝑢(𝑥, 𝑦) + 𝑑𝑥 ∗ 𝜕(𝑢	(𝑥, 𝑦) + 𝑂(𝑑𝑥4) + 𝑠𝑚𝑎𝑙𝑙𝑒𝑟	𝑡𝑒𝑟𝑚𝑠 (2.23) 
We obtain the following expression for the first derivatives in a centred difference scheme: 
 𝜕(𝑢	(𝑥, 𝑦) =
𝑢(𝑥 + 𝑑𝑥, 𝑦) − 𝑢(𝑥 − 𝑑𝑥, 𝑦)
2𝑑𝑥  
(2.24) 
Likewise, for	𝜕L𝑢	(𝑥, 𝑦): 
 𝜕L𝑢	(𝑥, 𝑦) =
𝑢(𝑥, 𝑦 + 𝑑𝑦) − 𝑢(𝑥, 𝑦 − 𝑑𝑦)
2𝑑𝑦  
(2.25) 
This approximation can be extended for the computation of second order partial derivatives 
such as those in the mono-domain equations:  
 𝜕((𝑢	(𝑥, 𝑦) =
𝑢(𝑥 + 𝑑𝑥, 𝑦) + 𝑢(𝑥 − 𝑑𝑥, 𝑦) − 2𝑢(𝑥, 𝑦)
𝑑𝑥4  
(2.26) 
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 𝜕LL𝑢	(𝑥, 𝑦) =
𝑢(𝑥, 𝑦 + 𝑑𝑦) + 𝑢(𝑥, 𝑦 − 𝑑𝑦) − 2𝑢(𝑥, 𝑦)
𝑑𝑦4  
(2.27) 
Using the formalism presented above, the transmembrane potential for a 1D cable of couples 








The voltage of every cell at any time point (𝑡 + 𝑑𝑡) can be calculated on application of the 
numerical solvers, FE and FDM discussed earlier in the discretized form given by 
  𝑉('26' = 𝑑𝑡 {




| + 𝑉(' (2.29) 
Note that even though FDM is straightforward and easy to implement, representing smooth 
surfaces found in cardiac geometries with steps poses a challenge in implementing boundary 
conditions. This puts a further constrain on the space step needed to adequately represent curved 
surfaces with a computational grid used in the FDM. Besides, the time and space step are chosen 





FEM is an alternative approach very widely used in cardiac modelling and simulation 
[14,154,155]. In this method the complex geometries are divided into small sub-domains that 
can be of non-uniform size and shape. The solution within each domain is approximated via 
interpolation functions. An advantage of FEM over FD is that complex, curved geometries can 
be modelled accurately [156]. However, FEM comes with higher computational and 
development effort compared to FD [27]. 
Software implementation 
The monodomain simulations of 3D atria models were performed using a parallelized FD solver 
originally implemented and validated by Clayton et al. [157]. The solver was coded in C and 
adapted under MPI to run on a local HPC server. Furthermore, the C code was also time 
optimised by converting to Cuda and adapting it to run on a GPU cluster. On top of the existing 
code, additional modules for (i) modelling fibrotic tissue and (ii) calculating the running 
position of the RD tip were implemented in 3D. The mathematical formulation for the latter is 
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described in Appendix 8.1.3. Finally, for post processing, Matlab toolkits were developed for 
construction of RD probability maps and target areas from 3D atrial simulation data. 
2.5.4 Role of modelling and simulations in understanding AF mechanisms  
The last two decades witnessed a rapid growth in the complexity in 3D biophysical atrial models 
to improve their physiological accuracy and predictive power, and as a result, in their ability to 
provide valuable insights into the complex mechanisms underlying AF. This section presents a 
brief overview of the models integrating atrial structure, electrical heterogeneity, anisotropy 
and AF remodelling. 
The role of atrial shape and structure in wave propagation during AF has been studied using 
models with variable degrees of anatomical detail. Earlier studies [158–160] used caricature 
atrial geometries, whereas recent models [147,148,154] have integrated detailed structural data 
obtained from ex-vivo or in-vivo atrial imaging (MRI, computed tomography). These studies 
highlighted the importance of specialised atrial structures in AF mechanisms. Thus, the crista 
terminalis and pectinate muscles were found to play an important role in the formation and 
maintenance of RDs during AF [148].  
Electrical heterogeneity within the atria is another factor that can affect AF dynamics. 
Experimental data from animal [161,162] and humans [163] have indicated the existence of  
intrinsic regional variations in AP morphology and APD within the atria. These regional 
differences in AP can be incorporated into 3D atrial models by altering the underlying cellular 
ion channel properties, to match the respective experimental data obtained from myocytes from 
different atrial regions. Such region-specific electrophysiology has been considered in 3D atrial 
models under healthy and remodelled conditions [145,164]. Computational studies have shown 
that APD gradients in the atria can lead to the generation of RDs [145,165] and  increase the 
complexity of arrhythmia [166] during AF. Moreover, modelling and simulation studies have 
reported that the regional differences in APD could play a more important role that the presence 
of AF-induced electrical remodelling [164]. 
In addition to APD heterogeneity, the atria are also characterised by high levels of conduction 
anisotropy due to the underlying complex arrangement of myocardial fibres. The fibre 
orientation in the atrium can be obtained from ex-vivo images [44,148] and mapped onto the 
3D atria using rule-based methods [164,167]. Simulation studies in animals and humans have 
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suggested the combined effect of anisotropy and electrical heterogeneity increases both the 
vulnerability window for initiation of RDs and the duration of AF episodes, especially at the 
PV sleeves [145,165,168,169]. 
As mentioned above, AF progression is strongly linked to both electrical and structural 
remodelling (see Section 2.4.1.3 for more details). The former reduces APD and the latter slows 
down AP conduction, and hence, jointly they reduce the atrial wavelength (proportional to a 
product of APD and CV), which facilitates the initiation and maintenance of RDs. Krogh-
Madsen et al. [170], modelled structural remodelling in chronic AF by decreasing diffusive 
coupling uniformly across the atria in the presence and absence of electrical remodelling (the 
latter was modelled as reduced APD). They found that: (i) RD duration and maximum number 
of RDs was inversely proportional to the wavelength and (ii) in the absence of either structural 
or electrical remodelling, flutter like re-entry circuits were found at anatomical obstacles (e.g., 
the PVs and MV). However, the combination of both types of remodelling facilitated sustained 
RDs in atrial free walls. The study highlighted the importance of including both electrical and 
structural remodelling in the 3D atrial models to study AF dynamics. However, the studies cited 
above lack considered patient-specific atrial structural features.  
More recent whole atrial models have started to incorporate patient-specific 3D atrial structure 
and fibrosis distribution obtained from medical imaging data [15,171–173]. Fibrosis has 
typically been reconstructed from LGE-MRI and modelled as regions of altered electrical 
properties in atrial tissue (described in Section 2.5.5 below). Modelling studies have found that 
patient-specific fibrotic distribution in the atria plays a critical role in determining the locations 
of RDs [14,15,174]. Zahid et al. reported that RDs localise at specific fibrotic tissue regions 
with high density and entropy. These findings were confirmed by identification of such RDs 
using non-invasive mapping data in humans [13,56]. The correlation between RD locations and 
fibrosis was higher in the LA compared to the RA [13,56]. Note, however, that there also exists 
evidence against the correlation of RDs locations and fibrotic regions [175,176]. Such variable 
results indicate that the specific locations of RDs within the atria may not only be determined 
by fibrosis alone but by a complex combination of atrial structural factors (geometry, thickness 
and fibres) [173]. Therefore, the systematic evaluation of all atrial structural factors is important 
for understanding the mechanisms of AF. 
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2.5.5 3D atrial models with patient-specific fibrosis 
Atrial fibrosis is multifactorial (see section 0), and hence, several modelling approaches have 
been developed to model different aspects of atrial structural changes associated with fibrosis.  
Fibrotic regions are commonly modelled as regions with reduced electrical conductivity and 
altered anisotropy, to reflect the decreases in inter-cellular coupling due to gap junction 
remodelling and interstitial collagen deposition [14,15,171,174]. However, the transition 
between healthy and fibrotic regions have been modelled using two different approaches. Some 
studies [14,15] have used binary intensity LGE-MRI  thresholding to distinguish between 
healthy and fibrotic tissue, whereas others [171] gradually reduced the diffusive coupling and 
increased the anisotropy radio depending on the LGE-MRI intensity. The later approaches 
enabled reproducing local activations in the patient-specific LA models, which were in 
agreement with clinical data. Moreover, this approach was consistent with in-vivo 
measurements of conduction velocity (CV), which showed lower CV values in areas with high 
LGE-MRI intensity associated with fibrosis [177]. Similar approach was adopted by Morgan et 
al. [174] to represent patchy fibrosis in the patient-specific 3D atrial model and show that RDs 
can anchor primarily to the border zone between healthy and fibrotic tissue.  
Modelling and simulation studies have also investigated the arrhythmogenic potential of 
fibrotic regions (discussed in Section 2.4.2.1) using models with variable structural complexity, 
for example, to study the effect of fibrosis micro-structure. Spach et al. [178] have mimicked 
the effect of diffuse fibrosis by removing lateral gap junction coupling between myocytes. They 
showed that introducing such anisotropy in the models increased the likelihood of partial 
conduction block and formation of RDs. Subsequent studies have modelled collagen deposition 
by representing them as insulating barriers or obstacles in atrial tissue [179–181]. Jacquemet et 
al. [179] represented intestinal fibrosis by introducing random collagenous septa disconnecting 
cardiac fibres in the transverse direction and showed that reduction in transverse CV was 
proportional to the length of the collagenous septa. Costa et al. [180], Vigmond et al. [181] and 
Tanaka et al. [182] have introduced nonconductive regions with various sizes throughout tissue 
based on patient-specific fibrosis imaging data. These studies provided insights into the effect 
of fibrosis at the microstructure level and allowed mimicking fractionation of atrial 
electrograms observed at arrhythmogenic sites using EAM. Although the effects of fibrosis at 
Chapter 2: Mathematical Modelling and Simulations
   | 69 
 
 
this micro-scale are an important contributor to AF arrhythmogenesis, the inherent limitations 
of LGE-MRI prevent it from identifying such fine details [183]. Therefore, in patient-specific 
LA models reconstructed from LGE-MRI typically include large, continuous fibrotic patches.  
Fibroblast proliferation and coupling with myocytes [184] have also been incorporated into 
atrial models by Morgen et al. [174], Maleckar et al. [185], McDowell et al. [172] and Ashihara 
et al. [186]. They have shown that an increase in myocyte-fibroblast coupling and fibroblast 
density reduces excitability and promotes APD reduction, facilitating slower conduction and 
wave breakup. Furthermore, McDowell et al. [172] reported that myocyte-fibroblast coupling 
is a necessary condition for the generation of RDs during ectopic pacing at PVs. However, a 
more recent study performed by Morgen et al. [174] using atrial fibroblast model has shown 
that the effects of decreased inter-myocyte coupling and increased anisotropy in fibrotic regions 
on conduction are greater than those of myocyte-fibroblast coupling.  
Thus, 3D atrial models have progressively incorporated several levels of electrophysiological 
and structural details, down to image-derived features such as patient-specific fibrosis 
distributions. However, a recent study by Roney et al. [187] has demonstrated that although 
models with different level of detail enable reproducing different features of AF dynamics,  
none of them has so far produced an exact representation of clinical data. Therefore, individual 
studies should focus on electrophysiological and structural details that are relevant to the 
aspects of AF dynamics under consideration. In future, even closer integration between cell-to-
organ 3D atrial models, experimental and clinical data will be required to establish a truly global 







Chapter 3: Introduction and Motivation   | 70 
 
 
Chapter 3  
A Mechanistic Study:  
Drift of RDs induced by AWT gradients  
3.1 Section Outline 
This chapter aims to investigate the effect of atrial wall thickness (AWT) on the dynamics of 
re-entrant drivers (RDs) associated with atrial fibrillation (AF) and to compare it to other known 
effects such as those of atrial fibrosis. In this proof-of-concept study, all the simulations were 
performed using a simple 3D slab representation of the LA wall. The motivation behind 
investigating effects of AWT on re-entry is summarised in Section 3.2, and the steps involved 
in the model construction and simulations are discussed in Section 3.3. The simulation study is 
divided into two parts: (i) Study 1a (Section 3.4.1) investigates the effect of AWT on the RD 
dynamics and (ii) Study 1b (Section 3.4.2) investigates the comparative effects of AWT and 
fibrosis on RDs. Section 3.5 analyses the simulation results, dissecting the AWT effects on RDs 
and comparing them with competing influence of fibrosis. Finally, the limitations (Section 
3.5.3) and the main findings of the chapter are summarised (Section 3.6). 
3.2 Introduction and Motivation 
The three-dimensional structure of atrial tissue is an important determinant of electrical 
behaviour [148,188]. In particular, experimental studies in isolated sheep hearts [189] and 
theoretical studies [190] have indicated AWT to be a potential factor that influences the 
dynamics of RDs underlying arrhythmias in the heart. Junctions between thick and thin tissue 
regions could create a source-to-sink mismatch which may affect the RD propagation and even 
anchor RDs [190]. However, even recent theoretical studies using established concepts such as 
filament tension have not fully explained AWT effects of RDs [190]. Therefore, there is a need 
to elucidate the mechanisms by which RDs can be affected by non-uniform atrial structure.  
Moreover, it is also important to evaluate the effect of AWT in comparison to/combination with 
other well-established factors such as atrial fibrosis (discussed in Chapter 2, Section 0), which 
affects the atrial electrophysiology by altering conduction velocity and anisotropy of the atrial 
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tissue. Computational and clinical studies have reported an association between fibrotic regions 
and RDs, indicating it as a potential target for CA [174,177,191]. However, the understanding 
of how RDs are influenced by a combination of structural factors, such as fibrosis and AWT, is 
limited. Evaluating the combined effects of these factors can be important in the identification 
of locations of RDs that could ultimately be used to guide CA procedures. 
The complexity of atrial structure (including 3D geometry, size, heterogeneous wall thickness 
and curvature, fibre arrangement, development of fibrosis) and function (heterogeneity in 
electrical properties, innervation, etc.) makes it extremely challenging to quantify the effect of 
individual factors on AF arrhythmogenesis from experimental recordings. In this situation, 
biophysical modelling and simulations provides a platform for integrating all these underlying 
factors and evaluating the contributions of specific factors affecting AF independently. 
The aim of this chapter is to use a simple atrial model to systematically analyse the mechanistic 
influence of AWT features and fibrotic tissue on the dynamics of RDs sustaining AF. The atrial 
wall geometry is represented by a 3D slab, abrupt changes in AWT are modelled using a step, 
and fibrotic tissue is modelled using a cylindrical region of altered tissue properties. Further in 
the thesis (Chapter 4) we will extend this mechanistic study to patient-specific atrial geometries 
that capture both realistic AWT variations and fibrotic tissue distributions.  
 
Figure 3.1: Diagram of the 3D atrial tissue setup. (A) The internal structure of the crista-terminalis (CT) with the 
orange bar indicating the change in thickness profile in the surrounding area. The setups used in Study 1a and 1b 
are shown in part (B) and (C), respectively. In the diagrams, the thick region is indicated with dark grey and has a 
constant height of H+ = 7.5 mm in both setups, whereas the thin side shown in light grey: (i) in study 1a has a 
varying height, H- between 5.7 mm to 3 mm and (ii) in study 1b has a constant H- of 4.8 mm. In addition to change 
in thickness, setup 1b (C) also has a cylindrical fibrotic patch of diameter, d = 9 mm, positioned on the thinner 
side at distance, e = 10.5 mm from the step.  




The study in this chapter is presented in two parts: (i) in Study 1a, we perform simulations in 
an idealized 3D atrial slab with a varying thickness step (Figure 3.1, B) to evaluate the 
mechanistic influence of AWT on the RDs dynamics; (ii) in Study 1b, we use a single 
cylindrical fibrotic patch added to the slab near the step (Figure 3.1, C) to investigate the 
competing effects of fibrosis and AWT on RDs. 
3.3.1 Simulating cardiac electrophysiology  
The electrical activation in the 3D atrial model was simulated based on the monodomain 
equations with no-flux boundary conditions imposed at the slab boundaries (described in 
Chapter 2, Section 2.5.2). The equations were solved using forward Euler and centred finite 
differences schemes with temporal and spatial steps of 0.005 ms and 0.3 mm. Our model was 
isotropic and the diffusion tensor was replaced by a scalar diffusion coefficient D = 0.1 mm2 
ms-1, carefully chosen to produce an atrial conduction velocity of 0.60 m s-1 within a typical 
range of AF [192]. These parameters were found to generate stable numerical solutions for the 
explored conditions (Appendix, Section 8.1.2). For membrane kinetics the ionic current, 𝐼!$%, 
in equation 2.17 (Chapter 2, Section 2.5.2.1) we used the Fenton-Karma model [71] modified 
to accurately described the restitution properties of remodelled atrial cells [144]. This atrial 
Fenton-Karma (aFK) cell electrophysiology model accurately captures the main characteristics 
of atrial action potential and its restitution, while keeping the computational time relatively 
short. More details of the model are presented in Chapter 2, Section 2.5.1.3.  
In order to check the independence of the simulation results on the choice of model, a subset of 
the simulations in Study 1a was repeated using the Courtemanche-Ramirez-Nattel (CRN) 
model [136], which describes atrial electrophysiology in more detail (Chapter 2, Section 
2.5.1.4). The latter has also been modified to match the restitution properties of remodelled 
atrial cells [145]. The APD90 restitution curves were found to closely match between aFK and 
remodelled CRN (Appendix, Figure A. 1). The diffusion coefficient for the CRN model was 
also chosen as 0.16 mm2 ms-1 to produce an atrial CV of 0.60 m s-1, same as in the aFK model.    
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3.3.2 Study 1a: Influence of AWT step on the RD dynamics 
Model Geometries: The simulations were performed on a 3D atrial tissue slab of 200 x 200 x 
25 voxels corresponding to a tissue size of 60 x 60 x 7.5 mm3 with a surface area of 3600 mm2, 
similar to that of the LA [193]. A diagram of this setup is presented in Figure 3.1B. Here, an 
AWT step was introduced at the middle of the slab, with thickness of the right-hand side (H+) 
fixed at 7.5 mm and that of the left-hand side (H-) was varied between 5.7 mm and 3 mm. Four 
atrial geometries were defined, H1 to H4 with H- ∈	{5.7,	4.8,	3.9,	3.0}.	Detailed description of 












H1 5.7 1.8 
H2 4.8 2.7 
H3 3.9 3.6 
H4 3.0 4.5 
Table 3. 1: The properties of the 3D atrial slabs (H1-H4). 
Simulation Protocol: RDs were initiated using the cross-field protocol shown in Figure 3.2. 
An S1 stimulus was applied by introducing a voltage step (voltage: 1 (aFK) and 20 mV (CRN); 
duration: 1 ms) to part of the tissue slab 0.15 x 60 x 7.5 mm3, initiating a plane wave with the 
wavefront parallel to the AWT step (Figure 3.2, A). After 70ms, an S2 stimulus was applied in 
the direction perpendicular to the wavefront, by resetting the voltage (voltage: 0 (aFK) and 20 
mV (CRN); duration: 2ms) in part of the tissue 60 x (30 + X) x 7.5 mm3 (Figure 3.2, B). The 
S1-S2 interval and the location X was varied to initiate RDs at multiple locations. In Study 1a, 
the location X was varied from 7.5 mm to 0 mm in steps of 1.5 mm on both sides of the step 
(Figure 3.2E). This was also repeated using the CRN model to check the independence of results 
on the model choice. The RDs tip trajectory was tracked for 10s in each simulation. 




Figure 3.2: The RD initiation protocol in the slab with an AWT step and varying stimulus locations. The change 
in voltage (V) over time on the flat top surface of the slab is presented above (A-D), where (A) show the S1 
stimulus applied at 0 ms, (B) the S2 stimulus applied at 70 ms and X indicates its position with respect to the AWT 
step. Panels (C-D) show the evolution of a RD over time. The diagrams in the panels below show all the different 
locations of the S2 stimulus (marked by a black circle) used for Study 1a (E) and Study 1b (F).   
Identifying and tracking the RD tip: The algorithm for tracking  the RD tip was adapted from 
the method described previously [71] and developed here for a 3D atrial tissue slab. The 
curvature of the wavefront is highest at the tip of the RD, and hence, it can be assumed [68] 
that the velocity at the tip (which is inversely proportional to the curvature) is approximately 
zero and the voltage does not change over small-time intervals. Therefore, in a given 2D plane 
(Figure 3.3), if the voltage, V, varies over time, t, at locations indicated by grid point (𝑥!, 𝑦M), 
then the tip is located at point p which satisfies the following interlinked equations: 
 𝜕𝑉
(𝒑, 𝑡)
𝜕𝑡 = 0	 
(3.1) 
 𝑉(𝒑, 𝑡) = 𝑉(𝒑, 𝑡 + 𝑑𝑡) = 	𝑉!&$			 (3.2) 
 
 




Figure 3.3: The steps involved in identifying the tip of the RD. (A) The spiral wave in a 2D cross-section of the 
plane-slab (Figure 1, H0). (B) Zooming in on the tip site and (C) tip location identified by bilinear interpolation at 
individual pixel level at a point in time. 
Following this assumption [68], the tip of a RD is identified by calculating the intersection point 
between two successive (i.e., separated by a time interval 𝑑𝑡) iso-potential lines of constant 
membrane potential (𝑉NOP) representing a boundary between the depolarized and repolarized 
regions of the tissue (Figure 3.3A). In our model, the tip tracking was performed with 𝑉NOP and 
𝑑𝑡 values set to 0.8 and 0.005 ms, respectively. However, the desired intersection point might 
not lie at the sampled grid points (Figure 3.3B) and could therefore result in a resolution-
dependent tip trajectory. In order to overcome this issue, Fenton et al. [71], proposed  using 
bilinear interpolation to approximate 𝑉(𝒑, 𝑡)	and 𝑉(𝒑, 𝑡 + 𝑑𝑡), which allows for more precise 
calculation for the RD tip position (Figure 3.3C). The steps involved in this interpolation and 
calculation of the RD tip are presented in detail in Appendix 8.1.3. In addition to tracking the 
RD tip, we also computed the velocity of the tip over the entire duration of the simulation at a 
time resolution of 1 ms. These calculations were performed on a 2D slice taken from the middle 
of the 3D slab. An example of the tracking of the RD tip and calculation of the tip velocity is 
presented in Figure 3.4 for a period of 1s. 




Figure 3.4: The hypotrochoidal (“flower-like”) pattern traced by the RD tip over time. Row 1: the snapshot of the 
voltage map of the RD at different instances of time (150 ms to 1000 ms). Row 2: the corresponding RD tip 
trajectory colour coded in time and Row 3: the corresponding tip velocity while the trajectory is being tracked. In 
rows 1 and 2, the axes labels are in units of mm. 
Tracking RD core and measuring drift velocity: The RD was undergoing two simultaneous 
motions: (i) meandering of the RD tip around a central core to form a flower-like pattern and 
(ii) a vertical drift due to the presence of the thickness gradient. In this study, we were 
particularly interested in the vertical drift motion induced by the presence of the AWT step. 
Therefore, the drift velocity of the RD for all the models was computed by tracking the central 
core of the flower-like pattern formed by the RD tip every second (Figure 3.5). As this pattern 
was symmetrical, the core was identified by surrounding the pattern with a square bounding 
box and computing its centre as shown in Figure 3.5A. The core was identified every 1s in order 
to track the movement (two examples, Figure 3.5 B & C) of the RD over 10s of simulation, and 
its drift velocity (Figure 3.5C) was computed by measuring the vertical displacement of the RD 
core over time (Figure 3.5D). 




Figure 3.5: Steps to track the RD core and calculate its drift velocity. Step 1, (A) identifying the core (black star) 
of the meandering trajectory of the RD tip (rainbow colour) using the centre of the bounding box (white). Step 2, 
tracking the RD core (X) every 1s; here we show two examples of RDs initiated at: (B) location 1 on the thinner 
side and (C) location 2 on the thicker side of the model H1. Here, t1 to tn indicate different locations of the core 
over 10s of simulation, which are connected using a black line to mark the path of the RD’s drift. Finally, in Step 
3 (D), the distance time plot for every location is generated and the slope is used as an estimate for the drift velocity. 
Computing Electrophysiology Metrics:  In order to evaluate the effect of AWT step on wave 
propagation, electrophysiology metrics, APD90 and CV, were computed for all the slab models 
of varying step height (H1-4) using the S1 stimulus applied after pre-pacing at a BCL of 400 
ms for 10 beats to achieve steady-state (Figure 3.6). The metrics were then quantified on the 
11th beat. Two separate wavefront propagation directions were considered: forward (initiated 
on the thicker side) and backward (initiated on the thinner side). The APD90 was defined as the 
time interval between the moments of AP initiation and 90% repolarization.  
 




Figure 3.6: CV and APD measured for forward and backward wave propagation directions. The left panels show 
the APD and CV profiles along a vertical line crossing the middle of the slab (black dotted line in A-B) in the 
plane just below the step.  
3.3.3 Study 1b: Comparative influence of fibrosis and AWT step on the RD dynamics 
Model Geometries: In Study 1b, the comparative effect of AWT and fibrosis on the RD 
dynamics was investigated by incorporating a cylindrical fibrotic patch of 9-mm diameter 
positioned 10.5 mm away from the AWT step on the thinner side (Figure 3.1, C). This was done 
for slab H2 with the step height of 2.7 mm. The rationale of placing the fibrotic region on the 
thinner side of the step was to mimic conditions when fibrotic tissue could be present in regions 
surrounding thick structures such as the crista terminalis (CT) in the RA. 
Model Parameters: To model patchy fibrosis, we adopted the methodology from the study of 
Morgan et al. [174]. Each fibrotic patch was divided into 5 distinct levels representing 
increasingly severe fibrosis. The diffusion coefficient D was progressively decreased by 
Chapter 3: Methods   | 79 
 
 
16.67% to model the effect of fibrosis on slowing atrial conduction in fibrotic regions: level 0 
corresponded to healthy tissue with D = 0.1 mm2 ms-1; inside the fibrosis patch, the value of D 
for levels 1 to 5 was 0.083 mm2 ms-1, 0.067 mm2 ms-1, 0.050 mm2 ms-1, 0.033 mm2 ms-1 and 
0.017 mm2 ms-1, respectively. We did not use the value D = 0 for level 5, because there is no 
experimental evidence suggesting that dense fibrotic regions are completely non-conductive. 
Stimulation Protocol and Analysis: RDs were initiated at multiple sites using the same cross-
field protocol as in Study 1a. However, in this case, the location of the S2 stimulus, X was 
varied relative to the step and the fibrotic patch (Figure 3.2F): (i) 4.5 mm away from the step 
on the thick side (column P), (ii) on the step (column Q), (iii) 7.5 mm (column R) and (iv) 
15mm (column S) away from the step on the thin side. The RD tip trajectories were analysed 
to explore their dynamics in each case. The choice of 4.5 mm as the extreme limit of the RD 
initiation distance to the left of the patch was to ensure that the RDs was sensitive only to the 
AWT gradient and not the fibrotic patch. Likewise, the choice of 15 mm as the extreme limit 
on the right side was to ensure the sensitivity of RDs only to the fibrotic patch. The tip of the 
RDs for all the simulations were tracked using the method described in Study 1a.   
 
Figure 3.7: CV and APD measured on the slab with a step and fibrotic patch. The left panel shows the APD and 
CV profile along a vertical line crossing the middle of the slab (black dotted line in A-B). 




3.4.1 Study 1a: 3D Atrial Slab with AWT step 
The RDs initiated in the 3D atrial tissue slab meandered to form a characteristic hypotrochoidal 
(“flower-like”) pattern, with the RD tip moving along the “petals” in the outward clockwise 
direction around a central core (Figure 3.4). The velocity of the RD tip was recorded as it was 
following the flower-like trajectory and presented in Figure 3.4, A3-E3. During the petal 
formation by the RD tip, the wavefront at the tip propagates through a region which is 
completely recovered, thereby giving the maximum curvature of the trajectory, with the tip 
propagating at 2.76 ± 0.37 m/s (Figure 3.4, A). However, when the tip is tracing an arc, the 
wavefront at the tip propagates through a region that is not completely recovered (Figure 3.4, 
B). This causes the front to propagate in another direction, where the tissue is more excitable. 
This deviation generates the low curvature part of the trajectory or the arc with tip propagating 
at a much lower velocity of 0.38 ± 0.19 m/s. This process occurs periodically, and the trajectory 
shown in Figure 3.4C is generated, which is being referred to as “the flower-like pattern”. This 
pattern was stable over the duration of 10s, its radius was 10.4 mm, and the RD tip motion to 
complete one rotation around the pattern took 500 ms (Figure 3.5, A).  
With the introduction of a step change in AWT in the slab (Figure 3.5, B and C), in addition to 
meandering around the core, the RD also drifted in a direction perpendicular to the direction of 
AWT change. Moreover, in these cases, the direction and nature in which the RD drifted was 
dependent on its initiation location with respect to the step and the step height.  
3.4.1.1 Effect of varying S2 stimulus location from the AWT step on RDs 
A map of trajectories for RD initiated from different locations (shown in Figure 3.2, E) using 
all the 4 models (H1-4, Table 3. 1) with varying step height is shown in the Appendix, Figure 
A. 5. In the main text, Figure 3.8 and Figure 3.9 present a simplified version of the former 
figure, summarising the key behaviours and drift directions observed from these representative 
simulations.  
The core of RDs initiated on the thicker side (L1, Figure 3.8D) first drifted towards the AWT 
step, eventually crossing it and drifting along it on the thinner side. The core of RDs initiated 
on the thinner side (L2-3, Figure 3.8D), on the other hand, drifted towards the step and along 
it, but didn’t cross over to the thicker side. Besides, RDs that were initiated far away from the 
step (Appendix, Figure A. 5) were not influenced by the AWT gradient and remained stationary. 
Chapter 3: Results   | 81 
 
 
This behaviour can be more noticeably observed in Figure 3.9A, where the trajectory of the RD 
is shown for each slab of increasing step height (H1-H4). Here, it can be clearly seen that after 
the RD anchored to the step, its core moved vertically along the step at a specific distance from 
it. The core always drifted on the thinner side, and its distance from the step decreased with 
increasing the step height (Figure 3.9 (i-iv)). For the chosen aFK model parameters with a 
diffusion coefficient of 0.1 mm2/ms, the RDs anchored to the AWT gradient if they were in the 
range between 1.8 and 4.5 mm (H1-4) from the step, when they were initiated on the thick side, 
or less than 12 mm (H1-3) / 15 mm (H4) on the thin side.  
3.4.1.2 Effect of varying AWT step height on RD velocity 
The RD drift along the AWT step became faster as the height of the step (H1- 4) was increased. 
The drift velocity was computed by measuring the vertical displacement of the RD core over 
time, which was done for each model (H1-4) as shown in Figure 3.9B. The drift velocity was 
2.3 mm/s for the smallest step H1 and 4.8 mm/s for the largest step H4, both measured for the 
initial location L1 on the thick side (Figure 3.8D) Similarly, for the initial location L3 on the 
thin side, drift velocity was 2 mm/s for H1 and 4 mm/s for H4. Therefore, drift velocity of the 
RD core increased with increasing the AWT gradient. Note that the direction in which the RD 
meanders to form the petals (clockwise in these simulations), and hence the direction of drift 
along the step (downwards here) is determined by the cross-field initiation protocol. However, 
the anchoring of the RD to the thickness step does not depend on the wave’s chirality. 
Additionally, with the introduction of the AWT step and its increasing height, the velocity of 
the RD tip was recorded, while the tip zigzagged between the thick and thin side of the step, 
and showed a large variation in peak velocity (Figure 3.10, B1-B3) compared to the control 
case of a uniform slab (Figure 3.10, B0). The RD tip moved from the thick to thin region of the 
slab (red dots, 2.13 ± 0.18 m/s) with an average higher velocity compared to the velocity with 
which it moved in the opposite direction (black dots, 0.4 ± 0.11 m/s). Moreover, the maximum 
velocity recorded for tips moving from thick to thin side of the step increased from the 
maximum velocity of 3.4 m/s in control to 4.43 m/s, 5.38 m/s, 6.56 m/s for slabs H2-H4. 
Therefore, as the height of the step was increased, the tip velocity when it moved from the thick 
to thin region also increased.  
 




Figure 3.8: Effects of AWT step on the RD dynamics in atrial slab (Study 1a) with the aFK model. Tip trajectories 
obtained by simulation of RDs at multiple locations on a 3D atrial slab with varying step height (H1-4): (A) RDs 
meander to form a flower-like pattern that was stationary in a slab with uniform thickness, but (B) in the slab with 
an AWT step, drifted towards and then along the step. (C) Outcome of the simulations for different RD initiation 
sites and step heights. (D) The RD tip trajectories for three initiation locations (L1-3): L1) on the thicker side 
closer to the step – RD drifted towards the thinner side and then downwards along the step, L2) on the step – RD 
drifted down along the step and L3) on the thinner side – RD drifted towards the step and then down along the 
step. A detailed version of Panel (D) can be found in Appendix, Figure A. 5. 




Figure 3.9: Effect of AWT gradients on the drift velocity of RDs in a slab (Study 1a) with aFK model. (A) 
Trajectories of the core of RDs initiated at multiple locations on the slabs with varying step height (H1-4, see 
Figure 3.8D) is shown with lines of different colours. Here the X marks the site of the initial RD core for every 
location and the white dashed line in each slab indicates the location where the core of all the RDs stabilised after 
anchoring to the AWT step. (B) Vertical displacements of the RD core for locations L1 on the thick side and L3 
on the thin side of the step (shown in Figure 3.8D) over 10s are shown in panel (B(i)) and (B(ii)), respectively, for 
each of the slabs with height H1-H4. As the height of the step was increased, the velocity of the vertical drift of 
the RDs also increased. 




Figure 3.10: Effect of AWT gradients on the tip velocity of RD as it zig-zagged between the thick and thin region 
of the atrial slab. The RD tip trajectory over 6s in the control uniform slab and the slabs with increasing AWT step 
height (H2-H4) is shown in A0 and A1-A3. The corresponding tip velocity for each case is presented on the left 
in B0 and B1-B3. In red, are all the points at which the tip transitioned from the thick to the thin side while in 
black are all the points at which the tip moved in the opposite direction. The velocity at the tip recorded in the 
former cases (red) is generally much greater than the latter (black) in cases H2-H4, approximately by ~81%. 
Moreover, the maximum tip velocity recorded increased from 3.4 m/s in control to 4.43 m/s, 5.38 m/s, 6.56 m/s 
for slabs H2-H4, indicating a relation between increase in the step height and tip velocity at the junction.    
3.4.1.3 Effect of change in atrial electrophysiology model on RDs  
Simulations of the 3D slab with the CRN atrial cell model demonstrated similar behaviour of 
the RDs (Figure 3.11). The RD tip in the CRN-based model also meandered to form a flower-
like pattern with radius of 12 mm and one complete rotation around the pattern taking about 
700 ms. Similar to the aFK-based model, anchoring of the RDs to the AWT step was observed, 
indicating that the anchoring phenomena is model-independent. 




Figure 3.11: Effects of AWT step on the RD dynamics in 3D slab with the CRN atrial cell model (Study 1a). The 
characteristic flower-like pattern formed by the RD tip was stationary on a uniform thickness slab (bottom panel) 
and drifted towards and then along the step for the slab with AWT gradient (other panels). The core of RDs initiated 
on the thicker side of the 3D slab crossed over to the thinner region before drifting along the step. Black arrows 
indicate the direction of the drift.  
3.4.2 Study 1b: Comparative effect of AWT and fibrosis on RDs 
Results of the simulations comparing the effects of AWT and fibrosis in the 3D slabs are shown 
in Figure 3.12 for all 12 different locations (Figure 3.2, F) of the RD initiation, with both the 
AWT step height (H2, 2.7 mm) and location of the synthetic fibrotic patch kept constant.  
In control cases of the AWT step only and the fibrotic patch only (Figure 3.12, A and B, 
respectively), the RDs either drifted towards and anchored to the step (9 out of 12 locations) or 
anchored to the fibrotic patch and drifted in a clockwise direction around it (4 out of 12 
locations). Note that the RDs did not anchor when initiated at a distance of 12 mm (Figure 3.12, 
A) and 10.5 mm (Figure 3.12, B) from the AWT step on the thinner side and fibrotic patch, 
respectively.  




Figure 3.12: Competing effects of AWT and fibrosis in the 3D atrial slab (Study 1b). Outcomes of the RD 
simulations performed for 12 initiation locations (P1 to S3) with: (A) a step change in AWT, (B) a cylindrical 
fibrotic patch (shown with a black circle), (C) both AWT step and fibrosis. In cases (A) and (B), RDs anchored to 
the step (for locations marked with a filled black circle) and fibrotic patch (for locations marked with black 
diamond), respectively. White circles mark locations where the RDs did not anchor to either. In case (C), the 
majority of the RDs anchored between the AWT step and fibrotic patch (for locations marked with a black 
triangle). These RD tip trajectories on the top surface of the 3D slab are shown for the 12 locations (P1 to S3) in 
the panel (D). Black arrows indicate the direction of RD core drift, and black squares mark locations where they 
became stationary and anchored. 
In the presence of both the AWT step and the patch together (Figure 3.12C), the majority of the 
RDs stabilised and anchored between the patch and the step (8 out of 12 locations). Analysing 
the RD trajectories in the latter case (Figure 3.12D), we found that RDs initiated on the thicker 
side, which were insensitive to the fibrotic patch alone, now drifted towards the patch located 
in the thinner region due to the influence of the AWT gradient. Once the RDs reached the region 
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between the AWT step and the fibrotic patch, they could either drift downwards along the step 
or drift rightward and rotate clockwise around the patch. Opposing influences from the AWT 
step and the fibrotic patch in this case can cancel each other out, with the RD becoming 
stationary and anchoring between the two structures. 
Furthermore, in case of location R2 (highlighted in Figure 3.12D), increasing the step height 
from H2 to H4 caused the RDs to anchor to the step (Appendix, Figure A. 6). However, 
increasing the distance between the step and the RD initiation site (from 7.5 mm to 15 mm), 
while preserving the distance between the initiation site and the patch, resulted in the RD 
anchoring to the patch (Appendix, Figure A. 6).  
3.5 Discussion 
The computational study performed on the 3D atrial tissue slabs enabled us to successfully 
evaluate the mechanistic influence of AWT step and fibrotic tissue on the drift and anchoring 
of the RDs sustaining AF. The key findings of the presented work are: (1) the sharp gradients 
of AWT act as anchoring locations for RDs; (2) in the presence of fibrosis, the AWT step acts 
as a competing attractor for the RDs. Such AWT gradients are commonly present between the 
RA wall and the CT and pectinate muscles [194] and could help explain the presence of RDs at 
these sites recorded in animal experimental models [173,189].  
The drifting behaviour of RDs caused by variation in myocardial thickness has previously been 
studied by Biktasheva el al. [190]. However, their numerical study was limited to simple 2 
variable ionic cell models (FitzHugh-Nagumo and self-oscillatory Oregonator model) and has 
not explained the mechanism underlying the anchoring of RDs to the AWT step. The study 
presented in this chapter reproduced their findings using the FK ionic model for remodelled 
atrial cells [71] and CRN model [136] that provides a detailed description of ionic currents and 
AP.  
The atrial FK and CRN models have slightly different shaped hypotrochoidal (“flower-like”) 
patterns. The latter (Figure 3.11) is more asymmetric with longer period of rotation compared 
to the former (Figure 3.8), which effects the drift velocity. Since both models have similar APD 
restitution curves (Figure A.1), the differences in meandering patterns could be explained by 
the differences in excitability of the underlying medium determined by the model parameters. 
However, despite these differences the anchoring of the RD to the AWT step was consistent 
between the models and the relationship between increase in height and increase in the drift 
Chapter 3: Discussion   | 88 
 
 
velocity was preserved. This suggests that the anchoring of RDs to regions with large AWT 
gradients is a model-independent phenomenon and is a purely structural effect inherent form 
the geometry. 
Furthermore, our study explored the underlying mechanisms. Our simulation results identified 
two factors that affected RD anchoring to the AWT step: (i) the position (thick or thin side) and 
distance from the step at which the RDs are located and (ii) the height of the step itself. 
3.5.1 Influence of the AWT step parameters on the RD dynamics 
The patterns of RD drifting and anchoring were investigated by initiating the RDs at multiple 
locations around the thick and thin areas of the slab (Figure 3.2E). Our results showed that only 
RDs initiated within a short distance from the AWT step ultimately anchored to it (Figure 3.8C). 
For our choice of model parameters, this distance range was 4.5 mm on the thicker side and 12 
mm (H1-3) to 15 mm (H4) on the thinner side from the step. RDs located within this range, 
however, showed two distinct patterns of anchoring, which depended on their position with 
respect to the step (Figure 3.8D). If initiated on the thicker side, RDs first drifted across the 
AWT step into the thin region and then drifted along the step. If initiated on the thinner side, 
RDs drifted towards the AWT step and remained on the same side, while drifting along the 
step. Moreover, the velocity with which the RD tip crossed over from the thick to the thin region 
(Figure 3.10, 2.13 ± 0.18m/s) was substantially higher than the tip velocity in the opposite 
direction (Figure 3.10, 0.4 ± 0.11m/s). These results suggest that the presence of a thickness 
step facilitates the anchoring of RDs exclusively on the thinner side of the step.  
The effect of the AWT step height on the anchoring of RD was investigated by using 4 atrial 
slab models of the increasing height (Table 3.1). AWT of the thicker side of the slabs (7.5 mm) 
was comparable to the range of 4.2 ± 1.2 mm to 6.3 ± 1.5 mm observed for CT in the RA [194], 
while the AWT of the thinner side (3 mm – 5.7 mm) was representative of AWT for the RA 
wall [195]. Our simulation results showed that an increase in the height of the AWT step leads 
to an increase in velocity with which the RDs drift along the step (Figure 3.9). This result is 
consistent with theoretical predictions by Biktasheva et al. [190], where the drift velocity of the 
RD was reported to be proportional to the height of the step. Note that the RD drift was absent 
for AWT step height of 0.3 mm, which is the resolution of the mesh used for the simulations. 
Moreover, for a thickness gradient below 1 mm, the drift velocity was negligible (< 1 mm/s). 
Therefore, critical thickness for observing RD drift is approximately 1 mm. However, it should 
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be noted that this value may be affected by model parameters (diffusion coefficient, excitability, 
etc.) and the location of the RD with respect to the step. The mechanism underlying the increase 
in drift velocity with increase of AWT step height could be linked with increasing source-sink 
mismatch, which facilitates faster condition in the direction along the gradients. 
3.5.2 Mechanisms of the AWT step effects on the RD dynamics 
We hypothesize that the drift of RDs towards regions of high AWT gradients and their 
subsequent anchoring is likely to be based on a large source-to-sink mismatch at the step 
between thin and thick tissue. Previous theoretical work by Wang et al. [196] and computational 
studies by Cherry et al. [197] and Connolly et al. [198], have explored the effects of tissue 
geometry on electronic modulation of repolarization. We believe that anchoring of RDs to the 
step between thick and thin tissue is a similar case, where repolarization and CV at the AWT 
gradient are altered due to source-to-sink mismatch, which facilitates the anchoring. 
3.5.1.1 RD drift from thin to thick side of AWT step 
The case of the RD tip propagating from the thin to thick side of an AWT step is shown in 
Figure 3.13, A-B. We hypothesise that an electrotonic current resulting from the source-to-sink 
mismatch at the step changes CV in the surrounding tissue, and the reduced CV helps stabilise 
the RDs in these locations. The simulation results confirmed our hypothesis by showing a 
decrease in CV from 0.6 m/s to 0.54 m/s (Figure 3.6, C and G) when a plane wave propagated 
from thin to thick side of the step. Moreover, the wavefront at the RD tip (Figure 3.13A) 
encounters a region of prolonged APD (+5 ms, Figure 3.6, D and H) due to the electrotonic 
effects at the AWT step. The latter are due to uneven electrotonic loading of the cells at the step 
by their neighbours from the thin and thick sides, which generates an inward current to the 
earlier repolarized cells and prolongs their APD [197,199]. As a wave propagating from the 
thin to thick side at the AWT step encounters lager number of cells upstream vs. downstream, 
APD is increased on the thin side (Figure 3.6D). Previous computer models and experimental 
studies have shown that in the presence of APD or CV gradients, RDs drift towards regions of 
longer APD [74,200,201] and slower propagation. For waves propagating from the thin to thick 
side, the AWT step meets both these conditions, and hence the RDs remain localised to the thin 
side of the step. 
 




Figure 3.13: Changes in the RD wavefront during propagation at the AWT step. Colour coded voltage maps 
showing the behaviour of the RDs in a slab with the AWT step (A-C, H4) and in a control uniform slab (D-F, H0) 
at different moments of time. In Panel G, the corresponding RD tip trajectories over the 40 ms are overlaid to show 
the trajectory changes between the step (blue, A-C) and control case (red, D-F). In the presence of the step, the tip 
moves vertically down before entering the thick part of the slab (G, A-B). This additional vertical drift accumulates 
over 700 ms and results in drift of the RD along the AWT step (H). In the absence of the step, the RD traces a 
perfect arc (G, D-E) and the flower-like pattern remains localised at the same position of the slab (I).   
Moreover, the prolonged APD at the step acts like a barrier preventing the spread of current 
produced by the wavefront: the effect of this can be seen as a characteristic notch on the RD 
wavefront (Figure 3.13B), which is absent in control (Figure 3.13E). This is equivalent to a 
local decrease in excitability of the tissue close to the step, and therefore an increase in the 
curvature of the trajectory [71], which results in the drift of the RD tip along the step (Figure 
3.13, G-H). An example trajectory of the RD tip travelling from the thin to thick side and back 
is shown in Figure 3.13G, where the trajectories in the presence and absence of AWT step in 
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the slab are overlaid in blue and red, respectively. In the former case, the tip encounters 
refractory tissue towards the thick side of the step. This causes the wavefront to propagate 
downwards along the step before entering the thick region, where the tissue is more excitable. 
This deviation increases the curvature of the trajectory, and the petal is formed at a lower 
position compared to control (Figure 3.13G). Furthermore, across a period of 700 ms, periodic 
interactions of the RD tip with the AWT step results in drift of the RD tip along the step (Figure 
3.13H) compared to control (Figure 3.13I). Similar mechanism has been proposed for RD drift 
and anchoring to non-excitable or partially excitable obstacles, such as fibrotic regions and 
ablation scar [202]. In our case, it explains the drift of the RD tip along the AWT step observed 
in our simulations and a lower RD tip velocity recorded during propagation from the thin to 
thick region compared to the opposite direction. 
3.5.1.2 RD drift from thick to thin side of AWT step 
Thus, wave propagation from the thin to thick side slows down due to source-sink mismatch at 
the step. Conversely, wave propagation in the opposite direction should speed up. Our CV 
measurements during plane-wave propagation were unable to capture this effect (Figure 3.6A). 
However, the velocity of the RD tip travelling from the thick to thin side was greater than that 
in the opposite direction (Figure 3.10). Moreover, in this case, the electrotonic loading effects 
at junction results in a decrease of APD (‒3 ms, Figure 3.6, B and F). Therefore, during wave 
propagation from the thick to thin side, the reduced APD coupled with increased CV does not 
facilitate the RD drift of towards the junction. This could explain why the RDs initiated on the 
thick side were not influenced by the present of the AWT step, unless the radius of the flower-
like pattern directly overlapped with the step location. Only in the latter cases, once the RD tip 
drifted to the thin side, the effects of source-sink mismatch described above prevented its return 
to the thick side and facilitated the RD anchoring to the AWT step on the thin side.  
3.5.1 Competing influence of fibrosis and AWT on RDs 
Fibrotic tissue in the atrial myocardium is widely believed to be one of the most important 
substrates that promotes abnormalities in local AP conduction and facilitates AF perpetuation 
[174,177,191]. However, the role of fibrosis in anchoring RDs has never been compared with 
other atrial structural features that can also affect the RD dynamics, such as sharp gradients in 
AWT observed within the atrial geometries.  
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For the first time, we showed the RD anchoring between regions with a sharp AWT gradient 
(such as the CT region) and local fibrosis patches. Hence, locations of the RD stabilisation in 
the atria can be strongly influenced by both the presence of fibrosis, as predicted in previous 
studies [15,174], and the AWT gradients. These results can be explained by relative effects of 
(i) fibrotic patches providing slow conduction zones anchoring RDs (Figure 3.7), and (ii) large 
AWT gradients creating substantial source-to-sink mismatches. Therefore, atrial tissue regions 
between a fibrotic patch and a large AWT gradient experience both competing influences and 
are most likely to anchor RDs. In addition, our simulations showed that RDs anchored to the 
fibrotic patch only when they were initiated further away from the AWT step. Hence, anchoring 
of the RDs to either the AWT gradients or fibrotic patches may depend on 1) their comparative 
ability to provide suitable substrate and 2) their relative distance from the RD initiation site. 
The specific detail in which the RDs anchor to fibrotic regions and their implications in patient-
specific AF models will be investigated in further detail in Chapter 4 and 5.  
3.6 Limitations 
Previous simulation studies have reported complex fibre orientation to have significant effects 
on atrial conduction [148,165]. In this study, however, we did not consider fibre orientations in 
the modelling approach specifically because we wanted to evaluate the effect of thickness 
independently in the absence of other factors which could influence the behaviour of the RDs. 
This is the main limitation of our work as abrupt changes in fibre orientations have been 
previously reported to affect the RD dynamics. Understanding the combined effect of AWT 
gradient and anisotropy warrants future investigation. Note also that the aFK model developed 
by Goodman et al. [144] was based on data from tachypaced sheep atrial cells, due to a lack of 
equivalent human data. However, comparison of APD between the aFK model and in the CRN 
model for a remodelled human atrial myocyte showed a good agreement between the two 
models: less than 5% difference in APD in the considered range of frequencies between 6-10 
Hz. Moreover, the main result of the study – that RDs anchor to regions with large AWT 
gradients – was qualitatively similar between the aFK and CRN models.  
Another limitation of this study is a simple representation of the atrial structure with a 3D slab 
geometry with a sharp transition in the AWT at the step. Such sharp transition in tissue 
properties is a simplification of the variety of thickness gradients observed in atrial anatomical 
structures, such as the crista terminalis, pectinate muscles, etc. However, as our primary 
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objective was to elucidate the mechanisms underlying the anchoring effect of a single AWT 
gradient, using the simple model was warranted. In the next Chapter, we will consider the 
dynamics and anchoring of RDs in realistic 3D atrial geometries with patient-specific AWT 
and fibrosis distributions. 
3.7 Conclusions 
This chapter elucidated the role of AWT in the dynamics of RDs and compared the AWT effects 
with the respective effects of fibrosis. The main finding is that sharp gradients of AWT provide 
anchoring locations for RDs. In this sense, AWT gradients have a comparable effect on RDs as 
fibrotic tissue, and hence both factors can equally influence RD activity during AF. 
Furthermore, we have elucidated the mechanism underlying the anchoring of RD to regions of 
sharp AWT gradients and concluded that drift and anchoring of RDs is dependent on the 
amplitude of the AWT gradient, as well as distance of the RD initiation site from the gradient. 
Therefore, it is important to consider the role of structural features with large AWT gradients, 
such as the CT in the RA, when identifying the RDs locations during AF treatment planning.   
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Chapter 4  
Image-Based Computational study:  
Role of Patient-Specific AWT and Fibrosis  
4.1 Section Outline 
This chapter aims to investigate the influence of AWT gradients on the RD dynamics in realistic 
3D atrial geometries and evaluate the comparative effects of patient-specific AWT gradients 
and fibrosis distribution. In the previous chapter, the effect of AWT on RDs was evaluated 
using a simple 3D slab model (Study 1 above). In this chapter, this study is extended to realistic 
RA and LA geometries. The motivation for investigating AWT and fibrosis is first described 
(Section 4.2), and the protocols used for constructing patient-specific RA and LA models and 
performing simulations are then detailed (Section 4.3). For both atria (RA: Study 2 and LA: 
Study 3), the study has two parts (Section 4.4). In part (a), the RD dynamics is evaluated only 
in the presence of AWT. In part (b), the RDs are explored in the presence of both AWT and 
fibrosis. Section 4.5 analyses the simulation results, compares the RD dynamics in LA and RA, 
with and without fibrosis, and discusses clinical implications. Finally, the limitations (Section 
4.6) and the main findings of the chapter are summarised (Section 4.7).  
4.2 Introduction and Aims 
AWT has emerged as a potential arrhythmogenic factor in AF patients and has been linked with 
both atrial remodelling [203,204] and post-ablation AF recurrence [205]. Optical recordings in 
sheep RA have provided experimental evidence for RDs stabilizing at interfaces between thick 
and thin atrial muscle [189]. Moreover, the association of complex fractionated electrograms 
(CFAE) with LA AWT has also been reported [206], pointing to the presence of AF substrate 
in these regions. These findings show a potential of AWT gradients as a marker for identifying 
RD locations in the atria. However, the influence of AWT gradients on the RD dynamics in 
realistic atrial geometries is unknown and warrants further investigation.  
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There are certainly other factors that influence the locations of the RDs in AF patients. One of 
the major candidates is atrial fibrosis, which is a product of AF-induced structural remodelling 
and is the most studied example of an arrhythmogenic substrate in AF patients. It has been 
reported to correlate with both AF incidence and post-ablation recurrence [120]. Moreover, 
recent clinical [13,56] and computational [15,174] have provided evidence that fibrotic tissue 
can stabilise RDs in AF patients. However, other studies have reported controversial results 
[175]. Such differences in RD behaviour among different studies / AF patient groups could be 
related to the effects of factors other than fibrosis, such as patient-specific atrial architecture 
and AWT. Previous simulation studies based on patient-specific atrial models have only 
accounted for atrial fibrosis and have not included details of AWT. Hence, this chapter aims to 
investigate the influence of AWT gradients on the RD dynamics in realistic atrial geometries 
and evaluate the comparative effects of patient-specific fibrosis distribution and AWT 
gradients.  
Until recently, the lack of imaging tools to generate whole organ AWT maps prevented 
modelling studies from reconstructing patient-specific atrial geometries. However, novel MRI 
[195] and computer-tomography [207] protocols now allow for generation of such patient-
specific AWT maps. These data provide the basis for exploring the RD dynamics in patient-
specific atrial models, to understand the role of AWT gradients in influencing RD locations. 
Moreover, MRI enables the reconstruction of fibrosis distributions in AF patient [81]. 
Elucidating the relationships between AWT gradients, fibrosis and RD locations can lead to an 
improved understanding of AF mechanisms, and ultimately help identify patient-specific 
ablation targets, improving the efficacy of treatment. 
In summary, this study aims to investigate the mechanistic influence of two structural factors: 
(i) AWT and (ii) fibrosis on the dynamics of RDs sustaining AF. To this end, computational 
simulations of atrial electrophysiology were performed on realistic RA and LA geometries 
obtained from MRI of 6 patients. Our working hypothesis is that competing influences of AWT 
gradients and fibrotic patches on conductive properties of atrial tissue determine anchoring 
locations of RDs in 3D atrial models.  
 




In the study presented in this chapter, we extend the study from the idealised 3D atrial slab with 
AWT step to simulations on realistic models of atrial geometries derived from MRI data.  The 
general workflow used for construction of the realistic models is shown in Figure 4.1. Here we 
first investigate the role of AWT and morphology of the RA (Study 2a) and LA (Study 3a) on 
the RD dynamics (Figure 4.1, top row). Then in the second part, we evaluate the combined 
effect of patient-specific AWT and fibrosis on the RD dynamics (Figure 4.1, bottom row). In 
the RA (Study 2b), the effect of fibrosis is modelled using a cylindrical fibrotic patch, while in 
the LA (Study 3b), fibrosis is incorporated from patient-specific late gadolinium enhanced 
(LGE) MRI. LGE-MRI data was not acquired in the right atrium in these patients. 
 
Figure 4.1: Workflow for the image-based atrial modelling (Studies 2 & 3). Top row: Segmentation and 
registration of LA and RA geometries from black-blood MRI used in simulations to investigate the role of AWT 
in the RD dynamics in the RA (Study 2a) and LA (Study 3a). Bottom row: Patient-specific fibrosis distributions 
segmented from LGE-MRI (bottom row) in the LA (Study 3b) and a synthetic fibrotic patch in the RA (Study 3a) 
used to evaluate the relative effects of fibrosis and AWT gradients on the RD dynamics in the realistic atrial 
geometries. 
4.3.1 Simulating cardiac electrophysiology 
The 3D atrial simulations were performed using the same framework, as described in Chapter 
2. Briefly, the standard mono-domain equation was solved with no-flux boundary conditions 
using forward Euler and centred finite differences schemes with temporal and spatial steps of 
0.005 ms and 0.3 mm. As in Chapter 3, our model was isotropic, and the diffusion tensor was 
replaced by a scalar diffusion coefficient D = 0.1 mm2 ms-1, carefully chosen to match an atrial 
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conduction velocity of 0.60 m s-1 typical of AF [192]. For 𝐼!$%, we used the Fenton-Karma 
electrophysiology model [71] modified to accurately described the restitution properties of 
remodelled atrial cells [144]. This atrial Fenton-Karma (aFK) cell model accurately captures 
the main characteristics of atrial action potentials and its restitution properties, while keeping 
the computational time relatively short.  
4.3.2 Study A: Influence of patient-specific AWT on the RD dynamics 
Reconstruction of atrial geometries and AWT: Four healthy volunteers and two paroxysmal 
AF patients were imaged using a black-blood MRI protocol (1.5T, cardiac and respiratory 
gating, acquisition resolution: 1.4 x 1.4 x 1.4 mm3). Further details on the image acquisition 
and analysis can be found in the original publication [195]. Briefly, the RA and LA geometries 
of healthy volunteers and patients, respectively, were obtained by manual segmentation using 
ITK - SNAP (Kitware). The segmented geometries were interpolated to an isotropic resolution 
of 0.3 mm using a custom build program in Matlab and smoothed using 3D Slicer [208], to 
produce geometries with resolutions suitable for simulations. Also, note that the RA geometries 
weren’t acquired in patients because of long scan times which were beyond the time restrictions 
placed on patient MRI scans. 
AWT measurements: The AWT was computed using the average of nearest neighbour 
method, adopted from Varela et al. [195]. This specific method was chosen because of its simple 
implementation, low computational cost and  its success  in measurements of cortical thickness 
in the brain [209,210]. Triangular meshes were computed for the epicardial and endocardial 
surfaces of the original geometries before interpolation using a marching cubes algorithm and 
resampled to increase mesh quality with Matlab, resulting in an average edge length of 0.96 ± 
0.03 mm. Following this, AWT maps were computed by: 1) measuring the distance between 
each node in the epicardial surface and its nearest node in the endocardial surface; 2) reversing 
this computation from the endocardial surface; 3) averaging the outcomes of 1) and 2). In the 
RA, the region with the highest AWT (5.10 ± 1.00 mm against 1.8 ± 0.4 mm in the surrounding 
RA wall) can be identified as the crista terminalis, CT [194]. We refer to this region as the CT 
in the following text. In 2 out of 4 patients, this region was characterised by a large AWT 
gradient (4.75 ± 0.95 mm in the CT region against 2.91 ± 0.60 mm in the RA wall), whereas in 
other patients the region was less prominent (2.90 ± 1.04 mm against 2.45 ± 0.54 mm in the 
RA). 
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4.3.3 Study B: Competing effect of AWT and fibrosis on the RD dynamics 
4.3.3.1 Study 2b (Model construction in the RA) 
In the RA, due to lack of patient-specific fibrosis data, we added a synthetic 3D spherical 
fibrotic patch of diameter 9 mm, with similar labels 1 to 5 of decreasing diffusion coefficient 
as done before for the 3D slab (described in Chapter 3, Section 3.3.3), in a region near the thick 
RA muscle bundle of the CT. This enabled a direct comparison of the effect of AWT and 
fibrosis on the RD dynamics in the RA. The choice of 9 mm diameter was based on calculating 
an average fibrotic patch size in the LA (Study 3b). 
4.3.3.2 Study 3b (Patient-specific fibrosis in the LA) 
The two paroxysmal AF patients also underwent LGE-MRI in the same scanning session and 
in the same phase of the cardiac cycle as the black-blood MRI acquisition, to detect fibrosis in 
the LA (1.5T, cardiac and respiratory gating, acquisition resolution: 1.3 x 1.3 x 2 mm3).  
For Study 3b, the segmentation of fibrotic LA tissue was performed by analysing the image 
intensity ratio (IIR), computed by dividing individual voxel intensities by the mean blood pool 
intensity. IIR values >1.08 were classified as the border zone (BZ) and >1. 24 as dense fibrosis. 
The lower IIR threshold of 1.08 was obtained as an average of the previously proposed values 
of 1.2 [88] and 0.97 [87]. The upper IIR threshold of 1.24 was chosen as all the LGE MR images 
were acquired post-ablation, and therefore, the IIR threshold had to be lower than that reported 
for dense scar representing the ablation lesions, 1.32 [88]. Transition from the BZ to dense 
fibrosis was represented by labelling segmented fibrotic tissue from 1 to 5 according to LGE-
MRI intensity, where level 5 corresponded to dense fibrosis (regions with IIR > 1.24) and level 
1-4 corresponded to variable degree of diffuse fibrosis (regions with 1.08 < IIR < 1.24 split into 
four equal intervals). Next, the LA geometry with realistic AWT and the fibrosis distribution 
had to be nonlinearly registered using MIRTK [211], as they were obtained from different MRI 
sequences as discussed above. Following this, fibrotic regions were projected onto the LA 
geometries with transmural uniformity for the same patients using Paraview (Kitware) and 
Matlab (Mathworks, Inc).  
The fibrotic regions with labels 1-5 were incorporated in the atrial model using the same 
diffusion coefficient values as Chapter 3 (Section 3.3.3), for computational tractability.    
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4.3.4 Simulation protocol for RD initiation 
A single RD was initiated using a cross-field protocol at different locations within the atrial 
geometries. In the RA (Study 2), RDs were initiated in the vicinity of the CT region at 6 to 9 
different locations, where a large AWT gradient was typically observed. The S1 stimulus (non-
dimensional voltage: 1; duration: 1ms) was applied along a plane parallel to the superior vena 
cava, and after 50 ms S2 stimulus (non-dimensional voltage: 0; duration: 2 ms) was applied in 
a plane perpendicular to that of S1. For each of the 4 RAs, the locations of S1 and S2 were 
varied such that the intersection between the two planes was located near the CT region. An 
example for Person 1 in Study 2(a) is shown in Figure 4.2, where 9 such locations have been 
marked with yellow crosses. Likewise, in Study 2(b), initiation locations were chosen such that 
in some cases the distance from the AWT gradient is fixed, but the distance from the fibrotic 
patch is varied and in others vice versa. Here again, an example of Person 1 is shown in Figure 
4.3. In the LA (Study 3), 4 initiation locations were selected across the atrial wall. Simulations 
were performed in both geometries with and without fibrosis for a duration of at least 3s: an 
example is shown in Figure 4.7 for Person 5. 
 
Figure 4.2: Anchoring of RD to AWT gradient at the CT region in the RA of Person 1. (A) All RD initiation 
locations are marked by yellow crosses, and in the table below, ü corresponds to anchoring to the CT region and 
û to no anchoring. The voltage maps for RD initiated at the location marked by a yellow circle (in A) is shown in 
panel B (i-iii) for different moments of time, and the complete tip trajectory with the RD anchored to the CT region 
is shown in panel B (iv). 
For each simulation, the movement of the RD was tracked by recording its tip location (see 
details above) for each time step over the duration of the entire simulation [71]. The protocol 
for calculating the RD tip, presented in Chapter 3, was extended to 3D to perform tip tracking 
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on the surface of the atrial walls. The resultant RD trajectories were then overlaid separately on 
the AWT and fibrosis maps for each patient-specific atrial geometry. 
 
Figure 4.3: Anchoring of RD to AWT gradient at the CT region and the fibrotic patch in the RA of Person 1. Line 
A marks an approximate horizontal distance of 3mm from the AWT gradient (CT region) and edge of the fibrotic 
patch, while Line B marks a horizontal distance of 13 mm from the CT region and 1 mm from the edge of the 
patch. The vertical distance of locations 1-3 from the centre of the fibrotic patch was gradually increased (A1, 
6.6mm; A2, 10.2 mm; A3, 13.8 mm), while the distance from the CT region was approximately constant. The 
voltage maps for RD initiated at location A1 and A3 are shown in Panel (A1) and (A3), respectively, at different 
moments of time (i-iii), and the RD tip trajectories are shown in (iv). For the initiation location A1 close to the 
fibrotic patch, the RDs anchored between the CT region and the fibrotic patch (A1). For the location A3 further 
away from the patch, the RDs drifted along the AWT gradient at the CT region towards the mitral valve (A3). The 
outcomes of simulations for the RDs initiated at different locations are provided in the table. 
4.4 Results 
In the patient-specific atrial models, RDs was successfully initiated in 4 RAs and 2 LAs using 
the cross-field protocol with or without fibrosis. This resulted in the formation of either 1-2 
RDs in the first 1s of simulation. In the following 3-5s, these RDs meandered and eventually 
either stabilised at distinctive locations in the atrial wall or broke down into multiple RDs, 
which were dependent on the patient-specific AWT gradients and fibrosis distribution. 
4.4.1 Study 2: Right Atrial Geometry  
The average AWT values computed in the CT region and the surrounding RA wall of Person 1 
(Figure 4.4A; CT: 3.45 ± 0.86 mm; RA: 2.09 ± 0.38 mm) and Person 2 (Figure 4.4B; CT: 4.75 
± 0.95 mm; RA: 2.91 ± 0.60 mm) showed a higher gradient in AWT compared to Person 3 
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(Figure 4.4C; CT: 3.04 ± 0.65 mm; RA: 3.00 ± 0.54 mm) and 4 (Figure 4.4D; CT: 2.90 ± 1.04 
mm; RA: 2.45 ± 0.54 mm). Hence, Person 1 and 2 had a more prominent CT region compared 
to Person 3 and 4 as shown in Figure 4.4 (A, B vs C, D).  
In the Person 1 and 2 with more prominent CT region, 55% of the RDs initiated at different 
locations drifted towards the CT region, either anchoring to it (Figure 4.4A (i), B (i)) or crossing 
over it to the posterior side of the RA (Figure 4.4A (ii), 4B (ii)).  As an example, the 3D atrial 
voltage map in Person 1 is shown in Figure 4.2. However, in the RA of Person 3 and 4 (Figure 
5C, 5D), the CT regions had thickness comparable to the remaining RA wall. Hence, the RDs 
neither drifted towards the CT nor anchored at any location (Figure 4.4C (i), D (i)). Instead, 
they either drifted towards the superior vena cava or the tricuspid valve or terminated. 
 
Figure 4.4: Effects of AWT on the RD dynamics on the RA. Trajectories of RDs (blue), initiated at 4 to 9 locations 
in the RA, are overlaid on the AWT map for 4 different subjects. In Person 1 (Panel A) and 2 (Panel B), the CT 
region had a higher AWT compared to rest of the RA wall, while in Person 3 (Panel C) and 4 (Panel D) the CT 
region was not distinguishable by thickness. The majority of RDs initiated in Person 1 (6 out of 9 sites), and Person 
2 (4 out of 9 sites) drifted towards the thick CT region and anchored to it (A (i) & B (i)), but some also drifted 
towards the opposite side of the RA geometry (A (ii) & B (ii)). However, none on four RDs initiated in Person 3 
and Person 4 anchored to the CT region, drifting away towards the SVC or TCV instead (C (i) & D (i)). Here and 
below, white arrows indicate the direction of RD drift after initiation. 
 When the RA simulations were repeated in the presence of a synthetic fibrotic patch, the RD 
trajectories were affected in all patients. The voltage maps for 2 different simulations in Person 
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1 are shown in Figure 4.3, and as an example, the summary of the RD trajectories in Person 1 
and 4 are presented in Figure 4.5. For the RA of Person 1 with a prominent CT region (Figure 
4.5A), RDs initiated closer to the fibrotic patch either stabilised between the CT region and the 
patch (Figure 4.5B (ii)), or anchored to the latter (Figure 4.5C (ii)), depending on the distance 
from their initiation site to either structure. However, in the RAs with no distinguishable 
thickness gradient at the CT region (Figure 4.5D), all RDs anchored to the fibrotic patch (Figure 
4.5E (ii) and F (ii)). 
For the RDs to anchor, the critical proximity to the CT region and the patch is challenging to 
determine in realistic RA geometry because, unlike AWT in a rectangular slab, the CT region 
is not a simple straight line. However, in an example provided for Person 1 (Figure 4.3), RDs 
initiated at the middle between edges of the CT region and the fibrotic patch (~3 mm from either 
structure horizontally and 6.6 mm vertically) (Figure 4.3, location A1), stabilised and anchored 
between them. Increasing the horizontal distance between the RD and the CT to 13 mm (Figure 
4.3, location B1) led to the RD anchoring to the fibrotic patch.  
 
Figure 4.5: Competing effects of AWT and fibrosis in the RA. The RD trajectories (blue) in the RA, obtained by 
initiating RDs at two locations (yellow dots) without and with the presence of fibrosis are overlaid on the maps of 
AWT and fibrosis distribution, respectively, for Person 1 (A) and 4 (D). In Person 1 in the absence of fibrosis, 
RDs initiated at both locations (B (i), C (i)) drifted towards the CT region with a large AWT gradient. However, 
in the presence of fibrosis, RD initiated at position 1 anchored between the CT and fibrotic patch (B (ii)), and 
while RD initiated at position 2 anchored to the patch (C (ii)) which was located further away from the CT region. 
In Person 4 in the absence of fibrosis, RDs initiated at both positions (E (i), F(i)) neither drifted towards the thin 
CT nor showed any anchoring. In the presence of fibrosis, RDs initiated at both positions (E (ii), F (ii)) anchored 
to the fibrotic patch. SVC: Superior vena cava. White squares mark locations where the RDs anchored. 
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4.4.2 Study 3: Left Atrial Geometry 
The AWT maps computed for LA geometry of Person 5 (Figure 4.6A) showed higher AWT in 
the LA roof (4.77 ± 0.60 mm) compared to the rest of the atrial wall (2.96 ± 0.31 mm). 
Therefore, in the respective simulations, RDs drifted towards and along the LA roof (Figure 
4.6C (i)) when initiated in its proximity but drifted towards the PVs (Figure 4.6B (i)) if initiated 
further away. The LA of Person 6 (Figure 4.6D) was characterised by roughly uniform AWT 
(2.53 ± 1.20 mm), and RDs initiated in this geometry drifted either towards the PVs (Figure 
4.6E (i)) or the mitral valve (Figure 4.6F (i)). 
In the LA, LGE-MRI intensity-based segmentations yielded different fibrosis distributions in 
the two AF patients, as shown in Figure 4.6A, D. Both Person 5 and 6 had fibrotic tissue in the 
LA regions surrounding the PVs, with a higher degree of fibrosis in one patient (14% of the 
atrial volume, Figure 4.6A) compared to the other (10%, Figure 4.6D). In Person 5, LA 
simulations repeated with the presence of fibrosis showed either stable RD anchoring to the 
BZs of fibrotic tissue (Figure 4.6C (ii)) or transient anchoring where RDs stabilised at a fibrotic 
patch in the first 1 s of simulation and then drifted to a new location in another fibrotic region 
and stabilised there (Figure 4.6B (ii)). 3D atrial voltage maps for the cases presented in Figure 
4.6C (i) and (ii) are illustrated in Figure 4.7A1 and A2, respectively. Furthermore, in one 
particular case, we also observed the breakdown of the primary RD into multiple wavelets 
meandering between fibrotic patches (Figure 4.7, B1) which was previously stable without the 
presence of fibrosis (Figure 4.7, B2). In Person 6 however, simulations repeated with the 
presence of fibrosis in the LA showed either stable RDs forming macroscopic re-entry around 
the PVs (Figure 4.6E (ii)) or RDs anchored to a fibrotic region (Figure 4.6F (ii)) near the PV. 




Figure 4.6: Competing effects of AWT and fibrosis in the LA. The RDs trajectories (blue) in the LA, obtained by 
initiating RDs at two locations (yellow dots), without and with the presence of fibrosis, are overlaid on the AWT 
map and fibrosis distribution (A & D), respectively, for Person 5 (top) and 6 (bottom). In Person 5 in the absence 
of fibrosis, RDs initiated at position 1 and 2 drifted towards the PVs (B (i)) and LA roof (C (i)), respectively. With 
additional fibrosis, RDs drifted from its initial location to a new location (B (ii)) for position 1 and anchored to the 
fibrotic patch (C (ii)) for position 2. In Person 6 without fibrosis, RDs initiated at positions 1 and 2 drifted towards 
the PVs (E (i)) and MV (F (i)), respectively. With fibrosis, RDs continued to drift towards the PVs (E (ii)) for 
position 1 but anchored to the fibrotic patch (F (ii)) for position 2. PV: Pulmonary vein, MV: Mitral valve. 




Figure 4.7: Competing effects of AWT and fibrosis in the LA. The voltage map for RD initiated at Position 2 and 
Position 3 are shown at different moments of time (i–iii) where red corresponds to excitation and blue to membrane 
potential closer to rest. Row 1 and 2 correspond to simulations without and with fibrosis, respectively. For each 
simulation, the RD tip trajectories (blue) are overlaid on their corresponding AWT and fibrosis map (iv). In 
simulations without fibrosis (at A1) RD drifts along the large AWT gradient at the LA roof and (at B2) RD stabilise 
near the PV. While in the presence of fibrosis (at A2), the same RD anchors to the fibrotic patch and (at B2), and 
the RD breakdown into multiple wavelets meandering between fibrotic patches.  




In this study, we used modelling and simulation to investigate the effect of AWT gradients on 
drift and anchoring of the RDs in both fibrotic and non-fibrotic atria for different patient-
specific fibrosis distribution using MRI-based realistic 3D atrial geometries. To the best of our 
knowledge, this is the first study that compares the direct influence of AWT and fibrosis on the 
dynamics of RDs in realistic atrial geometries. We further elucidated how AWT gradients 
interact with fibrosis to determine locations of RDs. The results obtained from the RA and LA 
model simulations confirmed that drift direction and anchoring points of RDs are determined 
by the interplay of competing influences of the patient-specific AWT gradients and fibrosis.  
4.5.1 Variation of AWT in subject-specific atrial geometries 
In this study, image-based RA and LA geometries from 4 healthy volunteers and 2 paroxysmal 
AF patients were used to assess the link between RD activity and regions of large AWT 
gradients. The subject-specific AWT maps were computed in accordance with the average of 
nearest neighbour method, proposed by Varela et al. [195]. This specific method was chosen 
because of its simple implementation, low computational cost and its success to measure 
cortical thickness in the brain [209,210]. It is worth noting that there are other methods for 
calculating the thickness, for example, those based on the Laplace’s equation [207], which may 
produce disparate thickness estimates, particularly in high-curvature regions.  
In the RA, the AWT measurements showed a large inter- and intra-subject variability. In 2 of 
the RAs, the CT was comparatively thicker (4.75 ± 0.95 mm in the CT region against 2.91 ± 
0.60 mm in the RA wall) than the surrounding atrial wall while in the others, such a distinction 
was absent (2.90 ± 1.04 mm against 2.45 ± 0.54 mm in the RA wall). The thickness values 
associated with the CT may be a result of its underlying morphology which is reported to vary 
among subjects depending on their gender, age, disease condition, etc. [194]. However, in the 
LA of two paroxysmal AF patients, the thickness of the atrial walls was roughly uniform, with 
an average of 2.96 ± 0.31 mm and 2.53 ± 1.20 mm, respectively. The atrial roof in one of the 
patients was thicker (4.77 ± 0.60 mm) compared to the rest of the atrial wall (2.96 ± 0.31 mm). 
This agrees with the LA roof measurements in AF patients [203]. The lack of AWT variability 
among our LA models could be due to our limited dataset of only 2 PAF patients. Further 
imaging studies are required to explore the AWT variability with AF disease type.  
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Furthermore, in the RA, the largest AWT is at the CT (6-8 mm). Given that the MRI resolution 
was 1.4 mm isotropic, this structure can be captured well. In the LA, the AWT gradient is largest 
at the LA-PV junction. However, these small gradients could lie below this MRI resolution. 
Hence, to avoid artefacts in this study the PV sleeves were removed. 
4.5.2 Effect of subject-specific AWT on the RD dynamics 
In Chapter 3, we used a simple 3D atrial slab model to conclude that regions with sharp AWT 
steps alter the excitability of the surrounding tissue and help in stabilizing RDs. In this study, 
we extended the same hypothesis to realistic atrial geometries. Our results in patient-specific 
atrial geometries are in agreement with our previous reported results in the 3D atrial slab. 
In the RA without fibrosis, our results showed that RDs anchored to the CT region in subjects 
with a large AWT relative to the surrounding RA wall (Person 1 and 2 in Figure 4.4). This 
finding is in agreement with previous clinical [212] and modelling [213,214] studies, which 
have reported RD activity at the CT region. It is currently accepted that CT acts as a line of 
conduction block due to its high anisotropy owing to abrupt changes in fibre orientation which 
facilitate faster conduction from the sinus node to the inferior RA but blocks conduction in the 
posterior wall [215], making it a common site for initiation and anchoring of RDs during atrial 
arrhythmias. However, in addition to the transverse conduction block, the thickness of the CT 
has also been attributed to clinical incidences of RA flutter. Morita et al. [216] reported that the 
thickness, width and area measured using intracardiac echocardiography was significantly 
higher in patients with typical atrial flutter (n = 12) than with non-atrial flutter (n = 13). 
Moreover, Ohkubo et al. [217] reported a thicker and more continuous CT region in chronic 
atrial flutter patients compared to PAF patients. Despite evidence that AWT could play an 
important role in RA arrhythmias, the underlying mechanism by which AWT gradients could 
play a role in stabilising RDs at the CT hasn’t been elucidated before. In our study, by directly 
using patient-specific RA models, we demonstrated that the source-sink effects associated with 
thickening (shown in Chapter 3) of the atrial myocardium at the CT, could facilitate anchoring 
of the RDs to this region. Sharp AWT gradients and abrupt changes in fibre orientation can act 
together to make CT a typical location and source of RA arrhythmias.  
In the two RA with more homogeneous AWT (Person 3 and 4 in Figure 4.4), there was no clear 
link between the RD dynamics and specific AWT features. Instead, the direction of RD drift 
was always towards the tricuspid valve in the RA. Of note, in this study, we only evaluated the 
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CT thickness of volunteers, and further studies are needed to understand how electrical and 
structural remodelling alters the thickness of the CT region in AF patients and how that would 
alter the locations of re-entrant activity.    
In the LA model without fibrosis, RDs were mostly localised in regions surrounding the PVs 
and MV openings (Figure 4.6 (i)). In the absence of structural features with large AWT gradient, 
the RD drift could be explained by the underlying curvature of the 3D atrial geometry [67,218]. 
The only exception was Person 5, where the RD anchored to a large AWT gradient at the LA 
roof. In fact, a recent clinical study by Kun et al. [203] reported a progressive increase of LA 
roof thickness with atrial remodelling and LA roof thickness > 3.10 mm to be a predictor of 
poor response to CA.  
Our findings suggest that information from AWT may aid in designing personalised ablation 
strategies in patients whose atria are characterised by large variations in thickness. Patient MRI 
can be used to reconstruct 3D atrial structure and identify patient-specific areas of large AWT 
gradients and fibrosis prior to CA procedures. Models built based on such data can then predict 
the RD locations, and therefore aid in selecting the optimal CA strategy for a given patient. 
4.5.3 Competing influence of subject-specific AWT and fibrosis on the RDs 
Incorporating atrial fibrosis in the models changed the anchoring locations of the RDs in the 
patient-specific RA and LA geometries (Figure 4.5 and Figure 4.6, (ii)). In the RA with thick 
CT, the RDs anchored at regions between areas with a large AWT gradient (such as the CT 
region) and the local fibrotic patch. In RAs with less prominent CT, the RDs were instead 
permanently localised in regions surrounding the fibrotic patch (Figure 4.5, E(ii) & F(ii)). 
Hence, in atrial geometries with large gradients of AWT, the locations of the RDs stabilisation 
can be strongly influenced by both the presence of fibrosis, as predicted by previous studies 
[15,174] and also the AWT gradients. These results are in close agreement with our study 
performed in a 3D slab, where RDs were anchored between the AWT step and fibrotic patch.  
The anchoring of the RD to these regions could be linked to two competing attractive influences 
from the slow conducting region of the fibrotic patch and source-sink mismatch from the large 
AWT gradient at the CT, which do not compensate each other exactly in these particular cases. 
However, if this balance is disturbed by either an increased thickness of the CT or a fibrotic 
patch located further away, the RD would have anchored instead to the other one. Therefore, 
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while evaluating the RD locations in atrial geometries with features of large AWT gradient, 
such as CT in the RA, patient-specific fibrosis distribution and AWT should be evaluated. Our 
results could explain why the correlation between LGE-derived fibrosis and RDs locations 
reported by Cochet et al. [13] was weaker in the RA than the LA. This may be explained by the 
higher variability in AWT in the RA compared to the LA, with the AWT gradients in the RA 
providing alternative anchoring locations for the RDs.  
In the LA, simulations repeated with LGE-MRI-derived fibrotic patches clearly showed 
stabilisation of RDs near the patches in all patients. In the exceptional case of Person 5 (Figure 
4.7, B2), with a high fibrosis burden, RDs were unstable and formed multiple wavelets 
meandering between fibrotic patches. These results may contribute to the understanding of why 
PVI is effective for paroxysmal AF patients with low fibrosis burden [219]. In paroxysmal AF, 
the number of RDs near the PVs is higher than the number of focal triggers [220] – the presence 
of RDs near the PVs, and therefore the success of PVI, in those patients may be explained by 
the lack of other anchoring locations, such as large AWT gradients or fibrotic patches. 
However, for AF patients with high fibrosis burden, the altered atrial substrates can result in 
the drift and multiplication of RDs in regions of slow conduction, such as the BZs of fibrotic 
tissue [174]. Therefore, assessment of patient-specific fibrosis distribution in the LA of 
persistent AF patients, facilitated by LGE-MRI, may assist in the prediction of RD locations. 
In the following part of this thesis, we will focus on the effects of patient-specific fibrosis 
distribution on the anchoring of RDs in the LA and the implication for AF therapy.  
4.6 Limitations 
In this study, we used a synthetic cylindrical fibrotic patch in the RA, which was a simplified 
representation of fibrotic patches of irregular geometry obtained from patient LGE-MRI. The 
lack of patient-specific RA fibrosis data in our study was due to routine pre-ablation LGE-MRI 
scans being restricted to the LA. Previous computational study by Zahid et al. [15] performed 
with patient-specific fibrosis distribution has linked RD behaviour to the heterogeneity fibrotic 
density. While a simple cylindrical patch in the RA was not patient-specific, using it enabled 
us to focus on the relative mechanistic influences of slow-conducting fibrotic tissue and AWT 
gradients, without considering additional complex effects of the fibrosis shape.  
Another important limitation of this study is related to the reconstruction of fibrosis from LGE-
MRI which has been discussed in Chapter 2, Section 2.4.2.2. Although these limitations need 
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to be careful considered when designing a personalized MRI-based CA therapy, we believe 
they do not impact the main mechanistic finding of our study – that RDs anchor to regions with 
large AWT gradients and fibrotic structures.  
In our study, fibrosis was modelled as regions of progressively slow conduction linked with 
LGE-MRI intensity. The LGE-MRI threshold of 1.08 IIR (level 1) and 1.24 IIR (level 5) was 
obtained from previous studies validated by electro-anatomical mapping data [87,88], but the 
IIR threshold values for splitting the border zone into levels 1 to 4 was not validated due to lack 
of experimental data. However, the correlation between decrease in conduction velocity and 
increase in IIR has been reported [177]. Therefore, our approach of gradually decreasing CV 
across fibrosis levels 0 to 5 is in agreement with patient studies. Recent studies have also shown 
that additional small effects of fibroblast-myocyte coupling [174] and paracrine effects [187] 
could also influence the RD stabilisation. However, data on such effects in human are 
unavailable, and modification of the model parameters based on ex-vivo animal data can 
produce results that are inconsistent with clinical data [187], and such effects were not 
considered in this study. Moreover, in this study we have only considered fully transmural 
fibrosis. Ex-vivo imaging studies show intramural fibrosis could affect the RD dynamics and 
facilitate epicardial-endocardial dissociation [221]. In future studies, intramural fibrosis should 
be incorporated to analyse its effects on epicardial-endocardial dissociation in AF [58,59,222]. 
However, atrial walls are very thin (< 3mm), which makes non-invasive imaging of transmural 
fibrosis challenging due to partial volume effects. 
Finally, this study was conducted with a small dataset of 6 atrial models. In future, the image-
based simulation pipeline developed in this chapter could be extended to include large number 
of patients and healthy volunteers of both genders. The other limitations consistent with work 
presented in other Chapters, and possible ways to address them in the future are summarised in 
Chapter 7. 
4.7 Conclusions 
This study (i) elucidated the role of AWT as a factor strongly influencing the RD dynamics and 
a marker for RD locations in the patient’s atria and (ii) compared the AWT effects with the 
respective effects of fibrosis. In the RA, RDs stabilised around structural features with large 
AWT gradients, while the addition of fibrotic patches provided an alternative attractor for the 
RDs. In the LA, which had more uniform AWT distributions, RD locations were determined 
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by the distribution of fibrotic patches or by anatomical features such as the PVs. These findings 
corroborate our hypothesis that anchoring locations of RDs are dependent on the relative 
influence of gradients in AWT and fibrosis, and suggests the non-invasive assessment of AWT 
and fibrosis using MRI may inform clinical interventions in AF patients. 
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Table 4.1: Effects of AWT and fibrosis of the RD dynamics. The table summarises the key results obtained from 
the study presented in Chapter 3 and 4 which were aimed at investigating the competing influence of AWT 







Chapter 5: Section Outline   | 112 
 
 
Chapter 5  
Predicting Locations of RDs from Patient-
Specific Distribution of Fibrosis in the LA 
5.1 Section Outline 
This chapter aims to use image-derived patient-specific LA models to explore RD stabilisation 
in fibrotic regions and generate maps of RD locations that can be targeted by therapy (Figure 
5.1). The motivation behind investigating the RD locations based on patient-specific fibrosis 
distribution is summarised in Section 5.2, and the steps involved in the model construction and 
simulations are discussed in Section 5.3. The results for the simulation study are presented in 
Section 5.4 and analysed in Section 5.5, dissecting the effects of patient-specific fibrosis 
distribution and burden on RDs and comparing them with competing prior studies. Finally, the 
clinical impact and the main findings of the chapter are summarised in Section 5.6. 
 
 
Figure 5.1: A schematic image of the chapter outline 
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5.2 Introduction and Motivation 
Catheter Ablation (CA) is a well-established strategy for the restoration of sinus rhythm in AF 
patients who do not respond well to anti-arrhythmic drugs, with success rates of up to 70% in 
patients with episodes of AF lasting less than 1 week (paroxysmal AF or PAF). The widely 
accepted CA strategy to restore sinus rhythm is the electrical isolation of pulmonary vein (PV) 
sleeves in the left atrium (LA), which are believed to be the primary substrate for the generation 
of the ectopic beats and/or anchoring of re-entrant drivers (RDs) responsible for triggering and 
sustaining AF in the LA [6–8]. However, about 30% of AF patients are asymptomatic, which 
leads to delayed diagnosis and the development of persistent AF (PsAF). In these patients, the 
success rate with CA drops to 42% [11], often requiring additional ablation procedures.  
A potential factor for the failure of CA, specifically in PsAF patients, could be the presence of 
high degrees of electrophysiological and structural remodelling, notably the development of 
fibrosis throughout the LA during the progression from PAF to PsAF [77,81,85,223]. As 
discussed in Chapter 2 (Section 0), fibrotic regions in the atria slow down or completely block 
propagation of electrical excitation waves, thus providing a substrate for RDs sustaining AF 
[75,221,224] beyond the PVs. This can explain the existence of multiple RDs far from the PV 
region in PsAF patients [55,114]. In these patients, despite advances in CA strategies – that 
either target the AF substrate by applying additional linear CA lesions in the LA roof and MV, 
or try to eliminate RDs by utilizing complex fractionated atrial electrograms (CFAE), focal and 
impulse rotor modulation (FIRM) or electrocardiographic imaging (ECGI) – the long-term 
therapy success is limited [106,117] (see also in Chapter 2, Section 2.4.3.3). This can be 
explained by the highly empirical nature of CA therapy, which targets atrial regions without 
knowledge of the underlying arrhythmogenic mechanisms and patient-specific nature of AF 
substrate.  
The extent of fibrosis quantified from LGE-MR images is known to be an important predictor 
of post-ablation recurrence [81]. Recent clinical studies have reported that low-voltage areas, 
identified from atrial tissue mapping and also associated with the presence of fibrosis, can be 
directly targeted by CA to improve patient outcomes [100,102,123,126]. However, in cases 
where fibrosis is extensive, particularly in patients with a high fibrotic burden (FB), creating 
ablation lesions around/over the entire fibrotic region can result in substantial damage to the 
atria. Therefore, despite the ability of imaging methods to identify and quantify the extent and 
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location of fibrosis in the atria, there exists a knowledge gap regarding optimal ways to target 
fibrotic regions during CA in a patient-specific manner. 
Recent computational studies of patient-specific atrial models, which have been based on the 
reconstruction of fibrosis from LGE-MRI, have provided the first insights into the role of 
fibrosis in the dynamics of electrical RDs sustaining AF [14,15,225]. In particular, patient-
specific models have suggested that  regions with a high heterogeneity in fibrotic density (the 
fibrosis border zone or BZ) are common anchoring sites for the RDs sustaining AF [15,174]. 
Targeting these fibrotic regions by CA procedures may, therefore, improve their outcomes. 
These computational model predictions have been validated in a recent clinical study that linked 
the patient-specific LGE areas with locations of RDs recorded using ECGI [13]. Moreover, 
very recent modelling studies performed in parallel by Boyle et al. [226,227] have indicated an 
83% overlap between RDs predicted by patient-specific biophysical models of the atria and the 
respective locations found with FIRM and a moderate agreement with ECGI. In addition to 
shedding light into the role of fibrosis in the RD dynamics, these studies pave the way for 
identification of patient-specific RDs locations from image-based 3D atrial models.  
Furthermore, Costa et al. [180], Vigmond et al. [181] and Tanaka et al. [182] have also 
introduced micro-structural nonconductive regions (percolation or edge-splitting) with various 
sizes throughout atrial tissue. These studies provided insights into the effect of fibrosis at the 
microstructure level and allowed mimicking fractionation of atrial electrograms observed at 
arrhythmogenic sites using EAM. Although the effects of fibrosis at this micro-scale are an 
important contributor to AF arrhythmogenesis, the inherent limitations of LGE-MRI prevent it 
from identifying such fine details [183]. The precision in imaging of atrial fibrosis with 
currently available LGE-MRI technologies remains limited. The imaging resolution only allows 
for capturing large (or clusters of small) fibrotic patches, but not for distinguishing between 
different types of fibrosis. Histological evidence points to the presence of such types as diffuse 
and interstitial fibrosis regions in the atrial myocardium, which cannot be captured reliably 
using MRI. Therefore, in patient-specific atrial models reconstructed from LGE-MRI typically 
include large, continuous fibrotic patches. 
In this chapter, we used patient-specific atrial models to identify optimal target areas for CA by 
exploring the links between MRI-derived fibrosis distributions and RD locations. Specifically, 
3D left atrial (LA) models based on patient LGE-MRI were used to achieve the following aims: 
Chapter 5: Methods   | 115 
 
 
1) explore the dynamics of RD stabilisation in patient-specific fibrotic areas and 2) generate 
personalised RD location maps – potential ablation target areas – that identify the regions with 
the highest probability of RDs. The findings were correlated with the MRI-based Utah fibrosis 
score [228]. The first aim can help clarify how different characteristics of fibrotic distributions 
can affect the RD dynamics, while the second may in the longer-term help predict patient-
specific CA targets. This will eliminate the need of extensive atrial voltage mapping and 
ablation in a patient, thus facilitating faster, safer and more efficient therapy. 
5.3 Methods 
5.3.1 Atrial electrophysiology model 
The atrial simulations were performed using the same framework as described in Chapter 4. 
 
Figure 5.2: Workflow for identifying patient-specific target areas with the highest probability of harbouring RDs. 
The personalised left atrial models are generated by segmentation of patient-specific LA geometry and fibrotic 
regions from LGE-MRI scans. 
5.3.2 3D patient-specific LA models 
The patient-specific LA geometries and fibrosis distribution were reconstructed from LGE-
MRI to generate patient-specific LA models. RDs were initiated at multiple (8-12) locations in 
each LA model using a cross field protocol and their tip was tracked for 6s. The locations where 
each RD stabilised after 6s was identified and labelled as being part of: (i) healthy tissue, (ii) 
PV region or (iii) fibrotic patches. Each tissue voxel was additionally assigned a probability 
value, by investigating how many times it was visited by an RD tip over the course of the 
simulation. The most likely locations of RDs are expected to be prime targets for CA and were 
thus defined as the target areas (see workflow in Figure 5.2). Note that the RDs which anchored 
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to the PV openings, which resulted from clipping of the PVs near their ostia and were non-
physiological, were excluded from the definition of the target areas. 
5.3.2.1 Reconstruction of patient-specific LA geometry and fibrosis distribution from LGE MRI  
Two PsAF and four PAF patients (see Table 5.1) were imaged under ethical approval and 
following written informed consent as a part of the study by Chubb et al. [229]. All imaging 
was performed on a 1.5T Phillips MRI scanner and included a LGE-MRI sequence: a 3D 
inversion recovery spoiled gradient echo, acquired 20-30 min after the administration of the 
extracellular gadolinium-based contrast agent Gadovist (Bayer Healthcare Pharmaceuticals). 
Images were acquired using cardiac and respiratory gating, with a spatial resolution of 1.3 x 1.3 
x 4 mm3. Further information about the used LGE sequence can be found in [229]. Moreover, 
the 3D LGE-MRI signal intensity was assessed following the approach of Chubb et al. [229], 
where a single signal intensity value was assigned to each point on the endocardial surface by 
using a  mean intensity projection (MIP) technique. 
Patient AF Age Gender % Fibrosis Utah Score 
P1 PsAF 71 Male  39 4 
P2 PsAF 65 Male  29 3 
P3 PAF 72 Male 25 3 
P4 PAF 57 Male 22 3 
P5 PAF 58 Male 16 2 
P6 PAF 53 Male 11 2 
Table 5.1: Characteristics of the 6 AF patients whose LA models were used in the study. PsAF: persistent AF, 
PAR: paroxysmal AF. The patients have been labelled 1 to 6 (column 1), in the decreasing order of their fibrosis 
burden (column 5) and assigned a Utah score (column 6) in accordance with [81]. 
The LA geometries were obtained by manual segmentation of the LGE MR images (Figure 5.2, 
, A) MITK [230], where the endocardial wall was identified by segmenting the LA blood pool 
(Figure 5.2, B). The epicardial wall was generated by dilating the endocardial wall by 3 mm 
(Figure 5.2, C), which is reported as the average LA wall thickness in AF patients [195]. The 
PV sleeves and MV were removed and the segmented image was resampled to a resolution of 
0.3 mm to generate patient-specific LA geometries, to be used in the finite difference 
electrophysiology simulations (Figure 5.2, D). 
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The patient-specific fibrosis distribution in the LA of the AF patient was generated based on 
the image intensity of the LGE-MRI data (Figure 5.2, E-G) similar to the method presented in 
Chapter 4, Section 4.3.3.2. Briefly, a voxel was considered to be part of a fibrotic patch when 
the ratio of the voxel intensity to the mean blood pool intensity, the image intensity ratio (IIR), 
exceeded an empirical threshold set by [87,88], as described previously in Chapter 4, Section 
4.3.3.2. An example of fibrosis quantification is shown in Figure 5.3A, B for Patient 2 (high 
fibrosis) and Patient 6 (low fibrosis), respectively. Voxels were labelled as being healthy tissue 
(IIR < 1.08, white region of the histogram in Table 5.2), dense fibrosis (IIR > 1.24, red region 
of the histogram) and the region around the dense fibrotic patch corresponds to the BZ (1.08 < 
IIR < 1.24, histogram with colours blue to yellow). The fibrosis maps obtained by intensity 
thresholding of LGE-MRI data for all the 6 AF patients are shown in Figure 5.4. These fibrotic 
regions were registered (Paraview, Kitware, Clifton Park, NY, USA) and subsequently 
projected onto the LA geometry (Matlab, Mathworks, Natick MA, USA), such that the fibrosis 
patches were fully transmural (Figure 5.2H). 
 
Figure 5.3: Left atrial fibrosis quantification from LGE-MRI. (A) Highly fibrotic LA of Patient 2 and (B) low 
fibrotic LA of Patient 6, with atrial shell threshold set at an IIR of 1.08 and 1.24. In the LGE images on the left of 
panel A and B, the white arrows point to regions of enhanced signal intensity.  
The 6 patients was classified into one of the following four Utah categories [81,228] described 
previously in Chapter 2, Section 2.4.3.3, depending on their relative fibrosis burden (FB): Utah 
1 (FB ≤ 5%), Utah 2 (5% < FB ≤ 20%), Utah 3 (20% < FB ≤ 35%) or Utah 4 (FB > 35%). As 
summarised in Table 5.2, the patients were labelled 1 to 6 in decreasing order of their FB. 
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5.3.2.2 Fibrosis implementation in the computational LA models 
To study how the RDs interact with fibrotic regions and to design a novel tool for identifying 
patient-specific regions where they stabilise, we used 3D atrial models with patchy fibrosis 
represented as regions of slow conduction [174]. Fukomuto et al. [177], performed LGE 
imaging and LA activation mapping during sinus rhythm in 22 patients before PVI and reported 
an association between CV and IIR (0.20 m/s decrease in CV per unit increase in IIR, P<0.001). 
In the fibrotic tissue therefore, the decrease in CV was set proportional to the recorded LGE-
MRI intensity. This was achieved by altering the diffusion coefficient, D, in these regions using 
the same method as that in Chapter 4. Briefly, healthy tissue with an IIR < 1.08 corresponded 
to D = 0.1 mm2/ms, dense fibrotic tissue with IIR > 1.24 to D = 0.017 mm2/ms and the fibrotic 
BZ with 1.08 < IIR < 1.24 to intermediate values of D calculated via linear interpolation 
between 0.1 and 0.017 mm2/ms (Table 5.2). In control models without fibrosis, the patient-
specific LA geometry was preserved, but D was set to 0.1 mm2/ms for all patients. 
 
Figure 5.4: Patient-specific fibrosis distribution in 6 AF patients with Utah scores from 2 to 4.  The fibrotic regions 
are colour-coded to show dense fibrotic tissue (red) surrounded by a BZ of intermediate properties. The healthy 
atrium is shown in white. LIPV: left Inferior PV, RIPV: Right Inferior PV, LSPV: left Superior PV, RSPV: Right 
Superior PV and LAA: Left Atrial Appendage. 
5.3.3 AF simulation protocol and data analysis 
Each patient-specific LA model was paced 7 times at a basic cycle length (BCL) of 130 ms at 
locations near the PVs (Figure 5.5, P1). A plane wave was initiated in 20 ms after the last 
ectopic beat (Figure 5.5, P2). The interaction between the plane wave and the ectopic beats 
allowed for the generation of RDs. By varying the pacing site, the direction of the plane wave 
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and the time interval between them, RDs were initiated in 8-12 different locations in each LA 
model. In each simulation, we: (i) tracked the RD tips for a duration of 6 s (using method 
described in Chapter 3), (ii) identified the regions where they were localised in the last 1 s of 
the simulation, and (iii) constructed a RD tip frequency map by recording the number of times 
each tissue voxel was visited by the RD tips over the entire course of the simulation. In all the 
cases, the RDs stabilised within 6s of the start of the simulations as illustrated in Figure 5.8 (A-
B) and Figure 5.9. Therefore, 6s was chosen as the upper limit for identifying the RD locations.  
 
Figure 5.5: AF initiation protocol. Two examples of RDs initiated using the cross-filed protocol is presented in 
rows, (A) and (B), respectively. Here in every simulation, P1 is the location of the ectopic beat near the PVs and 
P2 is the location of the plane wave. It is the interaction between P1 and P2 that results in the formation of RDs.   
For each patient, all the RD tip frequency maps obtained in the AF simulations were combined 
to construct patient-specific RD probability maps, showing the relative frequency with which, 
each voxel was visited by the RDs (see Figure 5.6). The normalised tip probability maps were 
thresholded to mark locations with the normalised probability over 0.2 as target areas. The 
simulations and the analysis process were performed in all the 6 LA models with and without 
the presence of fibrotic tissue. The target areas identified from both the cases were compared 
using the Dice score [231], a standard metric for measuring the degree of spatial overlap 
between two datasets, A and B using the following equation 5.2. 
 
𝑑𝑖𝑐𝑒(𝐴, 𝐵) = 	
2 ∗ |𝐴 ∩ 𝐵|
|𝐴| + |𝐵|  
 
(5.2) 




Figure 5.6: The pipeline for identifying target areas from the RD probability map. Sim: simulation 
Table 5.2: Segmentation and modelling of fibrosis. Labelling of voxels in the LA patient geometries according to 
their LGE-MRI intensity ratio (IIR) relative to the blood pool. Voxels with IIR>1.24 are part of a fibrotic core. 
IIR<1.08 corresponds to healthy tissue and the intermediate values of IIR form a fibrotic border zone with 




IIR  Classification 
D  
(mm2 ms-1) 





 𝐷 = −0.52 ∗ 𝐼𝐼𝑅 + 0.66 
 (5.1) 
  
IIR >1.24  Dense  0.017 




5.4.1 Patient-specific fibrosis distribution in 3D atrial models 
The LGE-MR image intensity-based reconstruction yielded different fibrosis distributions in 
all 6 AF patients, as shown in Figure 5.4. Large variations in the extent and severity of fibrosis 
were observed across the LA models (Table 5.3). Amongst the PsAF patients, P1 had the 
highest FB of 39% and was classified into Utah 4 category, and P2 with 29% FB was in Utah 
3 category. In the PAF patients, P3 and P4 with a moderate FB of 25% and 22%, respectively, 
were in Utah 3 category; P5 and P6 with mild FB were in Utah 2 category.  
Patient % FB % Volume of largest patch 
% FB of 
PVs 
% FB of 
LA wall 
% Volume* of 
dense tissue 
P1 39 37.95 28.84 71.16 12.98 
P2 29 18.27 42.86 57.14 6.38 
P3 25 16.63 35.31 64.69 6.37 
P4 22 8.54 63.28 36.82 8.18 
P5 16 6.42 42.10 52.10 6.48 
P6 11 4.08 64.53 35.47 0.24 
Table 5.3: Properties of patient-specific fibrosis distributions. The size of the primary fibrotic patch decreases with 
the fibrotic burden (FB).  
In addition to differences in severity, a large variation in the size distribution of the fibrotic 
patches was also observed across all patient-specific LA models, as summarised in Table 5.3. 
These estimates suggested the size of the largest fibrotic patch recorded per patient increased 
with increasing the overall FB. Moreover, each individual patient LA was characterised by the 
presence of a primary fibrotic patch with a volume significantly greater than the secondary 
surrounding patches. The distribution of fibrotic regions between the PV regions and remaining 
LA wall was recorded across the patient-specific LA models. In P1 (Utah 4), P2 and P3 (both 
Utah 3) with the highest FB, the majority of the fibrotic regions were at the LA wall and as the 
FB decreased the fibrotic regions were mostly located in the PV region in P4 – 6 (Table 5.3).   
5.4.2 Atrial fibrosis influences the distribution of RDs across patient-specific LA models 
In the patient-specific LA models, AF was successfully initiated in all 6 patients using the cross-
field protocol. The RD initiation protocol was applied to each patient-specific LA model, either 
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with or without fibrosis, and resulted in the formation of either 1-2 RDs in the first 1s of 
simulation. In the following 5s, these RDs meandered and eventually stabilised at distinctive 
locations in the atrial wall, which were dependent on the patient-specific fibrosis distribution 
and geometry. The choice of a total of 6s for the simulation was used to allow sufficient time 
for the transition to occur from the transient drifting of the RDs to their stable localization. To 
get a better understanding of how the distribution of RDs across the patient-specific geometries 
were affected by the overall FB, we classified the RDs in every model into 3 groups according 
to the region where they stabilised in the last 1s of the 6s-long simulations. The outcomes of 
this classification are summarised in Figure 5.7 with a bar plot showing the % of the total RDs 
anchored to: (i) fibrotic patch in blue, (ii) PVs in orange and (iii) healthy non-PV tissue in grey 
for all 6 patient-specific LA models with (A) and without fibrosis (B). 
Persistent AF Patients (Utah 4 &3: FB > 25%): In these patients (Figure 5.7A, Patient 1 and 2), 
the RDs stabilised primarily at fibrotic regions (P1: 56%, P2: 79%), compared to lower 
probabilities of stabilisation in the PVs region (P1: 17%, P2: 21%). However, when the same 
LA simulations were repeated for these patients without fibrosis, the RDs stabilised primarily 
at the PVs (Figure 5.7B, P1: 65%, P2: 79%). This suggests that in these PsAF patients with 
very high FB, the presence of large quantities of slow conducting fibrotic tissue influenced the 
RD locations, facilitating their anchoring to the fibrotic patches instead of the PVs.  
Paroxysmal AF Patients (Utah 3: 20% < FB < 25%): In this category of AF patients with 
intermediate levels of fibrosis (Patients 3 and 4), the RDs stabilised with similar probability in 
all three regions (Figure 5.7A, P3: 38%, P4: 48% at the PVs). Comparing the distribution of 
RDs across different regions in simulation with (Figure 5.7A) and without fibrosis (Figure 
5.7B) suggests that fibrosis around the PVs in these patients facilitated anchoring of RDs to the 
PVs. Moreover, despite having similar FB, the variation is distribution of the RDs across the 
patient-specific LA models (Figure 5.7 A, P3 & P4) can be explained by the difference in spatial 
distribution and sizes of fibrotic patches in the respective LA models. 
Paroxysmal AF Patients (Utah 2: FB < 20%): In this category of AF patients with the lowest 
FB (Figure 5.7A, Patients 5 and 6), the number of RDs anchoring to PVs (P5: 57%, P6: 35%) 
was higher than that in the fibrotic regions (P5: 25%, P6: 6%). This agrees with clinical 
observations that in PAF patients with lower FB, RDs are likely to be located at the PVs. In the 
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absence of strong fibrosis effects, the distributions of RDs across different region in simulation 
with (Figure 5.7A) and without fibrosis (Figure 5.7B) showed similar trends.  
 
Figure 5.7: Regions of RD stabilisation in patient-specific LA models.  The image shows bar chart with percentage 
of RDs found in different LA regions (blue: fibrosis, orange: PVs and grey: healthy LA tissue) after 6s of the 
simulation in the 6 patient-specific LA models with (A) and without fibrosis (B). A) In Utah 2 patients, the primary 
location for the RDs is the PVs. In Utah 3 patients, RDs are distributed between fibrotic regions and the PVs. In 
Utah 4 patients with severe fibrosis, the primary location of RDs are the fibrotic regions. FB: fibrotic burden.   
5.4.3 Patient-specific fibrosis determines the RD anchoring locations   
In the previous section, we reported the overall distribution of RDs across different regions of 
the atrial wall in the patient-specific LA models and found that RDs were most likely to anchor 
at fibrotic regions in patients with FB from Utah category 3 or 4. However, the basic knowledge 
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that RDs are present at fibrotic regions is insufficient to guide CA – we need to pinpoint the 
exact locations within the fibrotic patches where the RDs are localised. This warrants a detailed 
analysis of the mechanisms that affect RDs anchoring to specific fibrotic patches.  
To illustrate the concept, Figure 5.8A, B shows voltage maps and RD tip locations in a 
simulation of AF maintained by a single RD anchored to a fibrotic patch in the anterior LA 
wall. After the initial meandering, the RD tip (shown by a yellow dot) remained at a specific 
location inside the fibrotic patch for the entire duration of the simulation. Similar RD behaviour 
has been observed in other patients. However, the specific location where the RDs anchored to 
fibrotic regions was dependent on the size and distribution of fibrotic patches. Moreover, the 
same protocol when repeated in the absence of fibrosis resulted in formations of RDs that either 
remained stabilised at the region where they were initiated (as in Figure 5.8C, D) or they drifted 
towards the PVs and MV, under the influence of the underlying atrial curvature. 
 
Figure 5.8: The effect of fibrosis on the RD dynamics in a patient-specific LA model.  A & C: the colour-coded 
voltage maps (normalised, so that 0 is rest state and 1 is maximal activation) in the LA of Patient 3 over 6s of 
simulation with the yellow dot indicating the RD tip and the arrow pointing to the direction of rotation. B & D: 
the corresponding RD trajectories (grey-black) superimposed on the fibrosis distribution. In simulations with 
fibrosis (A-B), the primary RD drifts around and across the fibrotic patch within the first 1s and thereafter stabilises 
at a distinctive location within the fibrotic BZ. However, in the same simulation without fibrosis (C-D), the primary 
RD remains at the location of its initiation.  
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Further examples of RD trajectories under the influence of fibrotic patches for each of 6 patients 
are presented in Figure 5.9. In Patient 1 from Utah 4 category, more complex activation patterns 
in the voltage map were observed in addition to anchoring of RDs to fibrotic patches (Figure 
5.9, A1). This was due to breakdown of the initial RD into three new ones, which all stabilised 
at various locations around the largest fibrotic patch and surrounding BZ. In Patients 2, 3 and 4 
from Utah 3, the RDs stabilised at distinctive regions of fibrotic patches (Figure 5.9, A2-A4 
and B2-B4). In Patients 5 and 6 from Utah 2, fibrotic patches were much smaller compared to 
those in patients from Utah 3 and 4. Hence, the RDs often stabilised between two small fibrotic 
patches (Figure 5.9, A5 and B6), and if fibrotic patches were in regions around the PVs (Figure 
5.9, A6 and B5), fibrotic tissue aided the RDs moving towards and anchoring to the PV opening. 
All these examples highlight that patient-specific characteristics of fibrotic patches play a 
crucial role in detaining the dynamics and ultimate anchoring locations of RDs.  
The dynamic nature of the RD tip trajectory makes it harder to analyse the exact anchoring 
location. However, the tip probability map, unique to a patient-specific set of simulations, gives 
an in-depth view of the specific anchoring locations in each case. Sample RD tip probability 
maps for some of the simulations from Figure 5.9 can be found in Appendix (Figure A. 7).  
 




Figure 5.9: The anchoring of RDs to fibrotic patches in patient-specific LA models. For all the 6 AF patients 
(rows), sections A and B show the AF simulation outcomes for 2 different RD initiation sites. In each section, on 
the left are the colour-coded voltage maps and on the right, the respective RD trajectories (black) superimposed 
on the fibrosis distributions. The yellow arrows indicate the direction in which the RD drifted over 6s of the 
simulation. The colour map used in the figure is the same as Figure 5.8.  
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5.4.4  Targets for ablation identified from patient-specific LA models  
In the patient-specific LA models, as presented in the previous section, the RD anchoring 
locations were strongly dependent on the highly heterogeneous patterns of fibrosis distributions 
across the patient-specific LA models. Moreover, the anchoring locations were specific to 
individual patches. Therefore, by analysing all the RD tip trajectories obtained from numerous 
locations each of the 6 patient-specific LA models (using the protocol illustrated in Figure 5.6), 
we identified specific locations near fibrotic regions where the RDs were most likely to be 
found – the areas of high probability of the tip localisation – the target areas. 
 
Figure 5.10: Identifying RD location maps from patient-specific tip probability maps. (A) Shows the tip probability 
map across the entire LA model of patient, P1 and (B) shows the locations of target areas identified by thresholding 
the normalised probability map (A) at two levels (yellow, Th1: 0.2) and (orange, Th2: 0.15) and overlaid on the 
fibrosis map (greyscale).  
Figure 5.10, shows the normalised RD tip probability maps and target areas computed for the 
LA model of Patient 2. The tip probability map (Figure 5.10, A) captures all possible locations 
where the tip of the RDs have visited. The target areas (Figure 5.10, B) are computed by 
thresholding the probability maps such that only the locations which are most likely to be visited 
by the RDs are captured. In Patient 2, a higher threshold (Figure 5.10B, yellow), captures the 
fibrotic area which has the highest chances of anchoring RDs, while a lower threshold (Figure 
5.10B, orange) captures all possible fibrotic patches where RDs were stabilised. To terminate 
AF, all possible patches which anchor RDs need to be targeted. The choice of threshold could 
influence the order in which fibrotic regions are targeted by CA, helping to guide the CA 
procedures. 
The target areas calculated across all 6 patient-specific models with a threshold of 0.2 are shown 
in Figure 5.11. Here, on average 5.33 ± 2.94 target areas were identified per patient-specific 
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LA model. Moreover, by further analysing the distribution of the target areas (Figure 5.12A), 
we found that a higher percentage of target area were located within the fibrotic tissue region 
in patients in Utah 3 and 4 categories compared to patients in Utah 2 category. However, all 
target areas were relatively small, and the total volume of target areas was much lower than that 
of fibrosis in all patients (Figure 5.12B). The difference in the volume of fibrotic tissue and 
target areas was highest in Utah 4 patients, and lowest in Utah 2 patients, where RDs often 
stabilised around the PVs rather than fibrosis.  
 
Figure 5.11: Patient-specific RD location maps – potential target areas for CA. The images show colour-coded 
fibrosis distributions in the 6 patient-specific LA models (A-F), with the target areas superimposed. In Utah 3 and 
4 categories (Patients 1, 2 and 3), target areas are seen at specific locations within fibrotic patches and their BZs. 
In Utah 2 category (Patients 5 and 6), target areas are seen on the LA wall near small patches. Additionally, the 
target areas identified from simulations performed without fibrosis in the same LA model are presented in the 
Figure 5.13. 




Figure 5.12: Comparison of the fibrosis burden to target area volume of in each patient-specific LA models. A: 
distribution of target areas across different regions of the atrial wall; dense fibrotic region (black), border zone (BZ 
- dark grey) and healthy tissue (light grey). The majority of target areas lie in the fibrotic region in Patients 1, 2 
and 3 (FB > 25%, Utah 4 and 3), compared to much lower numbers in Patients from 4, 5 and 6 (FB < 25%, Utah 
3 and 4). B: bar chart with FB (blue) and volume of all identified target areas (orange) in each model. The 
difference between FB and target area volume decreases with the decrease in Utah score, showing that the 
predicted target areas can be most efficient in improving CA in Utah 3 and 4 patients. 
Additionally, we repeated all patient-specific LA simulations without fibrosis (Figure 5.13) and 
compared the target area locations to those in the respective LA models with fibrosis using the 
Dice score, a standard metric for the degree of spatial overlap. The Dice score was low for all 
patients, decreasing with the increase of FB. Thus, Patient 6 (FB: 11%) had Dice score of 0.52 
compared to Patient 1 (FB: 39%), who had an extremely low Dice score of 0.06. This means 
that, in the presence of large fibrotic areas, the RDs rarely were found in the same locations 
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where they would be found in the absence of fibrosis. These results provide further evidence 
for the role of fibrosis in determining the RD locations. 
 
Figure 5.13: Patient-specific RD location maps – catheter ablation targets. The images show colour-coded fibrosis 
distributions (greyscale) in the 6 patient-specific LA models, with the target areas (with fibrosis: yellow and 
without fibrosis: orange) superimposed. In Utah 4 patient (P1), target areas are seen at specific locations within 
fibrotic patches. In Utah 3 patients (P2, P3 and P4), target areas are distributed at the BZ between fibrotic patches 
and healthy tissue. In Utah 2 patients (P5 and P6), target areas are seen mostly on the LA wall with some near 
small patches. 




The association between atrial fibrosis and AF recurrence after CA is well established [81,232]. 
However, the role of fibrosis in AF arrhythmogenesis has not been well understood, and the 
application of fibrosis imaging in guiding CA procedures has been limited. Thus, despite recent 
achieving of LGE MR imaging in identifying and quantifying the extent and location of fibrosis 
across the atria, the knowledge about fibrotic regions has not been applied during CA. Image-
based computational modelling and simulation approaches help to understand the mechanistic 
influence of fibrosis in AF and to identify potential targets for CA. Specifically, they can predict 
the optimum locations of ablation lesions from patient-specific 3D atrial models, potentially 
helping to increase the efficiency of CA treatment in AF patients with high recurrence rates.  
This chapter is dedicated to the development of the novel image-based computational approach 
to exploring the dynamics of RDs in the presence of patient-specific fibrosis distribution and to 
identifying the locations which stabilise RDs sustaining AF. Specifically, we: 1) developed 3D 
LA models with patient-specific geometry and distribution of fibrosis obtained from LGE-MRI 
of 6 AF patients, 2) applied the models to explore the dynamics of RD stabilisation in the 
presence of slow-conducting fibrotic patches and 3) generated patient-specific target areas for 
the RD locations, relative to the distribution of fibrosis to identify potential target areas for CA.  
The main outcomes of this study were: (i) in AF patients from Utah 4 and 3 with high FB 
(>25%) RDs were more likely to be found at fibrotic regions compared to PVs (Figure 5.7A), 
(ii) RDs anchor to specific regions within the atrial walls, labelled as target areas identified 
from RD tip probability maps (Figure 5.11) and (iii) a higher percentage of target areas are 
located within the fibrotic tissue region in patients in Utah 3 and 4 categories compared to 
patients in Utah 2 category (Figure 5.12A). These results are consistent with observations in 
recent clinical and computational studies showing a strong spatial correlation between fibrotic 
regions identified from LGE-MR images and the locations of RDs sustaining AF [13,15,174]. 
5.5.1 Influence of atrial fibrosis on the distribution of RDs 
Our main finding is that fibrotic regions were the primary anchoring locations of RDs in AF 
patients from Utah 3 and 4 (with FB > 25%) compared to PVs in Utah 2 (with low FB < 20%). 
These results are in agreement with clinical studies that have shown low success rates of PV 
isolation in patients with high FB [232], as well as computational studies that showed the 
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persistence of AF primarily in patients in Utah 4 category [14]. Hence, the higher FB translates 
into a higher probability of RD localisation in fibrotic regions, and patients specifically from 
Utah 3 and 4 categories can benefit from fibrosis-based CA in addition to the standard PVI.  
It is worth noting that the RDs locations across patients with similar FB can be critically 
influenced by the specific fibrosis distributions. Thus, for Patients 3 and 4 (both from Utah 3 
category) with a similar FB (22 - 25%), there was a sizeable difference in the locations of RD 
stabilisation (Figure 5.7, A). The former had the same number of RDs anchoring at fibrotic 
regions and PVs, whereas in the latter majority of RDs were localised at the PV region. This 
could be explained by the differences in the spatial distribution of fibrosis in the two patients 
(Figure 5.4), with Patient 3 having a larger proportion of fibrotic patches in LA wall compared 
to the PV region. This result suggested that, in addition to stratifying patients for CA based on 
FB, as previously suggested [81,120,232], the influence of the spatial distribution of fibrosis 
should be taken into account. The stratification should be validated in future clinical studies. 
5.5.2 Comparison with previous studies of RDs and ablation 
In patients with high FB (Patients 1-3), the majority of the target areas in our patient-specific 
models were located at distinctive regions within fibrotic patches. Otherwise, in the models 
with low FB (Patients 4-6), the target areas are more evenly distributed across the LA wall. In 
average, 5.33 ± 2.94 number of target areas were identified per patient-specific model for a 
chosen threshold of 0.2 on the RD probability map. These findings are consistent with recent 
clinical studies that reported the persistence of RDs in a small number of distinctive locations 
[55,114]. For example, Haissaguerre et al. [114] used ECGI and reported 2-6 RD locations and 
Narayan et al. [55] used invasive basket mapping and also reported distinctive RD anchoring 
site which can be targeted by CA. In cases where RDs anchored to fibrotic patches, our 
simulation results consistently showed that only some regions of fibrotic tissue harbour RDs 
(i.e., the volume of target areas was lower than that of fibrotic regions, Figure 5.12B). Hence, 
only those relatively small regions should be targeted by CA.  
Furthermore, our findings agree with previous biophysical simulation studies that have also 
found an association between spatial distribution of fibrosis and anchoring locations of RDs 
[15,174,213]. In particular, Zahid et al. [15] and Boyle et al. [225–227] used similar patient-
specific LA models with fibrosis to demonstrate that AF was perpetuated by RDs that persist 
in spatially confined regions, such as BZs between fibrotic and non-fibrotic tissue. However, 
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in our simulations across all the models showed that some RD locations (target areas) were 
outside of the fibrotic BZ (Figure 5.12, A), particularly in the dense fibrotic area and healthy 
tissue regions near PVs. These differences could be attributed to the choice of methodology and 
specific electrophysiology parameters used for modelling of fibrotic regions [187,233,234].  
Our method to model fibrosis accounted for modification of electrical conductivity in fibrotic 
tissue, reflecting: (i) gap junction remodelling due to downregulation of Connexin 43 and (ii) 
reduced inter-myocyte coupling due to collagen deposition (discussed in Chapter 2, section 
2.5.5). Moreover, one important advantage of our method is that we incorporated a decreasing 
gradient in conductivity to represent electrical changes from non-fibrotic to fibrotic regions, 
rather than an abrupt change in conductivity as applied in previous studies by Zahid et al. [15] 
and Boyle et al. [226,227]. Our approach is more physiological compared to the binary model, 
since abrupt changes in tissue properties are not found atrial experiments. A similar approach 
has also been adopted in some previous studies by Morgan et al. [174] and Krueger et al. [171]. 
Having multiple levels of fibrosis within the same model allows us to overcome certain errors 
associated with thresholding and modelling of fibrosis. By incorporating multiple levels of 
fibrosis in the model, we captured the known dependence of conductive tissue properties on the 
level of fibrosis, as reported by Fukomuto et al [177], which can’t be done with a binary 
approach. Other studies have also incorporated the electrotonic effects of fibroblast-myocyte 
coupling [174], ionic changes due to paracrine effects [15] and represented deposition of 
collagen using percolation method [181] or discontinuous finite elements [180]. Computational 
studies that compared different fibrosis modelling methodologies have reported that these 
additional factors further facilitated the anchoring of RDs to the fibrotic areas and their BZ due 
to increased APD and lower CV [187,233]. This may explain why those simulations found a 
large number of RDs located at the fibrotic BZ, while ours show a wider distribution. We 
believe that, although our representation of fibrotic tissue is simple, it is adequate for patient-
specific models derived from clinical imaging data with limited resolution.  
Previous computational approaches to identify RD locations in patient-specific atrial models 
[14,15,226,227,235] have focused on the ability of fibrotic regions to generate RDs and 
subsequently anchor them. However, the RD formation is not exclusively mediated by fibrotic 
regions. Moreover, RDs are known to drift and meander within atrial tissue, and the initial RD 
location is not necessarily its anchoring location. Hence, in this study, we presented a unique 
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approach where the initiation of the RDs was independent of fibrotic regions, which allowed us 
to evaluate the ultimate anchoring locations of RDs in an unbiased manner. Moreover, in all 
our simulations, the tip of the RDs was calculated every 1ms, while in other studies this was 
limited to every second [15]. The advantage of such a high frequency of RD tip calculations is 
a deeper insight into the RD trajectory during the anchoring process. Although this comes at a 
higher computational cost, one of the aims of our study was to evaluate the dynamics of RD 
with respect to fibrotic regions. Moreover, in order to generate the probability maps for RD tip 
locations, higher resolution was necessary, which justifies our computational choice. 
5.5.3 Limitations 
The choice of atrial electrophysiology model is known to influence the RD tip locations 
[236,237], but sensitivity to such a choice was not investigated in this study. Besides, the 
presented model does not account for heterogeneous distributions of APD and CV in the atria 
[15,53,169,233]. Instead, we modelled a simpler condition where APD was homogeneous and 
both fibrotic and non-fibrotic regions have isotropic conduction properties and CV. Ideally, 
patient-specific models should be parameterised using CV and APD measurements from the 
same patients. However, data needed to create such complex models are unavailable due to the 
limitations in invasive mapping technology to sample the entire atria. Previous studies [15,233] 
have used values either limited data sampled from discrete locations in the atria of small patient 
groups [238], or ex-vivo ionic data derived from canine experimental models [148].  
Another limiting factor of the study is that all the subjects considered for the study were male. 
Gender related differences in LA electrophysiology [239], anatomy, structure and function 
[240,241] have been reported in animal studies [242]. These differences have been attributed 
to disparities identified in calcium and sodium channel regulation and the effects of sex 
hormones [241,243]. However, the question of atrial differences between the human genders 
remains controversial due to limited data. In this study, we considered only male subjects due 
to the availability of data. Further experimental and modelling studies are required to 
understand gender related differences in AF mechanisms. This will allow for further 
personalisation of AF therapy. 
Atrial fibre orientation is known to be complex [244] and can also have significant effects on 
atrial conduction [148,165]. Specifically, change in fibre orientation has been reported at the 
PV sleeves, which can lead to significant repolarization heterogeneities and unstable RD 
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behaviour [245,246]. Moreover, significant inter-patient variability in the PV fibre directions 
has been reported to affect inducibility and stabilisation of RDs at LA-PV junction [155]. 
Therefore, incorporating fibre information will increase the predictive strengths of the model. 
However, in this study fibre orientation was not incorporated due to the absence of relevant 
patience-specific data. An adequate reconstruction of the complex atrial fibre architecture from 
patient data is hindered by limitations of existing imaging techniques. The modelling approach 
presented in the current study is entirely based on patient imaging-derived data available in the 
clinic. Future studies aiming to incorporate information about fibre orientation into patient-
specific atrial models are discussed in Chapter 7, Section 7.3.  
Limitations of EAM in identified locations of RDs in the atria (discussed in Chapter 2, Section 
2.4.3.2) also led to a lack of validation for the predicted RD locations. Recent advances in 
identifying RDs using non-invasive ECGI [12,13,247] could be used for validation of the 
models by measuring the correlation between the model predictions and the actual recordings.  
Another simplification made in the study was that all the pacing locations (AF triggers) were 
kept in the regions surrounding the PVs. However, such triggers can sometimes arise from 
regions outside the PVs [248]. In future, the pacing location evenly cover the entire atrial wall 
rather than a few specific locations. Initiating RDs from every node within the geometry (> 
60000 points) for each patient data comes at a high computational cost (~3 hours per 
simulation), and an efficient approach should keep a balance between the two.  
In the image-processing pipeline, the empirical IIR threshold to differentiate between fibrotic 
and non-fibrotic regions from LGE-MR images will affect the shape and size of the fibrotic 
areas and the BZ and hence the dynamics of the RDs. However, the optimum value is unknown. 
Therefore, the work presented in Chapter 6 aims to investigate the sensitivity of the anchoring 
locations of the RDs – target areas to the change in shape and size of the fibrotic areas as a 
result of uncertainties in LGE thresholding. The other limitations consistent with work 
presented in other Chapters, and possible ways to address them in the future are summarised in 
Chapter 7. 
5.6 Conclusions 
In conclusion, this chapter presented an image-based computational workflow to identify 
patient-specific locations of RDs from LGE-MRI data. The simulations showed that RD 
sustaining AF typically anchored to specific regions of fibrotic patches. Therefore, the RD 
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locations were determined by unique patient-specific distributions of fibrotic tissue, identifying 
areas that may potentially be targeted by therapy. These results may be particularly relevant to 
AF patients with high fibrosis burden in the LA, where the model-predicted target areas could 
inform CA. The next chapter will use a subset of the predicted patient-specific target areas to 
test the efficacy of respective patient-specific CA strategies in-silico. 
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Chapter 6  
Virtual Catheter Ablation of Atrial Fibrillation:  
Target Areas Identified from Image-Based Models 
6.1 Section Outline 
The study presented in this chapter aims to: (1) test new CA strategies by simulating ablation 
of target areas predicted from image-based LA models (detailed in Chapter 5) and (2) explore 
the sensitivity of the predicted target areas locations on the choice of LGE-MR image intensity 
thresholding parameters. In this proof-of-concept study, all the simulations were performed 
using 2 of the 6 patient-specific LA models. The motivation behind investigating CA strategies 
is summarised in Section 6.2, and the methodology of the virtual ablation using the LA models 
and the sensitivity study are discussed in Section 6.3. Finally, the limitations (Section 6.5.3) 
and the main findings (Section 6.6) of the chapter are summarised. 
6.2 Introduction and Motivation 
Despite advances in CA therapy over recent decades, the success is limited particularly in PsAF 
patients with high post-ablation AF recurrence rates [249]. The extent of fibrosis characterised 
from  LGE-MR images is known to be an important predictor of post-ablation recurrence [81]. 
Ablation strategies that target low-voltage areas (believed to be a surrogate of fibrosis) in 
addition to pulmonary vein isolation (PVI) have shown to improve the success rate [100,123], 
although the superiority of this substrate-based ablation strategy compared to the PVI-only 
ablation has not yet been confirmed by large clinical trials. Moreover, CA strategies targeting 
fibrotic regions greatly vary between clinical centres. For instance, some studies target the 
entire fibrotic region [102], while others either isolate the fibrotic regions [100] or specifically 
target fibrotic areas with distinctive activation patterns [123]. This ambiguity can be explained 
by the lack of mechanistic knowledge of the links between fibrosis and AF. Moreover, empirical 
ablation of extensive fibrosis areas in patients with a high fibrotic burden (FB) can create 
proportionally extensive CA lesions and result in substantial damage to the atria. This warrants 
the development of mechanism-based strategies that can aid in the identification of optimal 
patient-specific ablation lesions and the standardisation of CA therapy across multiple centres. 
Chapter 6: Introduction and Motivation   | 138 
 
 
6.2.1 Model-based ablation strategies  
Personalised computational models provide a promising tool for improving CA [225,250–253], 
as also shown in the Chapter 5. For example, they can link the structural information obtained 
from atrial imaging data and electrophysiological information from ECGs and non-invasive 
mapping to elucidate the dynamics of AF drivers in a patient-specific manner [254]. Such 
studies have suggested that specific fibrotic architecture may be needed to harbour RDs, which 
could aid in the non-invasive identification of targets for CA [15]. Prakosa et al. [255] has 
proven that predictions based on personalised models can help in termination of infract-related 
ventricular tachycardia in both animals and patients without the need of prior electro-anatomic 
mapping. Similar approaches are also being developed for AF [225,252], but the progress is 
hindered by the complexity of its mechanisms and the underlying fibrosis architecture.  
Chapter 5 presented our own image-based computational workflow for the identification of the 
most likely anchoring location of RDs – potential target areas for CA. Specifically, the LA 
models with patient-specific fibrosis distribution were applied to simulate multiple AF scenario 
and to identify regions where the RDs are most likely to anchor in a given patient across all 
scenarios. The next logical step of this study is to test whether CA on these regions, would 
indeed be beneficial in terms of terminating RDs and preventing their recurrence. However, 
before such an approach could be tested in AF patients, using our computational workflow to 
perform virtual ablation of the target areas presents a safe exploratory option. Moreover, 
knowledge of the mechanistic links between RD locations and success of clinical CA strategies 
is limited. Therefore, the first aim of the study is to perform CA of the predicted target areas in 
the patient-specific models and then compare its success with the existing CA strategies, thus 
identifying the optimal strategy given the knowledge of RD locations.  
6.2.2 Challenges of fibrosis imaging in the atria 
Despite advances in personalised computational models in understanding and improving CA, 
their success ultimately comes down to the quality of imaging data the models are based on. 
Limitations of the image-based models that utilise patient-specific LA geometry and fibrosis 
distribution were discussed in the relevant section of Chapter 5. Here, we focus on the 
limitations of LGE-MRI data used to personalise the models. Throughout the study, we used 
the image intensity ratio (IIR) between atrial myocardium and the blood pool to identify and 
segment fibrosis from LGE-MR images [83]. However, the optimal cut-off value to 
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differentiate between fibrotic and non-fibrotic tissue is still being debated (also discussed 
further in Chapter 2, Section 2.4.2.2 ).  
Therefore, the second aim of the study was to perform a simple sensitivity analysis to determine 
how dynamics of RDs, and hence the target area locations, would be affected by alterations in 
intensity thresholding of the LGE-MRI. In order to achieve this, we first evaluated the RD 
dynamics in relation to a single fibrotic patch with varying size and shape in a 3D slab of atrial 
tissue. The results were then extended to a 3D patient-specific atrial model with multiple 
fibrotic regions. 
6.3 Methods 
6.3.1 Virtual ablation of the predicted target areas  
Figure 6.1 summarises the complete workflow for predicting optimal CA strategies from 
patient-specific biophysical models of the LA. The blue panels correspond to the construction 
of patient-specific models from LGE-MR images and generation of target areas (Figure 6.1, A-
D), which has been described in Chapter 5; the grey panels correspond to virtual ablation of the 
predicted target areas and beyond. In the first part of the study, we performed virtual ablation 
of the target areas (Figure 6.1, E) in 2 AF patients with fibrosis classification of Utah 3 (Patient 
2 & 3 from Chapter 5). In the following text, they will be referred to as P2 and P3.  
 
Figure 6.1: The workflow for reconstruction of the image-based LA model (A-B), perform patient-specific AF simulations 
(C), predict the RD locations (D) and then perform virtual ablations (E) of the predicted target areas.   
6.3.1.1 AF Ablation Strategies 
The CA lesions were modelled as cylindrical transmural regions of unexcitable tissue with a 
diameter of 3 mm [256] to account for the catheter tip shape. The continuous CA lesions were 
implemented using five strategies; Strategy 1 and 2 are used clinically [9], Strategy 3 is based 
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on our model’s predictions from Chapter 5 and Strategies 4 and 5 are combinations of the model 
predictions with clinical strategies. Further details of each strategy are provided below: 
1. Strategy 1: PV isolation (Figure 6.2, A)  
The 2 right and 2 left PVs were electrically isolated by a continuous set of ablation 
lesions encircling the PVs and isolating them from the remaining LA body.  
2. Strategy 2: PV isolation with linear lesions (Figure 6.2, B) 
If the RDs still persisted after the application of Strategy 1, additional linear lesions 
were applied: one on the LA roof to connect the left and right circular PVI lesions and 
another to connect the roof lines with the mitral valve (MV) opening.  
3. Strategy 3: target area guided ablation (Figure 6.2, C) 
Ablation lesions were applied to the voxels within the target areas identified from the 
patient-specific AF simulations. This approach has similarities to DECAAF II, an 
ongoing prospective multicentre randomised trial in which all fibrotic regions identified 
from LGE-MRI are targeted by CA. However, our approach only targets areas that 
typically are located near fibrotic regions but are much smaller than the entire fibrosis.  
4. Strategy 4: target area guided ablation with linear lesions (Figure 6.2, D) 
If RDs still persisted after the application of Strategy 3, additional linear lesions were 
applied to join the target areas to the nearest anatomical boundary – the PVs or the MV. 
5. Strategy 5: target area guided ablation with linear lesions and PVI (Figure 6.2, E) 
If the RDs still persisted after the application of Strategy 4, Strategy 1: PVI was applied. 
All CA lesions were applied after 6s of the AF simulation to analyse if these lesions terminated 
the existing RDs within 2 s. The CA strategy was considered successful if either AF converted 
to atrial tachycardia (AT) or the RDs were completely terminated. In this study, we refer to 
macroreentrant AT when re-entrant waves rotate around scar tissue formed after ablation 
(discussed in further detail in the Chapter 2, Section 2.4.3.2). The mean frequency (MF) of 
activations in the LA model before and after CA was recorded for all the strategies and 
conversion of AF to AT was evaluated by reduction in the MF [257]. The MF was computed 
by averaging over the dominant frequency calculated for every location of the LA geometry for 
the last 1s of the simulation. Moreover, for target area guided CA strategies 3 and 4, we also 
tested if these lesions prevented AF inducibility in the models. To achieve this, the protocol 
used for AF initiation was repeated after the application of the ablation lesions.  




Figure 6.2: CA strategies tested using virtual ablation platform. (A) Strategy 1: Circumferential PVI, (B) Strategy 
2: PVI plus additional linear lesions at the LA roof and a line joining the PV to the MV, (C) Strategy 3: ablation 
on the target areas, (D) Strategy 4: target area guided ablation with additional linear lesions leading to unexcitable 
boundaries (PV and MV) and (E) Strategy 5: target area guided ablation with linear lesions plus PVI. 
6.3.1.2 Virtual Ablation Simulation Protocol 
All the simulations were performed using the image-based 3D atrial models of Patients 2 and 3 
described in Chapter 5. The choice of these patient models was motivated by the highest 
correlation found between the RD location and fibrotic region in Figure 5.7. However, Patient 
1 was not ablated due to extensive fibrosis (Utah 4) and clinically they would not be considered 
for CA procedure. While, Utah 2 patients can probably be successfully ablated using PVI. 
6.3.2 LGE-MR intensity thresholding and RD locations 
In the second part of the study, the goal was to analyse the effect of IIR threshold on RD 
localisation and the corresponding target areas. Therefore, we systematically altered the chosen 
IIR threshold values in the original pipeline (Chapter 5, Section 5.3.2.1), which resulted in 
altering the size of the BZ surrounding the fibrotic patch. Previously, two IIR thresholds were 
used (Figure 6.3, B): (i) voxels below an IIR of 1.08 (referred to as I1) were healthy tissue, (ii) 
voxels above an IIR of 1.24 (referred to as I2) were dense fibrotic regions and the voxels with 
intermediate values between I1 and I2 correspond to the BZ. This gave us the control case, 
while fibrotic patches with varying BZ size were created by altering the IIR threshold, I1, which 
differentiates between healthy and fibrotic tissue while keeping I2 constant. The rationale 
behind altering only one of the two thresholds was to maintain computational tractability.  




Figure 6.3: LGE-MRI intensity thresholding for fibrosis assessment. (A) LGE MR image slice with arrows 
indicating fibrotic regions, (B) the intensity thresholding parameters and (C) the extracted fibrosis map.  
The study consists of two parts where we investigate the effects of BZ size in: (1) a 3D atrial 
slab with a single fibrotic patch and (2) the LA model with patient-specific fibrosis distribution. 
The second part in realistic atrial models will provide further insight on how the LGE-MRI 
thresholding affects the localisation of RDs in the presence of multiple fibrotic patches. 
6.3.2.1 Study 1: The 3D atrial slab study 
Model Geometries: The simulations were performed on a 3D atrial tissue slab of 200 x 200 x 
25 voxels corresponding to a tissue size of 60 x 60 x 7.5 mm3 with a surface area of 3600 mm2, 
similar to that described in Chapter 3. A diagram of this setup is presented in Figure 6.4. Here 
the effect of fibrotic patches with different BZ sizes on the RD dynamics was investigated by 
incorporating a realistic patch from the fibrosis distribution of Patient 2 (Figure 6.4, A).  
 
Figure 6.4: 3D atrial slab with realistic fibrotic patch. (A) LA model with patient-specific distribution of fibrosis 
and (B) Projection of the fibrotic patch on a 3D atrial slab with black dots indicating the RD initiation locations. 
Model Parameters: In the fibrotic patch, increasing and decreasing the control value for I1 by 
5% resulted in a relatively small and large BZ, respectively. Setting I1 equal to I2 generated 
conditions for no BZ. The different values for I1 used in the generation of fibrotic patches with 
no, small, and large BZs compared to the control are summarised in Table 6.1.  
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Model % Change I1 I2 
No BZ (I1noBZ) ‒100.0 1.240 
1.24 
Small BZ (I1+5%) ‒36.90 1.134 
Control (I1control) - 1.080 
Large BZ (I1-5%) +45.34 1.026 
Table 6.1: The chosen IIR cut-off values used in Study 1. Column 2 shows the % change in size of the 
BZ with respect to the control, while columns 3 and 4 present the IIR threshold values used. 
Stimulation Protocol and Analysis: RDs were initiated at multiple sites surrounding the 
fibrotic patch (Figure 6.4, B), using the same cross-field protocol as in Study 1 from Chapter 3. 
The tips of the RDs for all the simulations were tracked using the method described in Chapter 
3 and the target areas were computed using the method described in Chapter 5 (Figure 5.6).    
6.3.2.2 Study 2: The patient-specific LA study 
Model Geometries: All simulations were performed with the LA model of Patient 2 and 3.  
Model Parameters: The previously stated IIR thresholds (in Chapter 5) were altered by 
increasing the I1 by 1% and 3%. These values were selected such that the BZ decreased while 
the overall volume of fibrosis (i.e., FB) did not change by more than 10% (see Discussion).  
Model I1 I2 FB 
I1control  1.080 
1.24 
29 % 
I1+1% 1.091 27 % 
I1+3% 1.112 22 % 
Table 6.2: The chosen IIR values and resultant FB in Study 2. 
Stimulation Protocol and Analysis: RDs were initiated at multiple sites using the same 
protocol as in Chapter 5. The tip of the RDs for all the simulations were tracked and the target 
areas were computed using the method described in Chapter 5, Figure 5.6.  
Data Analysis: The degree of overlap between target areas in models based on I1control with 
those based on I1+1% and I1+3%, was evaluated by measuring the Dice score [231] of the CA 
lesions applied on top of the target areas and formed continuous fully transmural regions. 
  




6.4.1 Effect of different ablation strategies on the termination of RDs 
6.4.1.1 PV Isolation with and without linear lesions 
Ablation of the PVs (in Strategy 1) failed to terminate RDs in the majority of cases (P2: 6/10, 
P3: 4/8). As shown in Figure 6.5 (A1 and B1), RDs located far from the PVs were unaffected. 
These RDs persisted even after additional linear lesions were applied at the roof and the MV 
(Figure 6.5, C1 and D1, in Strategy 2). In the few cases where AF did terminate, the RDs were 
present inside or near the isolated PV regions. After CA, these RDs either anchored to the 
lesions encircling the PVs (P2: 1/10, P3: 2/8) resulting in AT or terminated (P2: 3/10, P3: 2/8).  
 
Figure 6.5: CA with the clinical used ablation Strategies 1 and 2 failed to terminate AF in the majority of cases. 
Left: Voltage maps showing the behaviour of RDs after: (A1-B1) Strategy 2 and (C1-D1) Strategy 2 in Patient 2 
and 3, respectively. Right: Transmembrane voltage at the point indicated by * in the respective LA models, plotted 
before (red) and after (blue) CA. Both strategies failed to terminate RDs in all cases and the mean frequency (MF) 
remained unaffected. Here and in the next figure, the white arrow indicates the directions of RD movement.  
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6.4.1.2 target area guided ablation with and without PVI 
CA on the target areas were performed using Strategies 3, 4 and 5. First, with Strategy 3, the 
application of CA lesions on top of the target areas either resulted in the RDs anchoring around 
the newly formed ablation scar (Figure 6.6, A1 and B1) and AF converting to AT (P2: 4/10, 
P3: 4/8) or had no effect (P2: 5/10, P3: 4/8). Examples of the conversion from AF to AT in 
Patient 2 and 3 are shown in Figure 6.6, A2 and B2. Here, MF dropped by 26% and 41%, 
respectively.  
 
Figure 6.6: Target area guided ablation with Strategy 5 successfully terminated AF. Voltage maps showing the 
behaviour of RDs after CA of: (A1-B1) target areas and (C1-D1) target areas plus linear lesions joining them to 
the PVI lesions and the mitral valve (MV) in Patient 2 and 3, respectively. Panels on the right (A2-D2) show the 
voltage at the point indicated by * in the respective LA models, before (red) and after (blue) CA. Out of the two 
strategies, PVI plus target area guided ablation successfully terminated AF in both patients.  
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However, Strategy 4 connecting the target areas with linear ablation lesions to the nearest 
boundary (the PVs or MV) terminated AF in the majority of the cases (P2: 6/10, P3:4/8). In 
case of Patient 2, all RDs were terminated (Figure 6.6, C1), while in Patient 3 AF was converted 
to AT (Figure 6.6, D1) with a reduction in MF by 59%. In Strategy 5, application of PVI in 
addition to Strategy 4 resulted in a further increase of AF termination rate in both patients (P2: 
9/10, P3: 8/8).  The outcomes for all virtual CA strategies in both patients are summarised in 
Figure 6.7.  
 
Figure 6.7: The outcome of CA using different strategies in Patient 2 (A) and Patient 3 (B). The summary of the 
mean frequencies (MF) recorded for these cases are presented in Appendix, Table A. 2.    
6.4.1.3 AF inducibility after ablation 
AF recurrence after CA is a huge clinical problem. In order to check for AF recurrence, we 
tested for AF inducibility (Figure 6.8) after CA with Strategies 3 and 4. CA performed using 
Strategy 3 did not prevent the RDs from being initiated in either patient. However, it resulted 
in AT rather than AF in the majority of cases (P2: 8/10, P3: 8/8), with MF of ~ 6 Hz (Figure 
6.8, A). In the remaining cases, RDs were located either outside the target areas or between the 
CA ablation lesion (Figure 6.8, C), and hence were induced in the same way as before CA. 
However, using Strategy 4 completely prevented the initiation of RDs: neither AF nor AT was 
initiated (Figure 6.8, B), even in 8 cases where AT was initiated after Strategy 3 in Patient 2. 
Moreover, joining the CA lesions converted AF to AT in one additional case (Figure 6.8, D). 
In Patient 3, all RDs corresponded to AT with a lower MF (~ 5 Hz) compared to Strategy 3. 




Figure 6.8:  AF inducibility following CA Strategies 3 and 4. (A and C) The RDs were initiated following ablation 
Strategy 3: (A) the RD anchored to the newly formed scar generating AT, or (C) the RD found a new pathway 
between two target areas and stabilised. However, following ablation Strategy 4 (B and D), where the target areas 
were connected to the PV or MV, the RD either terminated (B) or anchored around the MV and generated AT (D). 
6.4.2 Effect of IIR threshold on target areas  
6.4.2.1 The 3D atrial slab study 
In the 3D atrial slab with a single fibrotic patch, varying BZ size (Figure 6.9, A-D) influenced 
the specific meandering trajectories of the RDs around the patch. In the absence of BZ (Figure 
6.9, A), the RD did not meander and its trajectory encircled a portion of the dense fibrotic region 
(Figure 6.9, A (i)). Hence, the majority of the RDs (7/9) remained anchored to the fibrotic patch, 
whereas RDs initiated far from it meandered away (2/9). The target area, in this case, was 
located precisely at the border between fibrotic and non-fibrotic tissue (Figure 6.9, A (iv)). 
In the presence of a slow conducting BZ around the dense fibrotic region, the RD meandered 
zig-zagging between the dense fibrotic region and the surrounding BZ (Figure 6.9, B-D (ii)). 
The extent of meandering increased with the increased size of the BZ, and hence the target area 
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regions in such cases (Figure 6.9, B-D, (iv)) were further spread across the patch compared to 
the patch with no BZ. Moreover, as the BZ size was increased, the RDs – that had been anchored 
to the fibrotic patch in case with no BZ (7/9) – were no longer anchored and meandered away 
from the patch. In case of the smallest BZ, 4/9 RDs remained anchored at the patch, while for 
the largest BZ only 2/9 were anchored; other RDs meandered away. The degree of overlap 
between the identified target areas measured using the Dice score was 0.99 across all cases.   
 
Figure 6.9: Effect of the BZ size on the dynamics of RDs in a 3D tissue slab. The voltage maps showing the 
behaviour of RDs over a period of 150 ms, for a RD initiated at one of the 9 locations, are shown in panel (A-D, 
(i)). The further column (A-D, ii) shows the corresponding tip trajectories. Here each row (A-D) represent a fibrotic 
patch with (A) no BZ to a fibrotic patch with the (D) largest BZ, respectively. The RD tip probability maps and 
the corresponding target areas obtained for each case is shown in columns (iii) and (iv), respectively. Finally, the 
ablation lesions following the virtual CA of the identified target areas are shown in column (v).  
6.4.2.2 The patient-specific LA study 
In the patient-specific LA model, the sensitivity of the target areas to the IIR threshold (I1) was 
tested by increasing the control value (I1control) by 1% (I1+1%) and 3% (I1+3%), which decreased 
the FB by 2% and 5% (Table 6.2), respectively, and also decreased the size of the BZ 
surrounding the dense fibrotic region (Figure 6.10, A1-C1). On repeating the simulations from 
Chapter 5 (Section 5.3.3), we found that out of 5 target areas identified using I1control (Figure 
6.10, D, black), changing the intensity threshold to I1+1% resulted in 4 of the target areas (Figure 
6.10, D, blue) still present in the same fibrotic patch and 1 target area disappearing. Further 
increasing the threshold to I1+3% resulted in 3 of the target areas (Figure 6.10, D, orange) present 
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in the same position and 2 of the control target areas disappearing. The overlap between CA 
lesions targeting the target areas in the models with I1control and I1+1% and I1+3%, evaluated by 
computing the Dice score was 0.59 and 0.61, respectively.  
 
Figure 6.10: Effect of the BZ size on the dynamics of RDs in the patient-specific LA model. The fibrosis maps 
and the corresponding tip probability maps, for different sizes of BZ are shown in panels (A1–C1) and (A2–C2), 
respectively. Here, cases A-C were obtained by using the threshold I1, I1+1% and I1+3%, respectively. Panel D shows 
the overlap between the target areas for each BZ case (I1: black, I1+1%: blue and I1+3%: orange) with a sphere, 
whose centre is the centroid of the patch and the radius represent the size of the target areas. The control (I1) case 
had 5 distinct target areas regions, out of which 3 (label 1-3) consistently overlapped with target areas identified 









In Chapter 5, we presented an image-based computational workflow for the prediction of 
potential target areas for CA in AF patients with an existing LGE-MRI scans of the LA. In this 
chapter, we first used the previously constructed patient-specific LA models to perform virtual 
CA of our predicted target areas and compare its success in-silico with existing clinical CA 
strategies. Second, we investigated the sensitivity of the RD dynamics and the corresponding 
target area locations to the LGE intensity thresholding. Our simulation results showed that 
target area-guided CA combined with existing clinical strategies (Strategies 4-5) has a higher 
success rate compared to PVI with and without additional linear lesions (Strategies 1-2). 
Therefore, this study predicts that targeting atrial regions with high probability of RDs 
anchoring, as identified from patient-specific simulations, can improve the clinical CA efficacy 
in AF patients. However, our results also highlight the potential sensitivity of the identified 
patient-specific target areas to specific image processing methods used for the quantification of 
atrial fibrosis from LGE-MR images.  
6.5.1  Virtual Ablation on the predicted target areas 
To meet the first aim of the study, we used LA models of two AF patients from Utah 3 category 
(Chapter 5): one with persistent AF (Patient 2) and another with paroxysmal AF (Patient 3). 
We tested two clinical strategies: (1) PVI and (2) PVI with additional linear lesions at the LA 
roof and MV. The former is considered a cornerstone of CA in PAF patients [99], while the 
latter has been used in combination with PVI in patients with chronic forms of AF [258]. We 
then compared the outcomes of these two CA strategies with three target area guided ablation 
strategies: (3) ablation of the target areas only, (4) ablation of the target areas with additional 
application of linear lesions joining the target areas to the nearest boundary (the PVs or MV), 
and (5) the ultimate strategy that combined target area guided ablation with PVI and a 
connecting set of linear lesions.  
Our simulation results demonstrated that in cases where clinical CA strategies (Strategies 1-2) 
were unable to terminate AF, Strategy 4 successfully terminated AF in majority of these cases 
for both patient-specific LA models either by eliminating the RDs and AF or by converting AF 
to AT (Figure 6.7). Strategy 5, combining Strategies 1 with Strategy 4, resulted in an increase 
in AF termination rate (P2: 90%, P3: 100%) compared to Strategies 1 only (P2: 40%, P3:50%).  
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Our study shows that if RDs are present in regions far away from the PVs, clinical strategies 
based on PVI (Strategy 1) would not be efficient in terminating AF. Although the additional 
linear lesions joining the PVI at the roof and to the MV (Strategy 2) are known to modify the 
atrial substrate and compartmentalize the atria into smaller regions, we found it does not always 
facilitate the termination of RDs that are located within these compartments. This is most often 
the case in PsAF patients with fibrotic remodelling in the atria, which favours maintenance of 
AF drivers in regions outside the PVs, as evidenced by clinical findings [55,114]. The non-PV 
drivers can explain why large-scale randomised clinical trials have found a lack of reduction in 
the AF recurrence rates after PVI even with additional linear ablation lesions [106]. Moreover, 
AF-induced remodelling develops in a patient-specific manner [182], and hence the RD 
locations are also expected to be patient-specific and the standardised CA strategies may not 
work for everyone. This suggests that our image-based, mechanistic approach to CA, based on 
the knowledge of RD locations underlying AF, can help improve the existing CA strategies.  
Virtual ablation of target areas alone (Strategy 3) resulted in the stabilisation of meandering 
RDs in the vicinity of ablated regions, and the conversion of AF to AT with a lower MF (Figure 
6.6, A-B). Similar findings have been reported in a study by Bayer et al. [235], where CA 
directly targeted the RD tip. Although this strategy reduced MF to about 6 Hz in some 
simulations, in most cases the patients remained in rapid AT with MF of up to 8 Hz. However, 
connecting the target areas to the nearest boundary (PVs or MV) using additional linear lesions 
(Strategy 4) either terminated all RDs (Figure 6.6, C1) or generated a single re-entrant circuit 
(Figure 6.6, C2) with lower MF (5-6 Hz) than with Strategy 3. Moreover, Strategy 4 was also 
superior to Strategy 3 in preventing AF inducibility. Connecting all target area ablation lesions 
with linear lesions leading to unexcitable boundaries resulted in either termination of all RDs 
(Figure A. 8, A to B), or conversion of AF to AT due to an RD anchoring around the MV 
(Figure A. 8, C to D). Here the linear lesions connecting the target areas to the boundaries 
prevent the RD formation.  
Furthermore, when we combined target area guided ablation with PVI by joining the respective 
CA lesions with additional linear lesions (Strategy 5), the previously sustained RDs located far 
away from the PVI lesions were either completely terminated or AF converted to AT with a 
lower MF (< 5 Hz). These results are consistent with previous clinical studies that have shown 
that CA of regions with high-frequency activity (associated with RDs) identified with spectral 
Chapter 6: Discussion   | 152 
 
 
analysis resulted in AF termination by direct transition to either sinus rhythm or AT 
[111,257,259]. Moreover, CA at such high-frequency sites typically prolongs AF cycle length 
[257,260], which is consistent with the decrease in MF following target area ablation reported 
in this study.  Overall, our novel Strategy 5 proved to be the most efficient (P2: 90%, P3: 100%).  
Note that a recent clinical study by Calvo et al. [259] have used a similar approach, where 
ablation on RD domains identified using EAM was performed with limited linear lesions 
joining the identified RD domains with the unexcitable boundaries (PVI lesion in the LA). Their 
results showed a reduction in dominant frequency and acute termination to sinus rhythm in 15% 
of persistent AF patients, and 1 year follow up showed 70% of the patients to be free from AF. 
Our simulation results are consistent with these findings and can explain the mechanism 
underlying its success. Note also that Calvo et al. relied on EAM to identify the RD domains, 
which can be unreliable due to limitations of EAM technology (e.g., poor atrial coverage and 
mapping resolution). Our personalised image-based computational models can enable the 
identification of these regions with greater accuracy, which further highlights the potential of 
such models for improving the efficiency of CA in chronic AF patients. However, it is important 
to note that the acute termination does not predict long term success. Future clinical trials are 
required to predict the long-term success of this strategy. 
6.5.2 LGE-MR intensity thresholding and RD locations 
Patient-specific fibrosis distribution is an important component of personalised computational 
models [14,225,235,250]. Moreover, computational studies have shown that the spatial 
architecture of fibrosis influences the induction and anchoring locations of RDs associated with 
AF [15,182]. Therefore, a standardised method of extracting fibrosis distribution from patient 
LGE-MRI data is of great importance for the success of such approaches. However, there is no 
consensus on the LGE-MRI intensity threshold settings for clinical assessment of fibrosis.  
In this study, we varied the IIR threshold used for differentiating between fibrotic BZ and 
healthy tissue by ± 5% in the 3D slab model, while in the patient-specific models we varied it 
by +1% and +3% and evaluated its effects on the RD anchoring locations. A larger variation 
was used in case of the slab model, as we were interested in evaluating the effect of large 
changes in the BZ size on the RD dynamics. Our simulation results showed that, although 
anchoring of RDs to the fibrotic patch was affected by the BZ size, locations of the target areas 
remained unaltered within this patch. However, in the patient-specific models, we focused on 
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the identification of such target area locations with smaller variations that maintained realistic 
BZ size. 
Our simulation results in the patient-specific model show that altering the intensity threshold 
by up to +3%, 3 out of 5 target areas identified from the control are located within the same 
fibrotic patches with an average displacement of 3.21 ± 2.62 mm, while the remaining 2 
disappeared. This could be explained by a decrease in the BZ size due to increased intensity 
threshold, which influences the anchoring of the RDs to fibrotic patches as seen in our 3D slab 
simulations. These results demonstrate that the choice of the LGE-MRI intensity threshold for 
assessment of fibrosis can influence the locations of RDs.  
Although our results suggest that AF simulations performed with models based on I1control 
identified a subset of target areas that were consistent with models based on both I1+1% and 
I1+3%, a single threshold may not help identify all the target areas. Therefore, the clinical 
deployment of personalised computational models should take into careful consideration the 
fact that these models inherit the limitations of the current fibrosis imaging and mapping 
techniques. One of the major limitations is the dependence of both LGE-MR imaging and 
voltage mapping methods on a set of empirical intensity thresholds for the identification of 
fibrosis [87]. 
6.5.3 Limitations 
In the study, all the CA lesions were applied simultaneously. However, in the clinic, they are 
applied in a sequential manner. This could potentially influence the outcome of virtual ablation. 
Furthermore, the virtual lesions were ‘perfect lesions’ that were fully transmural and maintain 
a complete conduction block. This is hard to achieve clinically and depends on the operator and 
the location of ablation. Previous studies have shown that incomplete lesions can prevent 
termination of AF and increase its recurrence [261,262]. Another limitation of this study is that 
our AF simulation workflow used the cross-filed protocol rather than fast pacing (e.g., by 
McDowell et al. [14]) to initiate AF. Although the workflow is designed to predict the ultimate 
RD anchoring sites rather than the initiation sites, the latter may also be important for AF 
termination and its recurrence prevention. However, our workflow could be easily adjusted to 
include fast pacing for the evaluation of both RD anchoring and initiation mechanisms. 
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For the LGE-MRI segmentation sensitivity test, we only considered the effects of change in 
one of the IIR thresholding parameters, which differentiates between fibrotic BZ and healthy 
tissue. A more thorough evaluation of the fibrosis segmentation is warranted in future studies. 
Besides, we have not assessed the sensitivity to varying electrophysiological properties of atrial 
tissue (e.g., conduction velocity and APD), which should also be addressed in the future.  
6.6 Conclusions 
This chapter demonstrates how patient-specific computational models could be used for 
successfully guiding CA treatment for AF termination. Simulations of the patient-specific LA 
models showed that RDs sustaining AF were localised at specific regions of fibrotic tissue 
(target areas), which potentially could be targeted to optimize CA. Performing virtual ablations 
on the target areas and connecting them to the nearest PVs or MV has superior anti-fibrillatory 
effect compared to ablating the target areas alone, as well as compared to clinically accepted 
strategies such as PVI. Success of the image-based computational identification of RDs and 
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Chapter 7  
Conclusions 
7.1 Summary 
AF is the most common cardiac arrhythmia and a huge healthcare problem, but its mechanisms 
are incompletely understood, and clinical therapies such as CA have poor long-term outcomes. 
The work presented in this dissertation was set out to evaluate the influence of patient-specific 
atrial structure on electrophysiological mechanisms, specifically the dynamics of re-entrant 
drivers (RDs) of AF. The study focused on atrial wall thickness (AWT) and atrial fibrosis, both 
of which can be reconstructed from medical imaging data and have been linked to atrial 
structural remodelling underlying the progression of AF. The specific aims of this study were 
to: 1) develop image-based 3D atrial models using patient MRI data, 2) apply the models to 
dissect the mechanistic links between atrial structure and RD dynamics, 3) use the simulation 
outcomes to quantify the ultimate patient-specific RD locations, and then 4) evaluate CA 
strategies that can efficiently terminate the RDs and may improve AF therapy in the clinic. 
7.2 Main Findings 
The main outcomes of the work are summarised below reflecting the structure of its chapters 
1. Sharp gradients in AWT determine the drift direction and anchoring locations of RDs.  
Basic effects of AWT gradients on the dynamics of RDs were investigated in Chapter 3. In this 
study, we used a 3D atrial tissue slab with an AWT step to explore how sharp AWT gradients 
can stabilise RDs. Moreover, we combined the AWT step with the presence of fibrotic tissue 
to explore how additional structural effects can influence the RDs. The key findings of this 
work were: (i) the sharp gradients of AWT act as anchoring locations for RDs; (ii) in the 
presence of fibrosis, the AWT step acts as a competing attractor for the RDs. The underlying 
mechanism that enabled anchoring of RDs to these locations was based on slow conduction, 
which was due to a large source-to-sink mismatch in regions of high AWT gradient and reduced 
cell-to-cell coupling in fibrotic regions. Our simulations showed that several factors influenced 
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the dynamics of RDs: the height of the step, the distance of the RD initiation site from the AWT 
step, as well as the relative distance of the RD initiation site from the step and the fibrotic patch. 
2. Patient-specific AWT gradients and fibrotic patches are important attractors of RDs. 
In Chapter 4, we investigated the influence of AWT gradients on the RD dynamics in realistic, 
image-based atrial geometries and evaluated the comparative effects of patient-specific AWT 
gradients and fibrosis distribution. To the best of our knowledge, this is the first study that 
compares such effects in realistic atrial geometries. In this study, we used MRI-based RA and 
LA geometries from 4 healthy volunteers and 2 paroxysmal AF patients. The key findings of 
this work were as follows: (i) in the RA, RDs stabilised around structural features with large 
AWT gradients, while the addition of fibrotic patches provided an alternative attractor for the 
RDs and (ii) in the LA, which had more uniform AWT distribution, the RD locations were 
determined by the distribution of fibrotic patches or by anatomical features such as the PVs. 
These findings may explain why CA in the RA often targets the crista terminalis, a thick ridge 
forming a prominent AWT gradient, while CA procedures in the LA focus on the PVs. 
3. RD locations in the LA can be identified from patient-specific fibrosis distribution.  
In Chapter 5, we focused on the effects of fibrosis on RD dynamics in the LA. Specifically, we: 
(i) developed 3D LA models with patient-specific geometry and distribution of fibrosis 
obtained from LGE-MRI of 6 AF patients, (ii) applied the models to explore the dynamics of 
RD stabilisation in the presence of slow-conducting fibrotic patches and (iii) generated patient-
specific maps of the RD locations, relative to the distribution of fibrosis, to identify potential 
targets for CA. The key finding of this work was that RDs were typically found at fibrotic 
regions in AF patients from Utah 3 and 4 categories with high FB (>25%), but more often near 
the PVs in patients from Utah 2 category. The RDs anchored to specific, relatively small 
regions, labelled as target areas, with a high percentage of target areas located within the fibrotic 
tissue region in patients from Utah 3 and 4 categories. Thus, the RD locations in patients with 
high FB were determined by unique patient-specific fibrosis distribution. Such locations were 
much smaller than the entire fibrotic area and may potentially be targeted by CA therapy. 
4. Image-based models enable evaluation of efficient virtual ablation strategies for AF.  
Chapter 6 used predictions of the image-based LA models to simulate and evaluate several CA 
strategies for terminating AF. Specifically, we (i) simulated virtual ablation of target areas 
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predicted from the models and compared its success with existing clinical CA strategies and (2) 
explored sensitivity of the predicted target area locations on the choice of LGE-MRI 
thresholding parameters. The main finding of this work was that performing virtual ablations 
of the target areas and connecting them with linear lesions to the nearest PVs or MV had 
superior anti-fibrillatory effect compared to ablating the target areas alone, as well as compared 
to clinically accepted strategies such as PVI. However, the success of the image-based 
computational identification of RDs and guidance of CA can also depend on the accuracy of 
fibrosis segmentation from patient LGE-MRI data. These findings provide an initial evaluation 
of the image-based computational tools that, after careful clinical validation, can potentially be 
used for the guidance of CA in AF patients.  
7.3 Future work 
The image-based computational workflow presented in this dissertation is a promising tool 
which can build up on mechanistic knowledge and help improve CA therapy in the future. To 
facilitate future clinical application, it needs to be further developed and clinically validated. 
First, the workflow can be extended to incorporate further patient-specific details, such as atrial 
fibre orientation and electrophysiological heterogeneity. Such details have been shown to play 
important roles in the genesis of AF [145,147,148], and their integration may substantially 
increase the predictive power of the models. However, limitations of existing imaging 
techniques hinder an adequate reconstruction of the complex atrial fibre architecture from 
patient data. High resolution ex-vivo imaging protocols [263] cannot be applied to AF patients 
in a clinical setting, while alternative strategies based on invasive electro-anatomical mapping 
suffer from poor atrial coverage and resolution [264]. Hence, future patient-specific modelling 
will be reliant on the improvement of imaging technology to reconstruct fibre orientations in-
vivo.  
Second, one of the strengths of the workflow is in the simple and efficient representation of the 
atrial electrophysiology using the Fenton-Karma model. This was chosen due to its ability to 
reproduce APD restitution properties of remodelled atrial cells at a low computational cost. 
This allowed us to perform a large number of 3D image-based simulations within a clinically-
compatible timescale. Moreover, simple, standardised electrophysiology across patient-specific 
models enabled an unbiased evaluation of the atrial structure effects on AF dynamics. Future 
studies could extend the existing workflow to incorporate more detailed models that capture 
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multiple ionic currents in an atrial cell, as well as regional differences in atrial cellular 
electrophysiology, such as the CRN model and its modifications [145,153]. Although such 
models are more computationally expensive, they may help provide more in-depth insights into 
the interplay between atrial electrophysiology and structure during AF. This will facilitate 
future population studies into the role of inter-patient variability in AF dynamics [265]. 
Moreover, future studies will also need to investigate the influence of electro-mechanical 
coupling in the atria on AF [266]. This would lead to the improved understanding of the impact 
of RDs on atrial contraction, as well as the effects of contraction of the underlying 
electrophysiology via the stretch-activate channels. 
Third, translating the workflow to the clinic will require a further reduction of the related 
computational costs. Possible solutions include the application of graphics processing unit 
(GPU) technologies, enabling fast simulation on desktop computers, and well as the 
development of deep learning inspired tools that could be used to increase the predictive 
capabilities of the computational framework. Recent work from our group demonstrated that 
deep neural networks could be used to reduce the use of computational atrial models and to 
predict optimal CA strategies directly from patient-specific imaging data [267]. Hence, future 
image-based computational workflows could integrate deep learning algorithms as a low-cost 
step that complements or replaces the 3D models.  
Finally, the workflow for identification of CA targets needs to be validated against patient-
specific electrophysiology datasets and tested prospectively in a large cohort of AF patients.  
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Chapter 8  
Appendix 
8.1 Numerical Implementation 
8.1.1 A single cell model 
The atrial cell models used in work presented in this thesis were: (i) atrial Fenton Karma cell 
model (aFK) and the modified Courtemanche-Ramirez-Nattel (CRN) model. Figure A. 1 below 
shows the comparison of APD90 restitution curves.  
 






Appendix    | 160 
 
 
8.1.2 3D action potential propagation 
3D geometries used for performing simulations in this thesis were: (A) a rectangular 3D slab 
(Chapter 3) and (B) patient-specific 3D geometries derived from MRI data (Chapter 4-6). In 
these geometries, the isotropic mono-domain equation (Chapter 2, Section 2.5.2.1, eq 2.17) was 
solved with no-flux boundary condition. The space (dx) and time step (dt) were set to of 0.3 
mm and 0.005 ms, respectively. The isotropic diffusion coefficient (D) in the model used was 
0.1 mm2/s for healthy tissue. While, the lowest D used for the model was 0.016 mm/ms for 
dense fibrotic regions. Von Neumann stability analysis (described in Chapter 2, section 2.5.3.2) 
















2(3) = 0.1667																			  
 0.0056 ≤ 0.1667  
 Numerical integration steps satisfy Von Neumann stability criterion   
 
To test the convergence of the numerical solution is space, a benchmark problem was designed 
based on Niederer et al. [268]. Briefly, the tissue geometry used was a 3D rectangular slab of 
dimension 3 ´ 7 ´ 21 mm (Figure A. 2). The mono-domain equation was solved four spatial 
resolutions (dx = 0.1, 0.2, 0.3 and 0.5 mm), each with a time step of 0.005 ms and no-flux 
boundary conditions. The AP propagation was simulated with an initial stimulus delivered to a 
region of volume 1.5 ´ 1.5 ´ 1.5 mm, located at the corner of the cuboid (Figure A. 2, (A), red 
box) at BCL of 400ms. The activation time (AT), defined as the time at which the membrane 
potential reaches its peak value (V=1), was recorded for each spatial step at the 10th beat. The 
results were compared by analysing the AT values along a diagonal line across the geometry 
(Figure A. 2, P1-P3). The ATs measured at the far edge P3 obtained with different spatial steps 
are summarised in Table A. 1. These calculations show that for the spatial step of 0.3 mm, the 
error with respect to solution for the smallest special step of 0.1 mm is within 10% [27]. 
Therefore, 0.3 mm a viable choice for the numerical implementation.           
 




Figure A. 2: The numerical convergence test. (A) A schematic image of the geometry used for the simulations. 
The initial stimulus was applied on the region in red and the activation time (AT) was measured along a line from 
P1 to P3 and the plot of the AT is shown in panel (B). 




0.1 31.80 - 
0.2 33.00 3.88 % 
0.3 34.30 7.86 % 
0.5 38.10 19.81 % 
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8.1.3 Implementation for RD Tip Tracking Algorithm 
In the main text, we defined the tip of the RD as the intersection between two successive iso-
potential surfaces, 𝑣'(𝒓) = 𝑉!&$	, where 𝑉!&$ is a convenient choice of iso-value  to differentiate 
between wavefront and wave-back, 𝒓 = (𝑥, 𝑦, 𝑧) is the position vector and, 𝑑𝑣(𝑟)/𝑑𝑡 = 0. The 
simulations are performed in discrete space (𝑑𝑥, 𝑑𝑦	and	𝑑𝑧 = 	𝛥) and time (dt) steps, and 
therefore, the problem of finding the intersection points can be represented with 
 𝑣'(𝒓) = 𝑣'26'(𝒓) = 𝑉!&$ A.1 
In 3D geometry, the intersection between two successive iso-potential surfaces is a line (also 
known as filament) defined by a series of points inside the geometry. In our discrete 3D 
geometry with equal spacing (𝑑𝑥, 𝑑𝑦	and	𝑑𝑧 = 	𝛥), a location (𝑥, 𝑦, 𝑧) corresponds to a cubic 
voxel (Figure A. 3, A) of side 𝛥, centred at a point given by 𝑥 = 𝑖𝛥, 𝑦 = 𝑗𝛥 and 𝑧 = 	𝑘𝛥. Each 
point on the filament can be identified by calculating the intersection points between the two 
iso-potential lines on the all the faces of a cube with sides (𝑥 = 𝑖𝛥, 𝑦 = 𝑗𝛥 and 𝑧 = 	𝑘𝛥) centred 
at	(𝑖 + 0.5, 𝑗 + 0.5, 𝑘 + 0.5). Each face is defined by a set of 4 grid points and the voltage (V) 
within each face of the cube can be estimated using bilinear interpolation.  
 
Figure A. 3: Bilinear interpolation to calculate the location of the RD tip. (A) A voxel with centre defined at the 
grid point (i,j,k) and edges of length 𝛥, which group together in 8 to form a cube centred at (𝑖 + 0.5, 𝑗 + 0.5, 𝑘 +
0.5) and (B) the tip of the RD calculated on the z plane of this cube, where points (p,q) are defined in the local 
coordinates. (C) the filament of the RD (in red) identified by calculating the tip of the RD (marked by a black 
circle) on all faces of a cube defined by 8 grid points in the geometry.  
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For simplicity, we first calculate the position of the RD tip on the face of the cube where 𝑧 =
	𝑘𝛥 (Figure A. 3, B). Here, we begin by converting the global coordinate system into a local 
system by defining local coordinates for each dimension, such that they vary between 0 and 1: 








Then the voltage at a location (𝑝, 𝑞), at time	𝑡	and	𝑡 + 1, using bilinear interpolation estimate 
for a point inside this rectangle is given by a weighted sum of the measured voltage values at 
the four corners (equation A.4 and A.5). The weighted can be written in terms of the local 
coordinates of the target point, (𝑝, 𝑞) as follows;  
𝑉!,#$ =	𝑉%,&,'$ (1 − 𝑝)(1 − 𝑞) + 𝑉%(),&,'$ (𝑝)(1 − 𝑞) + 𝑉%(),&(),'$ (𝑝𝑞) + 𝑉%,&(),'$ (1 − 𝑝)(𝑞)     A.4 
𝑉!,#$() =	𝑉%,&,'$()(1 − 𝑝)(1 − 𝑞) + 𝑉%(),&,'$() (𝑝)(1 − 𝑞) + 𝑉%(),&(),'$() (𝑝𝑞) + 𝑉%,&(),'$() (1 − 𝑝)(𝑞)     A.5 
The location for the tip of the RD can be found at the point where	𝑣(𝑝, 𝑞) = 𝑣'26'(𝑝, 𝑞) = 𝑉!&$. 
Therefore, both equations A.4 and A.5 must be equated to 𝑉!&$. After re-arranging, this leads 
us to the following equations A.6 and A.7.  
𝑝𝑞)𝑉%,&,'$ − 𝑉%(),&,'$ + 𝑉%(),&(),'$ − 𝑉%,&(),'$ * + 𝑞)𝑉%,&(),'$ − 𝑉%,&,'$ * + 𝑝)𝑉%(),&,'$ − 𝑉%,&,'$ *
+ )𝑉%,&,'$ − 𝑉𝑖𝑠𝑜* = 0 
A.6 
	𝑝𝑞[𝑉𝑖,𝑗,𝑘𝑡+1 − 𝑉𝑖+1,𝑗,𝑘𝑡+1 + 𝑉𝑖+1,𝑗+1,𝑘𝑡+1 − 𝑉𝑖,𝑗+1,𝑘𝑡+1 ] + 𝑞[𝑉𝑖,𝑗+1,𝑘𝑡+1 − 𝑉𝑖,𝑗,𝑘𝑡+1] + 𝑝[𝑉𝑖+1,𝑗,𝑘𝑡+1 − 𝑉𝑖,𝑗,𝑘𝑡+1]
+ [𝑉𝑖,𝑗,𝑘𝑡+1 − 𝑉𝑖𝑠𝑜] = 0 
A.7 
The main idea is that we solve for p and q, which satisfy both equations A.6 and A.7.  
Here, a detailed derivation of the steps involved is provided:  
First, for the simplification purpose, we replace the constants in equations A.6 and A.7 with 
notations summarised below in A.9, to get to equation A.10 and A.11. 
AC= 𝑉𝑖,𝑗,𝑘𝑡+1 − 𝑉𝑖+1,𝑗,𝑘𝑡+1 + 𝑉𝑖+1,𝑗+1,𝑘𝑡+1 − 𝑉𝑖,𝑗+1,𝑘𝑡+1  AD = 𝑉𝑖,𝑗,𝑘𝑡+1 − 𝑉𝑖+1,𝑗,𝑘𝑡+1 + 𝑉𝑖+1,𝑗+1,𝑘𝑡+1 − 𝑉𝑖,𝑗+1,𝑘𝑡+1  
A.9 
GC= 𝑉𝑖,𝑗+1,𝑘𝑡 − 𝑉𝑖,𝑗,𝑘𝑡  GD = 𝑉𝑖,+1,𝑘𝑡+1 − 𝑉𝑖,𝑗,𝑘𝑡+1 
BC	= 𝑉%(),&,'$ − 𝑉%,&,'$  BDC	= 𝑉%(),&,'$() − 𝑉%,&,'$() 
DC= 𝑉%,&,'$ − 𝑉𝑖𝑠𝑜 DD= 𝑉%,&,'$() − 𝑉𝑖𝑠𝑜 
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This leads us to: 
0 = (𝑝 ∗ 𝑞 ∗ 𝐴𝐶) + (𝑞 ∗ 𝐺𝐶) + (𝑝 ∗ 𝐵𝐶) + 𝐷𝐶     A.10 
0 = (𝑝 ∗ 𝑞 ∗ 𝐴𝐷) + (𝑞 ∗ 𝐺𝐷) + (𝑝 ∗ 𝐵𝐷) + 𝐷𝐷     A.11 
Second, subtraction of equation A.10 from A.11 after the multiplication with the terms 
represented by AD and AC, respectively, gives us equation A.12. 
𝑞 ∗ [𝐺𝐶 ∗ 𝐴𝐷 − 𝐺𝐷 ∗ 𝐴𝐶] + 𝑝 ∗ [𝐵𝐶 ∗ 𝐴𝐷 − 𝐵𝐷 ∗ 𝐴𝐶] + [𝐷𝐶 ∗ 𝐴𝐷 ∗ 	𝐷𝐷 ∗ 	𝐴𝐶]=0 A.12 
Third, simplification of equation A.12 by replacing some of the constant terms using notations 
summarised in A.13 leads to equation 14.  
𝑅 = 𝐺𝐶 ∗ 𝐴𝐷	 − 𝐺𝐷 ∗ 𝐴𝐶     𝑆 = 𝐷𝐶 ∗ 𝐴𝐷 − 𝐷𝐷 ∗ 𝐴𝐶     
A.13 
𝑄 = 𝐵𝐶 ∗ 𝐴𝐷 − 𝐵𝐷 ∗ 𝐴𝐶      
(𝑞 ∗ 𝑅) + (𝑝 ∗ 𝑄) + 𝑆 = 0     A.14 
Equation A.14 can be rearranged to the value of q, 
	𝑞 = −(𝑝 ∗ 𝑄𝑅) − 𝑆𝑅     A.15 
Here, 𝑄𝑅 = 𝑄/𝑅 and 𝑆𝑅 = 𝑆/𝑅   
The next step is replacing q in equation A.10 with equation A.15 and forming the final quadratic 
equation A.16 with only one variable p.  
𝑝4 ∗ (𝐴𝐶 ∗ 𝑄𝑅) + 𝑝 ∗ (𝐴𝐶 ∗ 𝑆𝑅 + 𝐺𝐶 ∗ 𝑄𝑅 − 𝐵𝐶) + (𝐺𝐶 ∗ 𝑆𝑅 − 𝐷𝐶) = 0     A.16 
In order to solve equation A.16, we replace the constants with notations summarised below in 
A.17, and get the final simplified equation A.18. 
	𝑇 = 𝐴𝐶 ∗ 𝑄𝑅     𝑈 = 𝐴𝐶 ∗ 𝑆𝑅 + 𝐺𝐶 ∗ 𝑄𝑅 − 𝐵𝐶 
A.17 
𝑉𝑣 = 𝐺𝐶 ∗ 𝑆𝑅 − 𝐷𝐶      
𝑝4 ∗ 𝑇 + 𝑝 ∗ 𝑈 + 𝑉𝑣 = 0   A.18 
The final step is finding the solution to this quadratic equation A.18. Here, we evaluate the 
discriminant (D, equation A.19). The value of D provides critical information about the number 
and nature of the solutions to the quadratic equation. 
𝐷 = √𝑈4 − 4 ∗ 𝑇 ∗ 𝑉𝑣     A.19 
𝑝 = 1S±√V
4∗X
     A.20 
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In this context, if the value of 𝐷4 is negative, this would mean that the solutions of equation 
A.18 are imaginary. Therefore, the tip of the RD does not lie within these set of selected pixels. 
However, if the value of 𝐷4 is positive, this would mean the solutions are real and the RD tip 
could be located here. The value of p can be found using equation A.20, and subsequently, the 
value of q can be computed from equation A.15. However, the final test before we can compute 
the tip location is testing whether the value of p and q lie between 0 and 1, i.e. the bounds of 
the selected voxels. If they are within these limits, then the location of the tip in terms of its 
Cartesian coordinates can be calculated using the following equations A.21-23. 
	𝑥 = (𝑖 + 𝑝)𝛥     A.21 
𝑦 = (𝑗 + 𝑞)𝛥     A.22 
𝑧 = 𝑘𝛥     A.23 
Next, we repeat the same steps to determine the intersection of the filament with the other faces 
of the cube, 𝑥 = 	𝑖𝛥	and	𝑦	 = 	𝑗𝛥,	in a similar way. After identification of tips across all faces 
of the cube, we get the entire filament of the RD in 3D (Figure A. 3, C) and track its location 
over time. An example of the tip tracking on voltage data on a slab is shown in Figure A. 4 
 
Figure A. 4: Tracking the RD filament over time. The tracking algorithm was implemented with a Viso of 0.8 and 
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8.2 Appendix to Chapter 3  
8.2.1 RD tip trajectories in 3D slab with varying AWT step 
 
Figure A. 5: Effects of changes in AWT step height and RD initiation location on the anchoring of RDs in 3D 
atrial slab (Study 1a) with aFK model. Tip trajectories obtained by initiating RDs at multiple locations on the thick 
(A) and thin (B) side of the 3D slab, while varying the height of the step (H1-4). (A) RDs initiated on the thick 
side of the slab first drift towards the AWT step, eventually crossing it and drifting along it on the thinner side 
with exception to H2, where the RDs terminated. (B)  RDs initiated on the thin side drifted towards the step and 
along it, but didn’t cross over to the thicker side. Note that the core of the RDs initiated beyond 4.5 mm on the 
thick side and 12 mm (H1-3) / 15 mm (H4) on the thin side were not sensitive to the step (panels on the right). 
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8.2.2 Anchoring of RDs in 3D slab with ATW step and fibrotic patch 
C
 
Figure A. 6: RD tip trajectories with the AWT step and fibrosis in a 3D atrial slab. The trajectories are shown for 
the initiation location H2 (Figure 4D of the main thesis) in the slab with AWT step only (A), fibrotic patch only 
(B), and both (C). In the first two cases, the RD anchored to the step and the fibrotic patch, respectively. However, 
in the latter case the RD stopped drifting and stabilised between the step and the fibrotic patch. Increasing the step 
height from H2 to H4 resulted in the RD drifting to the step (D), while increasing the distance from the step to the 
RD initiation site (from 7.5 mm to 15 mm) resulted in the RD drifting to the fibrotic patch (E).  
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8.3 Appendix to Chapter 5  
8.3.1 Anchoring of RDs at specific locations inside fibrotic patches  
 
Figure A. 7: The anchoring of RDs to specific locations inside fibrotic patches across patient-specific LA models.  
Simulation results are shown for 4 AF patients (rows) from different Utah categories. On the left (A1 - 4) are the 
colour-coded voltage maps and in the middle (B1 - 4) are the respective RD trajectories (orange) superimposed on 
the fibrosis distributions. On the right (C1 – 4) are the corresponding RD tip probabilities, indicating the exact 
regions of the patch where the RDs anchored. The yellow arrows indicate the direction in which the RD drifted. 
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8.4 Appendix to Chapter 6 







1 10.06 ± 0.19 6.25 ± 0.02 5.62 ± 0.01 4.14 ± 0.30 
2 7.90 ± 0.30 8.11 ± 0.09 8.11 ± 0.09 0 
3 10.06 ± 0.20 9.37 ± 0.03 9.37 ± 0.03 0 
4 9.87 ± 0.68 5.84 ± 0.30 5.62 ± 0.00 4.09 ± 0.31 
5 10.23 ± 0.32 9.37 ± 0.03 9.37 ± 0.03 4.12 ± 0.31 
6 10.21 ± 0.34 5.94 ± 0.31 4.36 ± 0.11 4.03 ± 0.31 
7 10.19 ± 0.32 5.87 ± 0.31 4.35 ± 0.13 4.04 ± 0.31 
8 10.10 ± 0.28 10.09 ± 0.25 10.08 ± 0.25 4.03 ± 0.31 
  Control TA TA+L PVI+TA+L 
  Patient 3 
   







1 10.03 ± 0.26 10.03 ± 0.26 10.03 ± 0.27 0 
2 10.07 ± 0.26 7.50 ± 0.11 0 0 
3 10.10 ± 0.28 10.10 ± 0.28 10.10 ± 0.28 4.64 ± 1.45 
4 10.12 ± 0.27 7.50 ± 0.09 0 0 
5 10.41 ± 0.31 6.22 ± 0.15 0 0 
6 10.10 ± 0.29 10.10 ± 0.29 10.10 ± 0.29 4.38 ± 0.00 
7 10.40 ± 0.34 10.14 ± 0.34 0 0 
8 10.43 ± 0.29 6.25 ± 0.07 0 0 
9 10.02 ± 0.21 10.02 ± 0.21 10.02 ± 0.21 10.02 ± 0.21 
10 9.62 ± 0.62 8.12 ± 0.10 0 0 
  Control TA TA+L PVI+TA+L 
  
Patient 2 
Table A. 2: The mean frequencies (MF) calculated before and after virtual CA in Patient 2 (bottom) and 3 (top). 
TA: target areas    
 




Figure A. 8: The termination of AF using ablation Strategies 3 and 4 in Patient 2. The RDs did not terminate 
following ablation strategy 3 in either case (A and C). However, the RD terminated following ablation Strategy 2 
in both cases, where the target areas where connected to the PV (B) and the MV (D).
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